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Abstract
For a long time microorganisms have been used to produce beer and bread, and in the
last century also molecules such as penicillin and insulin. These same microorganisms
can potentially be used to produce a diverse range of other molecules and contribute
to a more sustainable future by reducing our dependency on oil. Producing a given
molecule at a yield high enough to be commercially viable, however, usually requires
cell metabolism to be modified extensively. Traditionally, these modifications have
been introduced through random mutagenesis and selection, which has been gradually
complemented by more targeted genetic engineering approaches that rely more and
more also on computational models of cell metabolism for target selection. Two main
types of models can be used here, stoichiometric models or kinetic models. The former
are easily built at genome-scale and assume the cell to be in a steady-state, giving
information only about the reactions’ fluxes, while the latter take into account enzyme
dynamics which makes it possible to model substrate-level enzyme regulation and get
information about metabolite concentrations and reaction fluxes over time, although
at the cost of introducing more parameters. Kinetic models have been plagued by
the lack of kinetic data.
The focus of this thesis are kinetic models of cell metabolism. In this work we
start by developing a software package to create a model ensemble for individual
enzymes in metabolism, where we decompose each reaction into elementary steps,
using mass action kinetics to model each step. The resulting rate constants are then
fitted to kinetic data (kcat, Km, Ki, etc.). We then use the package as the basis to
build a system-level kinetic model. To do so, we take two different approaches, and
in both we drop the assumption that xfree ≈ xtot, i.e. that the total concentration of
metabolite in the cell is approximately the same as the free concentration. In both
approaches preliminary results show that the fraction of bound metabolite in the
cell is not negligible, with some metabolites having an enzyme-bound concentration
up to 40%. Next, we address the issue of kinetic data scarcity by using molecular
dynamics simulations to estimate the difference in binding energies, ∆∆G, between
v
substrate(s) and a given enzyme and product(s) and the same enzyme for a chosen
reaction. Here, we show that these in silico determined ∆∆G significantly reduce the
amount of rate constants combinations allowed in each model ensemble. Finally, we
combine a kinetic model of glycolysis in Saccharomyces cerevisiae with time-resolved
NMR experiments to study the cellular response to a glucose pulse, and show the
model simulations to be in agreement with the experimental results.
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Sammenfatning
Mikroorganismer har længe været anvendt til produktion af øl og brød, og gennem
det seneste århundrede også til fremstilling af molekyler som penicillin og insulin.
Disse mikroorganismer kan potentielt også bruges til at producere en bred vifte af
andre molekyler, og derved bidrage til en mere bæredygtig fremtid ved at reduc-
ere vores afhængighed af olie. At producere et givent molekyle med et udbytte der
er højt nok til at være kommercielt levedygtigt, kræver dog som regel at cellens
metabolisme modificeres radikalt. Traditionelt er disse modifikationer blevet udført
ved hjælp af tilfældig mutagenese og selektion, hvilket gradvist er blevet komple-
menteret af mere målrettede genteknologiske metoder, der samtidig afhænger mere
og mere af computermodeller af metabolismen til at udvælge targets. Der er to hov-
edtyper af modeller, der kan anvendes i denne sammenhæng: støkiometriske modeller
og kinetiske modeller. Førstnævnte kan let konstrueres på genom-skala og antager
at cellen er i steady-state. Dette giver kun information om reaktionernes flux, hvo-
rimod sidstnævnte medregner enzymdynamik, hvilket gør det muligt at modellere
enzymregulering på substratniveau, og få information om metabolitkoncentrationer
og reaktionsflux over tid. Kinetiske modeller har dog længe været plaget af mangel
på kinetiske data.
Fokus for denne afhandling er kinetiske modeller af metabolismen i celler. Vi
har udviklet en softwarepakke til at lave et ensemble af modeller for individuelle
metaboliske enzymer. Hver reaktion blev opdelt i elementære trin ved hjælp af mass
action kinetik til at modellere hvert trin. De resulterende hastighedskonstanter kunne
herefter fittes til kinetisk data (kcat, Km, Ki, etc.). Herefter anvendte vi denne pakke
som grundlag for at konstruere en systemisk kinetisk model. Til dette anvendte vi to
forskellige fremgangsmåder, hvor vi i begge tilfælde udelod antagelsen at xfri ≈ xtotal,
altså at den totale koncentration af metabolit i cellen tilnærmelsesvis er lig den frie
koncentration. Ved begge fremgangsmåder viste foreløbige resultater at fraktionen
af bundet metabolit i cellen ikke er ubetydelig, hvor nogle metabolitter havde en
enzymbunden koncentration på op til 40% at den totale koncentration. Herefter
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arbejdede vi på at løse problemet med mangel på kinetisk data, ved at anvende
molekylære dynamiske simuleringer til at estimere forskellen i bindingsenergi, ∆∆G,
mellem substrat(er) og et givent enzym samt mellem produkt(er) og det samme enzym
for en udvalgt reaktion. Vi viser her, at denne in silico-bestemte ∆∆G signifikant
reducerede antallet af kombinationer af hastighedskonstanter der er tilladt i et model-
ensemble. Endelig kombinerede vi en kinetisk model for glykolysen i Saccharomyces
cerevisiae med time-resolved NMR eksperimenter for at studere den cellulære respons
på en glukose-puls, samt for at vise at model simuleringerne var i overensstemmelse
med de eksperimentelle resultater.
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Chapter 1
Introduction and synopsis
With the widespread use of high throughput technologies that allow for, e.g. the
sequencing of a cell’s whole genome or the measurement of its metabolome, a more
holistic approach is needed to understand the cell’s inner workings. Systems biology
is such an approach, which aims at studying the whole system rather than studying
each component individually. To make sense of the large amount of data produced
by omics technologies, computational models are often used. A common approach to
study the interactions between different cellular components is to model the system
as a network. Three major types of networks can be distinguished: 1) gene regu-
latory networks, capturing the interactions between transcription factors and genes,
2) signaling networks, modeling signal transduction from cellular receptors to tran-
scription factors, and 3) metabolic networks, encompassing the biochemical reactions
that convert various substrates into products. All three networks are encoded in the
genome of a cell. Furthermore, all three networks are interconnected, since extra-
cellular signals received by the cell are carried down to transcription factors which
affect gene expression, which in turn will affect protein/enzyme expression, while
metabolic reaction products also affect gene regulation by modulating the activity of
transcription factors. Due to computational limitations, these networks are generally
studied separately, although different approaches have been developed to study the
interactions between some of these networks [7, 32, 35], and a whole cell model has
been recently created for Mycoplasma genitalium [25]. In this work we will focus on
metabolic networks.
Cell metabolism encompasses the set of biochemical reactions that transform sub-
strates into products. These reactions are catalyzed by enzymes which transform, for
instance, sugars into the various building blocks of a cell, e.g. nucleotides, amino acids,
and lipids. Understanding cellular metabolism is key to understanding a wide range
1
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of diseases, e.g. the high glycolytic rate exhibited by cancer cells under aerobic condi-
tions commonly known as the Warburg effect [72] or the various monogenic disorders
described in Garrod’s ’Inborn errors of metabolism [19]. Understanding metabolism,
however, is not only important to cure disease but also holds the promise to a more
sustainable world, by engineering microorganisms to produce the myriad of chemicals
we rely on.
Microorganisms have long been used to produce beer or make bread, and during
the past century they have also been adopted to produce pharmaceuticals such as
penicillin or insulin. However, to produce non-native molecules or increase yields
to a point where they become commercially viable, the cell metabolism needs to be
manipulated. While in the past this was done mostly through random mutagenesis,
now a more rational strain design approach is followed where it is common to use
computational models to guide experiments and develop industrial strains [2, 34].
1.1 Computational models for cell metabolism
Computational models of cell metabolism can be divided in two main types: sto-
ichiometric models and kinetic models. Stoichiometric models consist basically of
the set of biochemical reactions encoded by the organism’s genome. To build such
a model all we need is the organism’s genome and respective annotation to know
which enzymes can in principle be expressed by the cell. Once the model is built, we
can use constraint-based methods to predict phenotypic states using the model. A
key assumption used in stoichiometric models is that the system is in a steady-state,
i.e. metabolite and enzyme concentrations are constant over time, therefore we can
only get information about the metabolic fluxes through the model’s reactions. A
commonly used constraint-based method is Flux Balance Analysis [14, 39], where an
objective function is either maximized or minimized subject to the steady-state con-
dition and, if known, lower and upper bounds on the reactions’ fluxes. The objective
function typically represents cell growth or ATP production. Other methods, such as
MOMA [64] or ROOM [65], can also be used to assess the impact of gene knockouts.
Stoichiometric models can be used to improve cell factory performance [43, 2, 34],
as well as to understand disease mechanisms [38, 43, 49] and predict drug targets [29,
36]. However, while these models are relatively easy to build at genome scale, they
don’t usually account for substrate-level enzyme regulation, which tends to lead to
2
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erroneous predictions, often overproduction of the molecule of interest [27], as regula-
tion imposes a lower upper limit on reactions’ fluxes. Approaches to take into account
substrate-level enzyme regulation have recently been developed [42, 56], however, a
more straightforward way to account for substrate-level enzyme regulation is to use
kinetic models.
Kinetic models are built on top of stoichiometric models by taking into account
the dynamics of the system, i.e. changes in metabolite concentrations and reactions’
fluxes along time, by modeling the kinetics of the catalyzing enzymes. A kinetic
model has the general form
dx
dt
= Sv(E,k,x,Keq)
where S is the stoichiometric matrix encoding reaction stoichiometry and v are
rate laws that model each reaction’s flux. Rate laws v are usually functions of metabo-
lite and enzyme concentrations (x and E) as well as enzyme-dependent kinetic pa-
rameters k. Sometimes they also include thermodynamic information in the form of
equilibrium constants Keq that are independent of the respective enzymes.
Michaelis-Menten rate laws [44] have been widely used to model metabolism, as
these account for enzyme saturation and, for reactions without inhibitors or activa-
tors, depend only on either two or three parameters. Either the turnover constant,
kcat, the half saturation constant, Km, and the enzyme concentrations, Etot, are mea-
sured explicitly or the saturating flux, Vmax = [Etot] ·kcat and the half saturation con-
stant, Km, are measured instead. The enzyme concentration is typically a constant
in metabolic models. These parameters are fairly easy to characterize in vitro. If the
enzyme is known to be inhibited or activated by other metabolites, additional inhibi-
tion/activation constants and inhibitor/activator metabolite concentrations need to
be measured as well. Yet, Michaelis-Menten kinetics do not account for allostery, and
the Monod-Wyman-Changeux (MWC) [48] or the Koshland, Nemethy and Filmer
(KNF) [31] models need to be used, e.g. by coupling Michaelis-Menten rate law
with the MWC model following the generalized MWC model [53]. Recently, a more
general type of rate law, convenience kinetics [41], was proposed. These rate laws
have similar form to Michaelis-Menten rate laws but model enzyme allostery while
requiring a similar amount of parameters and being thermodynamically consistent.
Due to kinetic data scarcity, however, rate law parameterization is one of the major
bottlenecks in kinetic model construction. Over the years, other simplified rate laws
3
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have been developed that still model the enzyme kinetics while relying on less pa-
rameters, examples are log-lin [21], lin-log [71], S-systems [62], or generalized mass
action, however, these do not necessarily satisfy thermodynamic constraints. On the
other hand, mechanistic approaches have recently been used to build more detailed
kinetic models [69, 57, 58, 28] at the cost of introducing more parameters.
1.2 Kinetic modeling approaches
Independently of the chosen rate laws, approaches to build a kinetic model can be
roughly divided into top-down or bottom-up approaches. In a bottom-up approach,
each enzyme reaction is parameterized individually and all enzymes are then com-
bined to form a systems-level model, while in a top-down approach the whole system
is parameterized globally instead of reaction by reaction. Bottom-up approaches typ-
ically rely on in vitro measured parameters, kcat, Km, Ki, to parameterize the model’s
rate laws. This approach has two main drawbacks though, as in vitro measurements
are often performed under non-physiological conditions thus often not reproducing
the in vivo behavior, and different parameters are often measured under different
conditions, e.g. different pH or temperature, therefore hampering a correct descrip-
tion of the in vivo system. Teusink et al. [68] built a kinetic model for glycolysis in
Saccharomyces cerevisiae by gathering kinetic parameters from the literature which
were measured in vitro, and showed the model was not always able to reproduce the
in vivo behavior.
To alleviate this issue, kinetic parameters should be measured in conditions that
mimic the in vivo conditions as closely as possible [70, 13, 66]. Another option is to
adjust the kinetic parameters to reproduce the in vivo behavior [54], in a way similar to
a top-down approach. Top-down approaches avoid incompatibilities between kinetic
parameters by fitting the kinetic parameters to omics data, thus in principle, modeling
the in vivo behavior better. However, these approaches require a large amount of
data and are computationally challenging, as they require fitting algorithms capable
of fitting dozens of parameters at once. Also, identifiability issues arise [18] when
insufficient data is available, which may lead to overfitting. Nevertheless, kinetic
models built in a top-down fashion can still produce accurate predictions without
precise parameters [20].
In reality though, models are often built by combining bottom-up and top-down
approaches. For instance, when using Michaelis-Menten rate laws to build a model
it is common to include the kinetic parameters whose values are known and then fit
4
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the remaining parameters simultaneously to omics data, or to simply re-adjust the
experimental kinetic parameters to omics data [26, 8, 46].
Several approaches/frameworks have been proposed to build kinetic models over
the years, examples are MASS [24], ORACLE [47], Ensemble Modeling (EM) [69],
and GRASP-ABC [59, 57].
In the MASS (Mass Action Stoichiometric Simulation) framework, mass action
kinetics are used to model each reaction, where the reverse rate constant is substituted
by the reaction’s equilibrium constant, and fluxomics and metabolomics data are used
to calculate the forward rate constant, a pseudo-elementary rate constant (PERC).
This approach cannot predict network states too far from the initial state, however,
it is scalable to genome scale.
ORACLE, Optimization and Risk Analysis of Complex Living Entities, is another
approximate yet scalable approach,. ORACLE relies on stoichiometric and thermo-
dynamics constraints plus metabolomics and fluxomics data, to build a population
of models that are thermodynamically and stoichiometrically consistent by sampling
metabolite concentrations and enzyme elasticities.
Ensemble modeling (EM), as described in [69], on the other hand, uses elementary
reaction mass action kinetics, where each reaction is decomposed in elementary steps
according to its mechanism. Here, rate constants are defined in terms of reversibil-
ities and scaled enzyme form concentrations, i.e. the total enzyme concentration
measured experimentally is decomposed into free enzyme and enzyme bound to dif-
ferent substrate(s)/product(s). By sampling reaction reversibilities and scaled enzyme
form concentrations, different sets of rate constants are obtained that reproduce the
original experimental data equally well, resulting in a model ensemble. This model
ensemble is then reduced by adding more experimental data. By considering a set
of models that reproduce the original data similarly well, the EM formalism avoids
overfitting and is able to predict metabolic states far from the initial one, unlike
MASS or ORACLE. EM was applied in to build kinetic models for Escherichia coli.
However, more generally, a model ensemble may refer simply to a set of models with
the same structure and different parameter values. For instance, in [37, 26] model
ensembles were built by sampling different parameter values for each model to address
parameter identifiability issues.
Recently, Saa and Nielsen [59, 57], introduced the GRASP, General Reaction
and Assembly Platform, framework combined with Approximate Bayesian computa-
tion (ABC). In this approach GRASP is used to generate a set of stoichiometrically
and thermodynamically consistent models as priors for the ABC optimization part.
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GRASP does so by decomposing each reaction flux as the product of a catalytic and
a regulatory function, where the catalytic function is built in a similar way to the EM
formalism described above while the regulatory function is based on the generalized
MWC model [53]. Once the set of model candidates is produced, the ABC approach
is used to produce a set of models that fit the experimental omics data.
Recent approaches have combined kinetic information with stoichiometric models
in order to improve predictions. For instance, k-OptForce [11] includes kinetic data
for given reactions in the stoichiometric model to improve model predictions, while
GECKO [60] integrates kcats and enzyme concentrations for each reaction in the
stoichiometric model by defining an extra constraint: v ≤ kcat [E]. This leads to
improved predictions and a decrease in flux variability in more than 60% of the
reactions.
1.2.1 Software for kinetic modeling
Different software/web applications are available to build, simulate, and analyze ki-
netic models. Perhaps the most widely used software application being COPASI [22].
With COPASI we can build, simulate, and analyze kinetic models. When building a
model we can use predefined rate laws and estimate parameters using the methods
provided, which include genetic algorithms, particle swarm, derivative based methods
such as the Levenberg-Marquardt algorithm, among others. The same methods used
for parameter estimation, can also be used for general optimization tasks. Methods
available for model analysis include Metabolic Control Analysis (MCA), sensitivity
analyses of which MCA if part of, time-scale decomposition analysis, calculation of
Lyapunov exponents, linear noise approximation to estimate the covariance between
particle numbers of different species, etc. Furthermore, COPASI is able to perform
both deterministic and stochastic model simulations, as well as a hybrid approach
where only some reactions are simulated stochastically. COPASI not only has a
friendly graphical interface, but can also be run from the command line and pro-
vides bindings for different programming languages, e.g. Python or Java. PySCeS
[50] is another software package implemented in Python suited for model simulation,
structural and bifurcation analysis, which also supports MCA, and parameter scans.
While both COPASI as PySCeS are stand-alone tools that run oﬄine in the user’s
computer, JWS Online [51] is a user friendly web application that provides most
features available in PySCeS but online, without the need of installing a program.
Besides, JWS allows one to build their own model and includes a database of curated
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models. Yet, note that the model database included in JWS is not as comprehensive
as the Biomodels Database . More focused on parameter estimation and identifia-
bility analysis is the AMIGO toolbox [3] which is implemented in Matlab. On the
same line, SensA [15] is a web application that allows the user to upload an SBML
model and do sensitivity analysis, from local to time-dependent sensitivity analysis.
While the above mentioned software solutions focus mostly on model simulation and
analysis, CellDesigner [16] focuses on the process of building the model. It allows
the user to draw a model on a canvas which is then converted into an SBML model.
One can also add rate laws and mathematical equations to these models, which can
also be simulated through CellDesigner. Additionally CellDesigner supports param-
eter search as well. Another application aimed at helping non-expert users create
kinetic models is SYCAMORE [73]. It is a web-based application and interfaces with
BRENDA [52] and SABIO-RK [74] (both are databases that contain kinetic data)
to obtain the required kinetic parameters and equations to build a kinetic model.
Moreover, it provides access to parameter estimation based on protein structure [17].
Once the model is built sensitivity analysis can be performed, and the model can be
simulated through COPASI on the SYCAMORE server.
All software/web applications mentioned above are compatible with SBML [23],
the standard format to store systems biology models. Note that there are many more
software solutions for kinetic modeling than the ones mentioned above though [12,
10, 61, 63, 55, 73].
1.3 Thesis motivation and organization
Motivation
Traditional bottom-up kinetic models are usually based on approximate rate laws
whose parameters are estimated through in vitro experiments, which do not always
reproduce the in vivo measured data without parameter adjustment [68, 54, 13, 66,
46]. While top-down kinetic models generally suffer from parameter identifiability
issues, resulting in “sloppy” parameters [20, 58]. Therefore, in this thesis we propose
a new formalism to build kinetic models that bridges both approaches and aims at a
more accurate description of the metabolism dynamics.
We first propose a formalism to model each enzymatic reaction individually which
avoids assumptions such as the quasi-steady-state or rapid equilibrium assumptions
underlying Michaelis-Menten kinetics (see Chapter 2). In this formalism we model
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each enzymatic reaction individually by decomposing the reaction into elementary
steps according to the enzyme mechanism and generating a mass action rate law for
each step. Thus, we avoid implicit assumptions regarding the enzyme mechanism.
This results in several elementary rate constants k, which are then fitted to kinetic
data obtained from literature, e.g. kcat, Km, Ki, while being constrained by the
respective Haldane relation [1] and equilibrium constant. This ensures that the gen-
erated rate constants are stoichiometrically and thermodynamically consistent. We
term this formalism elementary MASS (eMASS), as it is based on the MASS formal-
ism [24] but decomposes all reactions into elementary steps and not just regulatory
reactions. Following this formalism we can also account for kinetic data measured
under different conditions, e.g. different cosubstrate concentrations, pH, or temper-
ature. Finally, because the kinetic data used to fit the model can be reproduced
equally well by different elementary rate constant k sets, we end up not with a single
model but with a model ensemble per enzymatic reaction.
In Chapter 3, we build a prototype model ensemble for eight enzymes in Es-
cherichia coli’s glycolysis. We take two different approaches there and compare the
results. In a first approach we integrate fluxomics data with each enzyme-level kinetic
model generated through eMASS to get fully functional enzyme-level kinetic models.
We then define the system-level model to be the combination of the enzyme-level ki-
netic models. However, for some metabolites, this resulted in a non-negligible amount
of metabolite bound to the enzyme, i.e. the assumption xfree ≈ xtot typically made
when building kinetic models, does not necessarily hold. Free metabolite concentra-
tions are represented by xfree, while xtot represents the total metabolite concentration
in the cell (both free and bound to enzymes). Knowing that mass spectrometry tech-
niques currently used to measure absolute metabolite concentrations cannot distin-
guish free intracellular metabolites from enzyme-bound metabolites [5, 4, 26, 6], we
develop a new approach to integrate the enzyme-level models that distinguishes free
metabolite from total metabolite concentrations. Hence, we take the enzyme-level
models, define the flux distribution, and sample total enzyme and free metabolite
concentrations that reproduce the systems-level fluxomics data. Thus, starting from
a base ensemble of models for each enzymatic reaction, this approach is able to fit
different phenotypes simply by integrating the respective fluxomics data. Preliminary
results show that up to 40% of the total metabolite concentration can be bound to
enzyme, a finding that raises concerns about the commonly used assumption that the
fraction of bound metabolite is negligible in metabolomics data.
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Next we address the issue of kinetic data scarcity in Chapter 4. In particular, we
use MM-PBSA [67, 30] to estimate the difference in binding energies, ∆∆G, between a
given enzymatic reaction’s product(s) and substrate(s). We did this for three enzymes
in E. coli’s central carbon metabolism and integrated the resulting ∆∆G with the
respective enzyme-level kinetic models. We show a considerable reduction in the
number of combinations of elementary rate constants allowed for each model ensemble.
The same approach can be used to integrate the effect of enzyme point mutations in
kinetic models [45].
Finally, in Chapter 5, we collaborated with experimental scientists to study the
cellular response of Saccharomyces cerevisiae to different glucose pulses. Metabolite
time-courses were measured by hyperpolarized NMR spectroscopy in three different
experiments: a) a glucose pulse, b) a glucose + acetaldehyde pulse, and c) a glucose +
ethanol pulse experiment. We used a published model for S. cerevisiae’s glycolysis [66]
to simulate the pulse experiments and compare the accumulation in intermediate gly-
colytic metabolites to the change in the NAD+/NADH ratio. The simulation results,
consistent with the experiments and the literature, corroborate the hypothesis that
accumulation of different metabolites may be driven by changes in the NAD+/NADH
ratio.
Thesis outline
This thesis is divided into the following chapters:
Chapter 2 Describes eMASS and respective implementation as a software package,
MASSef. It is based on the article: Daniel C. Zielinski*, Marta R.A. Matos*, James E.
de Bree, Nikolaus Sonnenschein, Bernhard O. Palsson. Bottom-up parameterization
of enzyme rate constants using corrected enzyme kinetic data (in preparation).
Chapter 3 Construction of a prototype model ensemble using eMASS and eMASS2
which address free vs. total metabolite concentrations. It is based on the article:
Marta R. A. Matos, Daniel C. Zielinski, Bernhard O. Palsson, Nikolaus Sonnenschein,
Elementary Mass Action Stoichiometric Simulation models predict non-negligible frac-
tions of enzyme-bound metabolites (in preparation).
Chapter 4 Integration of relative binding energies estimated through molecular
dynamics with enzyme-level kinetic models. It is based on the article: Marta R. A.
Matos, Nathan Mih, Daniel C. Zielinski, Bernhard O. Palsson, Nikolaus Sonnenschein,
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Elizabeth Brunk. Using molecular dynamics simulations to parameterize models of
enzyme reaction kinetics (in preparation).
Chapter 5 Integration of NMR data with a kinetic model of S. cerevisiae glycolysis
to study the cellular response to different glucose pulses. It is based on the article:
Pernille R. Jensen, Marta R. A. Matos, Nikolaus Sonnenschein, and Sebastian Meier.
Reaction control is altered on the seconds timescale in pre-steady state glycolysis: a
rapid injection NMR study and its computational simulation (ready for submission).
Chapter 6 Summary of the work done in this thesis, discussion of the difficulties
faced in each project and presentation of possible solutions and future work.
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Chapter 2
Bottom-up parameterization of
enzyme rate constants using
corrected enzyme kinetic data
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Abstract
Biochemical kinetic models are becoming increasingly useful in solidify-
ing theoretical understanding of biological processes. Due to a number
of issues, including nonlinearity and poor scaling, parameterizing these
models has generally been difficult. Top-down methods such as param-
eter sampling and system-level fitting have largely been adopted to deal
with data gaps. However, bottom-up methods have the advantage of
utilizing the vast amount of measured kinetic data, if challenges such
as gaps in data and in vitro to in vivo differences can be overcome.
Here, we introduce eMASS (elementary Mass Action Stoichiometry Sim-
ulation), a computational workflow for the robust calculation of rate con-
stants of enzyme-level kinetic models that fit kinetic data while taking
into account uncertainty. The eMASS framework is implemented as a
software package, termed MASSef (Mass Action Stoichiometry Simula-
tion enzyme fitting), and can handle the majority of standard enzyme
parameters, including, Km, kcat, Ki, Keq, and nH . Furthermore, the
approach can use the media conditions under which the data was mea-
sured to handle different co-substrate concentrations and perform cer-
tain corrections for ion binding and assay temperature to in vivo-like
conditions when possible. We provide four case studies demonstrating
the approach for various inhibition schemes, enzyme activation, different
kinetic behavior, and temperature correction. The code is provided in
the MASSef package (https://github.com/martamatos/MASSef) built on
top of the MASS Toolbox (http://opencobra.github.io/MASS-Toolbox/)
in Mathematicar. The determination of biochemical elementary reac-
tion parameters is a fundamental pursuit in understanding the genotype-
phenotype relationship mechanistically and should support further efforts
towards prospective modeling of emergent network behavior.
2.1 Introduction
There has been a resurgence of interest in the construction of large-scale kinetic mod-
els of metabolism for model organisms in recent years [38, 27, 23]. These models hold
promise in a number of applications that other models, such as stoichiometric models,
have difficulty addressing, for instance the role of metabolite concentrations and al-
losteric regulation in the control of metabolic flux [26, 4, 35, 7]. However, the primary
issue impeding the development of practical large-scale kinetic models of metabolism
is the need for a large number of kinetic parameters, the vast majority of which have
not been experimentally measured [18]. These additional parameters arise because
kinetic models require specification of reaction rate laws, which generally contain
initial metabolite concentrations, enzyme concentrations, reaction equilibrium con-
stants, and various kinetic constants. However, the majority of models are condition
specific and include inherent assumptions, making their generalizability and scala-
bility uncertain. Biochemical reactions fundamentally occur via elementary reaction
steps with rate laws that are often of a known form but have unknown parameters.
A number of approaches for the parameterization of kinetic models of metabolism
have been developed. These approaches can be loosely classified into sampling, top-
down, and bottom-up methods, based on the type of data used to parameterize
the model. Sampling methods randomly sample parameters in particular expected
ranges, sometimes with certain constraints such as thermodynamic consistency en-
forced in the sampling procedure [33, 28, 41]. Top-down parameterization methods
use data on the kinetic behavior of the entire system and parameterize the entire
model simultaneously to match this data [6, 41, 23]. Both sampling and top-down
methods can efficiently define the large number of parameters required by a kinetic
model. Further, a number of software tools are available for parameterization using
these methods [1, 15, 19, 14]. However, these methods can suffer from the potential
issues related to limited predictability due to either attempting to sample too wide
a parameter space in the case of sampling methods, or having too many parameters
for the limited amount of data, resulting in overfitting in the case of system-level
parameterization. Both of these issues raise problems in the ability of these models
to accurately predict system behavior in new conditions. Bottom-up methods on the
other hand use data related to the individual components of the network to con-
struct a model piece by piece. Bottom-up methods have the advantage of utilizing
the vast amount of historical enzyme data [30, 9]. However, there are a number of
difficulties with bottom-up construction of kinetic models that have impeded their
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development. First, the majority of enzymes do not have detailed kinetic assays per-
formed to measure the required kinetic parameters to construct such models. As
a result, kinetic models are often highly underdetermined and methods to estimate
missing parameters must be developed [24]. Also, enzyme kinetics are often mea-
sured under non-physiological conditions, raising questions about their relevance to
modeling in vivo systems [39, 12, 42, 16]. However, recent high-throughput studies
have shown substantial correlations between in vivo and in vitro kinetic parameters,
supporting the use of available enzyme kinetic data [10, 5]. Furthermore, model-
ing studies attempting to build kinetic models from single enzyme information have
been fairly successful [20, 42, 37]. Thus, it appears that bottom-up methods may
be promising complementary alternatives for the construction of large-scale kinetic
models of metabolism if current challenges can be overcome.
Here, we present a computational workflow that attempts to address a number
of open issues with bottom-up construction of kinetic models of metabolism. This
workflow is based on the Mass Action Stoichiometric Simulation (MASS) framework
[21]. However, the focus here is not on modeling each reaction with generalized mass
action rate laws and use omics data together with equilibrium constants to parame-
terize the model. Instead, we parameterize enzyme-level kinetic models where each
reaction is decomposed into elementary reactions according to the enzyme mecha-
nism, which are then modeled by a mass action rate law. Therefore we call this
workflow elementary MASS (eMASS). By using eMASS we parameterize rate con-
stants in a manner that satisfies a variety of measured enzyme data types, accounts
for parameter uncertainty, and allows the correction of data to in vivo-like condi-
tions where data is available. This workflow is implemented as a software package
in Mathematicar termed MASSef (Mass Action Stoichiometry Simulation enzyme
fitting). There are three core features of this software package: 1) a symbolic algebra
system that generates equations for comparison despite the complexity of the enzyme
mechanism, 2) a data processing procedure that utilizes reported experimental condi-
tions to handle different co-substrate concentrations and allow biophysical corrections
to in vivo-like conditions where possible, and 3) robust nonlinear optimization to fit
the model to data while accounting for uncertainty. We first present an overview of
the computational workflow for parameter fitting before discussing the details of in-
dividual components, and then present four case studies demonstrating the workflow
for enzymes with different available kinetic data and regulation.
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2.2 Results
Overview of computational parameter fitting pipeline
eMASS is divided into five key steps, which are shown in Figure 2.1. 1) Gather
enzyme data to be used in rate constant fitting and annotate experimental conditions.
Data point weights are defined by the user, which determine the weighting of each
data point in the fitting procedure. 2) The enzymatic reaction is decomposed into
elementary steps by the user according to the respective enzyme mechanism, and a
mass action rate law is generated for each elementary reaction. 3) Using the generated
rate laws, define equations corresponding to the data points that are to be fitted in
step 5. 4) Process the data to be fitted with experimental conditions in a way that
allows direct comparison to the equations defined in step 3. 5) Fit the equations
defined in step 3 to the processed data in step 4 using a multi-step nonlinear least
squares optimization. We repeat this optimization N times and cluster the resulting
rate constant sets to try and identify a reduced number of characteristic rate constant
sets for the enzyme. Optionally, to build a fully functional enzyme-level ODE model,
a final step can be to integrate metabolomics data and either fluxomics data or
proteomics data. We will use enolase (ENO) to exemplify some of the steps.
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Figure 2.1: Workflow for parameterization of rate constants using enzyme kinetic
data. This workflow consists of five steps: 1) Gathering and curating kinetic data,
2) defining an enzyme mechanism, 3) processing kinetic data and correcting it to in
vivo-like conditions, 4) defining equations that relate model behavior to each data
type, 5) a nonlinear least-squares optimization to identify rate constant sets that fit
available kinetic data.
Preparation of enzyme kinetic data
First, kinetic data on enzymes is gathered, curated, and placed into a table in a
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Parameter Value Reference (PMID)
EC number 4.2.1.11 -
Organism E. coli -
Reaction 2PG
 PEP +H2O -
Mechanism Null -
# Subunits Null -
#Active sites 2 11676541
#Allosteric sites 2 11676541
(a)
Parameter Weight Metabolite Co-substrate Value Uncertainty Units T (C) pH Buffer Salts Reference
(PMID)
Keq 1 2PG - 5.19 [4.9305,
5.4495]
Null 25 7.5 - - eQuilibrator
kcat 1 2PG - 330 [313.5, 346.5] s−1 30 8.1 trishcl, 0.05 Cl, 0.1;
K, 0.1
estimated
Km 1 2PG Mg2+, 0.001;
SO4, 0.001
0.0001 [0.000095,
0.000105]
M 30 trishcl, 0.05 Cl, 0.1;
K, 0.1
4942326
(b)
Table 2.1: (a) Data relative to the reaction overall and the enzyme structure. (b)
Available kinetic data for ENO and conditions in which it was measured.
standard format. Data types currently handled include enzyme structure, reaction
stoichiometry, reaction mechanism, reaction equilibrium constant, Keq, dissociation
constants, Kd, and standard initial rate kinetic assay constants such as Km, kcat,
and Ki. For reaction equilibrium constants and initial rate constants, experimental
data such as media conditions, pH, and temperature are also extracted for possible
use in data adjustments to in vivo-like conditions, as discussed later. Data point
weights are set in a continuous range as determined by the user. This allows the user
additional control over how heavily to consider data that may be conflicting with
other data measurements or have other reliability issues. Additionally, data point
weights can be used to distribute the error between the measured data points and the
values predicted by the model more evenly. Instead of, e.g. fitting data points with
high absolute values better than data points with low absolute values. This will be
illustrated later in the case studies.
For ENO the available data is shown in Table 2.1.
Specify the enzyme mechanism
A mechanism for the enzymatic reaction is to be specified by the user, including
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binding of substrates to the enzyme, conversion, and product release. As these reac-
tion steps do not proceed through a single transition state, we do not consider them to
be true elementary reactions, but instead, and according to Cleland’s nomenclature
[8], microscopic reaction steps with microscopic kinetic rate constants. However, to
be consistent with the literature in the field, we will still refer to them as elementary
reactions [32].
The method is flexible to various reaction schemes, such as binding order, bi-bi
mechanisms, ping-pong mechanisms, and slow enzyme transitions. Both reversible
and irreversible reactions can be specified, but fully reversible mechanisms are recom-
mended for later use of thermodynamic Haldane relationships [3]. Conversion steps
are typically represented as a single transition between reactants and products; how-
ever, in principle more detailed mechanisms involving individual reaction steps of
catalytic residues could also be modeled. Generally, protons and water are assumed
constants and are excluded from reaction mechanisms. At this stage, individual cat-
alytic pathways and thermodynamic cycles can be defined by the user to serve as
Haldane thermodynamic constraints, arising from the First Law of Thermodynamics.
A catalytic pathway consists of a particular set of catalytic reactions that convert
substrates into products. Haldane constraints, which correspond to pathways from
the substrate to the product, are later fitted based on the reaction Keq. Thermo-
dynamic cycles with the enzyme are equivalent catalytic sub-pathways within the
enzyme mechanism that must be balanced and thus reduce the number of degrees of
freedom of the rate constants by one.
In addition, substrate-level enzyme inhibition and activation can be modeled by
adding the elementary reactions corresponding to the respective mechanism. For
enzyme activation, competitive, uncompetitive, and mixed inhibition mechanisms
these reactions are added automatically if the inhibitor/activator and metabolites
affected by the inhibitor are specified.
Finally, once the elementary reactions are specified, a mass action rate law is
generated for each elementary reaction.
For ENO, we decompose the overall reaction
2PG
 PEP
into the following elementary steps:
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ENO + 2PG
 ENO&2PG
 ENO&PEP 
 ENO + PEP
where ENO&2PG is the complex formed by the enzyme and the substrate 2PG.
In this case there is only one catalytic pathway, which contains all the elementary
reactions defined above. We then generate a mass action rate law for each step:
v1 =
−→
k 1[ENO][2PG]−←−k 1[ENO&2PG]
v2 =
−→
k 2[ENO&2PG]−←−k 2[ENO&PEP ]
v3 =
−→
k 3[ENO&PEP ]−←−k 3[ENO][PEP ]
where the square brackets denote the time dependent concentration of the enzyme
form/metabolite. By enzyme forms we mean both free enzyme and enzyme bound to
substrate(s)/product(s).
If ENO is activated by metabolite A, we would add the following set of elementary
reactions:
ENO + A
 ENO&A
ENO&A+ 2PG
 ENO&A&2PG
ENO&A&2PG
 ENO&A&PEP
ENO&A&PEP 
 ENO&A+ PEP
If, instead, ENO was inhibited competitively by metabolite I with regards to 2PG
we would add the elementary reaction:
ENO + I 
 ENO&I
To illustrate the importance of defining catalytic pathways, we will consider
fructose-bisphosphate aldolase class I (FBA1) and assume the products are released
in random order for illustrative purposes. FBA1 catalyzes the reaction:
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FDP 
 DHAP +G3P
the elementary reactions would be:
FBA1 + FDP 
 FBA1&FDP
FBA1&FDP 
 FBA1&DHAP&G3P
FBA1&DHAP&G3P 
 FBA1&DHAP +G3P
FBA1&DHAP 
 FBA1 +DHAP
FBA1&DHAP&G3P 
 FBA1&G3P +DHAP
FBA1&G3P 
 FBA1 +G3P
This mechanism leads to two individual catalytic pathways:
1 :FBA1 + FDP 
 FBA1&FDP 
 FBA1&DHAP&G3P 


 FBA1&DHAP +G3P 
 FBA1 +DHAP
2 :FBA1 + FDP 
 FBA1&FDP 
 FBA1&DHAP&G3P 


 FBA1&G3P +DHAP 
 FBA1 +G3P
where each track needs to satisfy the respective Haldane relation, i.e.,
∏n
i=1
−→
k1i∏n
i=1
←−
k1i
= Keq,FBA1
∏n
i=1
−→
k2i∏n
i=1
←−
k2i
= Keq,FBA1
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where −→k1i and ←−k1i represent the rate constants in the forward and reverse direc-
tions, respectively, for the catalytic pathway one, and −→k2i and ←−k2i represent the rate
constants for the catalytic pathway two. n is the number of elementary reactions in
the respective catalytic pathway. Keq,FBA1 is the equilibrium constant for FBA1.
Constructing symbolic comparison equations
Once kinetic data are processed, equations that represent the model behavior equiv-
alent to these data types are generated to begin setting up a non-linear least squares
problem. These equations are specific to each data type. For Keq values, Haldane
relationships are defined as the ratio of forward and reverse rate constants for each
catalytic pathway. For ENO, the Haldane relation used to fit the reaction’s Keq is:
Keq =
−→
k 1
−→
k 2
−→
k 3←−
k 1
←−
k 2
←−
k 3
For kcat and Km values, equations are derived from the overall steady-state flux
equation, vss. The reason we use steady-state equations to fit the data is because
we are fitting data which was determined by assuming the steady-state. The overall
flux equation for each reaction is assumed to be the same as the flux through the
conversion elementary reaction, i.e. the elementary reaction in which substrates are
converted into products. By solving the system of mass balance equations at steady-
state for all enzyme-form concentrations together with a total enzyme sum equation,
we find the enzyme-form concentrations at steady-state in terms of rate constants
k and metabolite concentrations. By substituting the steady-state concentrations
of the enzyme-substrate(s) and enzyme-product(s) complexes into the overall flux
equation, we get the overall steady-state equation. This overall steady-state equations
is now defined in terms of rate constants, total enzyme concentration, and metabolite
concentrations.
For ENO, the overall flux equation is:
vENO = v2 =
−→
k 2[ENO&2PG]−←−k 2[ENO&PEP ] (2.1)
To determine the overall steady-state flux equation, we need to find the steady-
state concentration for [ENO&2PG] and [ENO&PEP ] in terms of rate constants k
and metabolite concentrations [2PG] and [PEP ]. To do so, we solve the following
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system of steady-state equations for all enzyme-form concentrations together with
the total enzyme conservation equation:
d
dt
[ENO] = v3 − v1 = 0 (2.2)
d
dt
[ENO&2PG] = v1 − v2 = 0
d
dt
[ENO&PEP ] = v2 − v3 = 0
ENOtot = [ENO] + [ENO&2PG] + [ENO&PEP ]
After solving this system of equations we know
[ENO&2PG] = h[ENO&2PG](ENOtot, 2PG,PEP,k)
and
[ENO&PEP ] = h[ENO&PEP ](ENOtot, 2PG,PEP,k)
at steady-state, and substitute these into equation system 2.2 to get:
vss = fvss(ENO, 2PG,PEP,k) (2.3)
= −→k 2 · h[ENO&2pg](ENOtot, 2PG,PEP,k)−←−k 2 · h[ENO&pep](ENOtot, 2PG,PEP,k)
= [ENOtot]([2PG]
−→
k 1
−→
k 2
−→
k 3 − [PEP ]←−k 1←−k 2←−k 3)
[2PG]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3 + [PEP ]←−k 3(←−k 1 +←−k 2 +−→k 2)
This overall steady-state flux equation becomes an effective kcat value, kcat,eff ,
when divided by an arbitrary total enzyme value, which we set to 1, and given sat-
urating concentrations of substrates and no product concentrations. It can then be
used for direct comparison to kcat (kcat = Vmax/[Etot]). The motivation to use an
effective kcat equation instead of the theoretical equation for kcat – which is based on
the limit of the steady-state flux equation when product concentration is zero and
substrate concentration tends to infinity – is two-fold: 1) to the best of our knowledge,
kcat values are typically determined by using saturating substrate concentrations and
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fitting the reaction’s rate to the irreversible Michaelis-Menten equations for a one sub-
strate reaction, using the Lineweaver-Burk plot [25] or similar methods. In that case,
substrate concentrations may be saturating, but not infinite. Thus, the measured
kcat is actually an effective kcat and not the theoretical one. Furthermore, kcat values
are often reported for different substrate concentrations, which we would not be able
to fit with a theoretical kcat equation; 2) for reactions with more than one substrate
taking the limit of the forward flux equation when all substrates concentrations tend
to infinity is not a straightforward task.
For ENO, to generate the equation used to fit the forward kcat value, we assume
vss = Vmax,eff and kcat,eff = Vmax,eff/[Etot] when substrate concentrations are satu-
rating and product concentrations are null. In practice, this means that we divide vss
by [ENOtot] and set [PEP ] = 0, resulting in:
kcat,eff =
[2PG]−→k 1−→k 2−→k 3
[2PG]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3
(2.4)
By using an effective kcat equation to fit the measured kcat values, we can fit
different kcat values measured for different substrate concentrations.
To generate the equation to fit Km values, equations for the relative velocity of
the enzyme compared to Vmax,eff (v/Vmax,eff ) are defined by dividing the overall rate
law by the same rate law when the substrate concentration is saturating. In general
we assume saturating concentrations to be 1 M, but the value can be changed by the
user.
For ENO, to generate the equations used to fit the effective Km for 2PG, we take
equation 2.4 and divide it by itself when [2PG] is saturating, i.e. 1 M, leading to:
vrel =
[2PG](←−k 1(−→k 3 +←−k 2)) +−→k 2−→k 3 +−→k 1(−→k 3 +←−k 2 +−→k 2)
[2PG]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3
This equation can take values from 0 to 1, and by solving it for [2PG] when
vrel = 0.5 we get the effective Km value for 2PG.
To fit inhibition constants, we also use a relative rate flux equation with the
appropriate metabolite concentrations defined. If the inhibition step is a dead-end,
i.e. once the inhibitor binds the reaction cannot progress, we also fit the inhibition
constant to the inhibitor dissociation constant.
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Preparing kinetic data for fitting
The kinetic data, such as Keq, kcat, Km, and Ki, are then converted to a form that
allows direct comparison to model behavior. For Keq values, the form is simply the
value itself as well as the corresponding conditions (pH, IS, and T). For kcat, the form
is again the value as well as the measured experimental conditions, including substrate
concentrations. If substrate concentrations are not available, a concentration that is
likely to be saturating (e.g.. 1M), is assumed, to represent the excess concentrations
typically used in the measurement of turnover rates. For Km and Ki, an initial rate
curve is generated using the classical Michaelis-Menten equation with the Km and
Ki value substituted when applicable. This curve is simulated at different substrate
concentrations in between an order of magnitude above and below the measured
Km value. Other experimental conditions such as co-substrate concentration and
media conditions are reported when available. In case we are fitting a Ki this curve
is generated for different inhibitor concentrations. If instead of a Michalis-Menten
constant we have a S0.5 value and the respective Hill coefficient, a Hill equation is used
to generate the data to be fitted. This procedure attempts to simulate the original
experiment. In principle, instead of this experimental plot simulation procedure, raw
data could be used as well. Furthermore, by simulating the initial rate curve, we can
fit different types of kinetics, e.g. Michaelis-Menten kinetics or Hill kinetics, as long
as the enzyme mechanism is specified correctly.
To attempt to correct these values for in vitro to in vivo differences, we can apply
a couple of adjustments to the data. First, kcat can be adjusted to in vivo temperature
from in vitro conditions using a user defined Q10 temperature coefficient value for the
enzyme. The Q10 coefficient defines, in this case, how much the kcat value increases as
a response to a temperature increase of 10 C. The Q10 coefficient is initially assumed
to have a typical value of 2.5. However, the Q10 for mesophilic enzymes can range
from ∼ 1.5 to ∼ 3 [11, 31, 43]. Second, inhibitory effects of pH changes on enzyme
behavior can be modeled by adding proton binding and dissociation reactions to the
enzyme mechanism with associated dissociation constants, as has been done in the
enzymology literature [40].
For ENO, the data table to be generated is the following:
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Weight [2PG] [PEP ] [ENOtot] pH T (°C) Function file Target value
1 0 0 1 7.5 25 haldaneRatio_1.txt 5.19
1 0.01 0 1 8.1 30 absRateFor.txt 330
1 0.00001 0 1 8.1 30 relRateFor_2pg_1.txt 0.091
1 0.000016 0 1 8.1 30 relRateFor_2pg_1.txt 0.137
1 0.000025 0 1 8.1 30 relRateFor_2pg_1.txt 0.201
1 0.00004 0 1 8.1 30 relRateFor_2pg_1.txt 0.285
1 0.000063 0 1 8.1 30 relRateFor_2pg_1.txt 0.387
1 0.0001 0 1 8.1 30 relRateFor_2pg_1.txt 0.5
1 0.00016 0 1 8.1 30 relRateFor_2pg_1.txt 0.613
1 0.00025 0 1 8.1 30 relRateFor_2pg_1.txt 0.715
1 0.0004 0 1 8.1 30 relRateFor_2pg_1.txt 0.799
1 0.00063 0 1 8.1 30 relRateFor_2pg_1.txt 0.863
1 0.001 0 1 8.1 30 relRateFor_2pg_1.txt 0.909
where the first entry is the data point to fit the Keq, the second entry is the data
point to fit the kcat, and all the other data points are used to fit the Km for 2PG. One
way to address the uncertainty associated with the measurement of kinetic data is
to generate different datasets for different data values sampled from the uncertainty
interval defined in the table 2.1. These datasets would then be fitted independently.
Two-stage randomized fitting
Once both the data and equations have been prepared, these are passed to a two-
stage nonlinear least squares optimization procedure. The target values, i.e. the
values to be fitted by the equations, are given by the data, while the model values
are given by the equations with the experimental conditions substituted into them .
Once the experimental conditions are substituted into the equations, these become a
function of the rate constants only. The fitting procedure then yields rate constants
with which the enzyme model can reproduce the measured data. As an objective,
we use the absolute difference between the logarithm of the predicted data values
and the logarithm of the data points being fitted. This difference is then multiplied
by the user-defined weights for each data point. The logarithm is used here so that
we can fit parameters with different orders of magnitude. We use bounds on rate
constants of 10−6 s−1 and 109 s−1 based on generally assumed limits of diffusion and
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an arbitrarily slow lower bound [2]. These bounds may not be relevant for reactions
not involving association or dissociation, such as conversion steps. However, we have
not found these bounds to affect the error for the cases we have examined thus far.
Additionally, to address the poor scaling of rate constants, we log transform the rate
constants during this optimization.
Yet, the equations are highly nonlinear, causing many optimization algorithms to
fail to converge to an acceptable fit. To address this challenge, we first run a non-
derivative based particle swarm optimization (PSO) to find rate constant sets that
fit the data well enough to serve as initial points for a more precise derivative-based
optimization. The second optimization is a Levenberg-Marquadt (LMA) derivative-
based optimization with the same log-parameter scaling and objective. Resulting
fits are examined for total residual and points that fit satisfactorily are kept. These
rate constants are then once more substituted into the equations for the kinetic data
to verify that the enzyme kinetic data such as Km, kcat, and Keq are reproduced.
Another way to address the uncertainty associated with the measurement of kinetic
data, is to consider fitted rate constant sets that do not exactly reproduce the kinetic
data but do so within 5-10% of the measured value.
Importantly, as PSO is a randomized algorithm, initial points passed to LMA are
different each time the algorithm is run. As a result, different rate constant sets are
returned by the optimization every time, each of which fits the kinetic data equiv-
alently well. This effectively samples the rate constant space in the prevalent cases
where rate constants are not uniquely specified by the available kinetic data. Thus,
this procedure inherently addresses the under-specification issue in parameterization
of microscopic enzyme reaction mechanisms.
Cluster parameters
The fitting procedure is then repeated a number of times until the space of equiva-
lent optima has been sufficiently sampled. As initial points to the LMA optimization
are defined pseudo-randomly based on the PSO optimization results, the resulting rate
constants are usually different in different optimizations. To check whether the space
of equivalent optima has been sufficiently sampled we take each resulting rate constant
set, and discretize the rate constant values by binning them. Since k ∈ [10−6, 109], we
consider the following bins [10−6, 10−3[, [10−3, 100[, [100, 103[, [103, 106[, [106, 109]. We
call a pattern to each binned set of rate constants. For instance, if we have the set
of rate constants (2.1× 103, 1.5× 108, 7.8× 101, 4.2× 103, 6.4× 104, 5.1× 108), this
would lead to the following pattern (4, 5, 3, 4, 4, 5), where each number corresponds
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to a bin. If new fitted rate constant sets fall mostly into existing patterns, we consider
the sampling space to have been sufficiently covered.
Integrate omics data to build fully functional enzyme-level models (op-
tional)
Once rate constant sets are determined, we use steady-state metabolomics data
to define the initial metabolite concentrations. To determine all enzyme form initial
concentrations, we can either use steady-state fluxomics or proteomics. Once the
reaction’s rate constants, initial metabolite concentrations, and initial enzyme form
concentrations are specified the model is ready to be simulated.
To determine the enzyme form initial concentrations for ENO using steady-state
proteomics data, we take the system of steady-state equations for all enzyme forms
generated earlier:
d
dt
[ENO] = v3 − v1 = 0
d
dt
[ENO&2PG] = v1 − v2 = 0
d
dt
[ENO&PEP ] = v2 − v3 = 0
solving this system of equations for the enzyme form concentrations, leads to:
[ENO] = [ENOtot]A[2PG]B + [PEP ]C +D
[ENO&2PG] = [ENOtot]A[2PG]B + [PEP ]C +D (2.5)
[ENO&PEP ] = [ENOtot]([2PG]E + [PEP ]F )[2PG]B + [PEP ]C +D
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where
A =←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3
B =−→k 1−→k 3 +−→k 1←−k 2 +−→k 1−→k 2
C =←−k 3(←−k 1 +←−k 2 +−→k 2)
D =−→k 2−→k 3 +←−k 1(−→k 3 +←−k 2)
E =−→k 1−→k 2
F =←−k 3(←−k 1 +−→k 2)
By substituting the rate constant values, and the steady-state concentrations for
ENO, 2PG, and PEP, we obtain the concentrations for all the enzyme forms: free
enzyme and enzyme bound to 2PG and PEP.
If we want to determine the enzyme form concentrations by integrating steady-
state flux data instead of proteomics, we can solve the steady-state flux equation 2.3
for [ENOtot] and then substitute [ENOtot] in equation 2.5. Thus, taking the original
steady-state flux equation,
vss =
[ENOtot]([2PG]
−→
k 1
−→
k 2
−→
k 3 − [PEP ]←−k 1←−k 2←−k 3)
[2PG]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3 + [PEP ]←−k 3(←−k 1 +←−k 2 +−→k 2)
we solve it for [ENOtot] and get:
[ENOtot] =
vss([PEP ]A+ [2PG]B + C)
[2PG]D − [PEP ]E
where
A =←−k 1←−k 3 +←−k 2←−k 3 +←−k 3−→k 2
B =−→k 1−→k 3 +−→k 1−→k 2 +−→k 1←−k 2
C =←−k 1−→k 3 +←−k 1←−k 2 +−→k 2−→k 3
D =−→k 1−→k 2−→k 3
E =←−k 1←−k 2←−k 3
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this leads to:
[ENO] = vss(
←−
k 1(
−→
k 3 +
←−
k 2) +
−→
k 2
−→
k 3)
[2PG]−→k 1−→k 2−→k 3 − [PEP ]←−k 1←−k 2←−k 3
[ENO&2PG] = vss([PEP ]
←−
k 2
←−
k 3 + [2PG]
−→
k 1(
−→
k 3 +
←−
k 2))
[2PG]−→k 1−→k 2−→k 3 − [PEP ]←−k 1←−k 2←−k 3
[ENO&PEP ] = vss([2PG]
−→
k 1
−→
k 2 + [PEP ]
←−
k 3(
←−
k 1 +
−→
k 2)
[2PG]−→k 1−→k 2−→k 3 − [PEP ]←−k 1←−k 2←−k 3
where we simply need to substitute [PEP] and [2PG] for their steady-state con-
centrations and vss for the steady-state flux for ENO.
Now that we know all the initial metabolite and enzyme concentrations are known,
we can simulate our enzyme-level ODE model:
d
dt
[2PG] =←−k 1[ENO&2PG]−−→k 1[ENO][2PG]
d
dt
[PEP ] = −→k 3[ENO&PEP ]−←−k 3[ENO][PEP ]
d
dt
[ENO] =←−k 1[ENO&2PG]−−→k 1[ENO][2PG] +−→k 3[ENO&PEP ]
−←−k 3[ENO][PEP ]
d
dt
[ENO&2PG] = −−→k 2[ENO&2PG] +←−k 2[ENO&PEP ]−←−k 1[ENO&2PG]
+−→k 1[ENO][2PG]
d
dt
[ENO&PEP ] = −→k 2[ENO&2PG]−←−k 2[ENO&PEP ]−−→k 3[ENO&PEP ]
+←−k 3[ENO][PEP ]
2.2.1 Case studies
Having described the workflow for parameterizing rate constants for elementary mass
action reaction mechanisms using enzyme kinetic data, we now present four case stud-
ies demonstrating the workflow in action when different types of data are available.
The Mathematicar notebooks for these case studies are available as examples in the
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github repository (https://github.com/martamatos/MASSef). For all case studies
the kcat values were corrected to 37 C using a Q10 of 2.5. The Keq was obtained from
the eQuilibrator website [13] for pH 7.5 and IS 0.25 M. The assumed total enzyme
concentration was 1 M. We used scipy’s [22] hierarchical clustering (hierarchy()
function) to cluster all rate constant sets, we chose ’Ward’ as the clustering method
and the euclidean distance as the distance metric.
Case study 1: Fitting the classical enzyme kinetic constants kcat, Km, and
Keq for Triose-phosphate Isomerase (TPI)
We start by using MASSef to fit a simple enzyme, TPI, which converts D-glyceraldehyde
3-phosphate (G3P) into dihydroxyacetone phosphate (DHAP). The enzymatic mech-
anism is depicted in Fig. 2.2A, and the available kinetic data for TPI is shown in Fig.
2.2B. All data point weights were set to 1. We fit the enzyme 100 times, so that we
generate 100 rate constant sets. Only rate constant sets that lead to a sum of squared
log-deviations (ssld) less than 0.1 are considered. The sum of squared log-deviations
is defined as:
ssld =
n∑
i=0
(log (xdatai)− log (xpredictedi))2
Where xpredicted are the values that result from substituting the estimated rate
constant values into the equations used for fitting the kinetic data. The reason why
we take the logarithm of the data points to be fitted and the predicted data points,
is that the data points used to fit the data have different orders of magnitude. Thus,
by taking the logarithm, when we select a given threshold for the ssld, we get rate
constant sets that fit all data points similarly well, instead of getting rate constant
sets that fit one data point very well, but do not fit another data point at all.
For TPI, an ssld below 0.1 means that the highest deviation from the true value
is lower than 0.06%. All 100 fits have an ssld below 0.1.
The equations used for fitting are the following:
kcat =
[G3P ]−→k 1−→k 2−→k 3
[G3P ]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3
To generate the equation used to fit the Km for G3P , we take the above equation
and divide it by itself when [G3P ] → 1 M, i.e. the G3P concentration is saturating,
leading to:
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vss
Vmax,eff
= [G3P ]
←−
k 1(
−→
k 3 +
←−
k 2) +
−→
k 2
−→
k 3 +
−→
k 1(
−→
k 3 +
←−
k 2 +
−→
k 2)
[G3P ]−→k 1(−→k 3 +←−k 2 +−→k 2) +←−k 1(−→k 3 +←−k 2) +−→k 2−→k 3
When we solve vss/Vmax,eff = 0.5 for [G3P], the result is the effective Km for G3P.
Finally, the Haldane relation used to fit the reaction’s equilibrium constant is:
Keq =
−→
k 1
−→
k 2
−→
k 3←−
k 1
←−
k 2
←−
k 3
These equations are also used to obtain the kinetic parameters predicted values
after fitting the enzyme, i.e. for each rate constant set, we integrate into the above
equations the fitted rate constant values and the metabolite/enzyme concentrations
used for the fitting. In Fig. 2.2C, we show the prediction error for each kinetic
parameter, calculated as
Prediction error (%) = xdata − xpredicted
xdata
× 100
where x is the respective kinetic parameter, Km, kcat, or Keq. Overall the error is
very low.
In Fig. 2.2D we show the clustering of all rate constant sets, where the rate
constant values range from 100 to 109. Overall, the forward rate constant for the
binding step, −→k1 , is faster than the respective reverse rate constant, ←−k1 , while the
opposite is true for the product release step. Setting the cut-off distance between
clusters to 5, we distinguish four clusters in Fig. 2.2E. Here, we can see that in the
first cluster the forward rate constant for the conversion step, −→k2 , tends to be lower
than the respective reverse rate constant,←−k2 , while−→k3 tends to be higher than←−k3 , both
being generally high. On cluster three, however, −→k3 is generally lower than←−k3 and −→k2
is generally higher than←−k2 . The same is true for cluster four, however the magnitudes
for −→k2 and ←−k2 are lower than in cluster three and ←−k3 has higher magnitude than in
cluster three. This seems to indicate that, as expected, the rate constant values are
not independent, i.e. if the value of a given rate constant changes then another rate
constant value(s) need to change as well to fit the kinetic data properly.
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Figure 2.2: (A) The enzyme mechanism for TPI. (B) The kinetic data used to fit
the enzyme. (C) The relative error associated with the prediction of each parameter
from each rate constant set. (D) Clustering of all rate constant sets. The blue bar
indicates the cutoff distance to define individual clusters. (E) Clusters obtained when
setting the cutoff distance to 5.
To assess the reproducibility of the above results we repeated the set of 100 fits
three times. The results are very similar between the three resulting sets of 100 fits.
To try and quantify how similar the rate constant sets are between different sets of
100 fits, we discretize their values by binning them and generate a pattern for each
rate constant set, as explained previously.
For each of the three sets of 100 fits, we bin all the rate constant sets and find
that all three sets of 100 fits have 15 patterns in common, and that each set of 100
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fits has between 3 and 4 patterns that are not present in any of the other two sets. .
This seems to indicate that for TPI 100 fits are enough to explore the solution space,
and that the amount of combinations of rate constant values that fit the kinetic data
well is relatively small.
Case study 2: Handling parameters measured under different condi-
tions in Fructose-bisphosphate Aldolase class I (FBA1)
With FBA1, we show MASSef’s ability to handle measurements of the same kinetic
parameter in different conditions. For FBA1 we have kcat and Km values measured
both in the presence and absence of citrate, see Fig. 2.3B. To be able to fit both mea-
surements we consider two sets of elementary reactions, i.e. two catalytic pathways:
one in which citrate is bound to FBA1 and one in which it is not, as depicted in Fig.
2.3A. To increase the number of good fits, we set the weights for Km to 10, the kcat
measured in the absence of citrate and the Keq to 2, while the weight for the kcat
measured in the presence of citrate is set to 1. For each 100 enzyme fits we only get
5-6 fits with an ssld below 0.005, which in this case means that the error associated to
the kinetic parameters prediction is less than 26%. Thus, to get more good fits and
analyze the results, we fit the enzyme 1000 times and get 57 fits with an ssd below
0.005. Most likely, the reason it is harder to fit this enzyme, in the sense that most
of the sampled rate constant sets do not fit the kinetic data, is that we are fitting
different values for the same parameters.
The results for the rate constant sets that lead to an ssld below 0.005 are shown in
Figs. 2.3C-D. In Fig. 2.3C we see that, overall, the error associated to the prediction
of each data point is very small, with some outliers for the equilibrium constants,
where the highest error is∼ 5% for theKeq associated to the citrate catalytic pathway.
In Fig. 2.3D we show the clustering results of all rate constant sets with ssd below
0.005. Overall the rate constant sets are quite different from each other, especially
when comparing to TPI. Since, in this case, it is hard to interpret the clustering
results in terms of rate constants, we convert each set of rate constants into a set
of elementary equilibrium constants, where an elementary equilibrium constant is
defined as
Keq,i =
−→
ki←−
ki
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In Fig. 2.4A we show the clustering results in terms of elementary equilibrium
constants, and by using a distance cutoff of 33, we distinguish three different clusters
in Fig. 2.4B. In cluster one the release of DHAP in the absence of citrate, K4, seems
to be slightly more favorable than in the other clusters, while the release of G3P both
in the absence and presence of citrate, K3 and K3,cit, seems less favorable than in the
other clusters. In cluster three the release of G3P in the presence of citrate, K3,cit,
seems more favorable than in clusters one and two. Overall the binding of citrate,
Kcit, seems to be favorable in all clusters, as well as the binding of FBP, K1 and K1,cit.
While the conversion step, K2 and K2,cit, seems to be unfavorable in all clusters
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Figure 2.3: (A) Enzyme mechanism for FBA1 with two catalytic pathways, one where
citrate is absent and the other where citrate is bound to the enzyme. (B) Data used
to fit the enzyme rate constants. (C) Error associated to the prediction of each data
point used in the fitting. (D) Clustering of rate constant sets with ssld lower than
0.005.
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Figure 2.4: (A) Clustering of all sets of elementary equilibrium constants with ssld<
0.005. The blue bar indicates the cutoff distance to define individual clusters. (B)
Clusters obtained when the cutoff distance between clusters is set to 33.
To fit the equilibrium constant we have two Haldane relations, one for the catalytic
pathway where citrate is bound to the enzyme and the other where citrate is not bound
to the enzyme:
Keq =
−→
k 1
−→
k 2
−→
k 3
−→
k 4←−
k 1
←−
k 2
←−
k 3
←−
k 4
Keq,cit =
−→
k 1,cit
−→
k 2,cit
−→
k 3,cit
−→
k 4,cit←−
k 1,cit
←−
k 2,cit
←−
k 3,cit
←−
k 4,cit
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The equations used to fit the effective kcat and Km for FBP can be found in section
2.4.2.1.
To assess the results reproducibility in terms of rate constant sets, we repeated
the set of 1000 fits three times. We binned the rate constant sets, as we did for
TPI, and checked how many resulting patterns were common among the three sets
of 1000 fits. We considered only rate constant sets with an associated ssld below
0.005. We found no common patterns among the three sets of fits. This might be due
to the high number of rate constants, which means that many more combinations
are possible. Also, there are more combinations of rate constant sets that can fit
the kinetic data equally well, and 1000 fits are apparently not enough to find all the
possible combinations.
However, when we use these rate constant sets to build a full ODE model for
the enzyme and simulate the resulting models as a closed system, the metabolite
time-courses are fairly similar, see Fig. 2.5. Each column in the figure represents
the resulting enzyme-level ODE model ensemble for the respective set of 1000 fits,
considering only the rate constant sets where ssld < 0.005. The omics data used to
generate the model can be found in section 2.4.8.
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Figure 2.5: Time-course metabolite concentrations for three enzyme-level model en-
sembles for FBA1. Each row corresponds to a different metabolite, from top to bot-
tom: FDP, DHAP, and G3P. Each column corresponds to a different model ensemble,
each with 59 models. Each line corresponds to one model.
Case study 3: Handling sigmoidal kinetics in Fructose-1,6-bisphosphatase
2 (FBP2)
Here, we show the ability of MASSef to fit not only Michaelis-Menten kinetics, but
also Hill kinetics. We use FBP2, an enzyme with two subunits and two active sites
showing Hill kinetics with a Hill coefficient of 2.05. Even though more kinetic data is
available for this enzyme, we only use the data shown in Fig. 2.6B. This is because we
want to focus on the sigmoidal kinetic behavior. The enzymatic mechanism assumed
is depicted in Fig. 2.6A, where we assume, as a simplification, that both molecules
of F6P are released before any phosphate molecule is released. The results in Figs.
2.6C-E include only rate constant sets with ssld lower than 0.1, which, in this case
means that the errors associated to the kinetic parameters prediction are below 5%.
We got 90 rate constant sets out of 100 with ssld lower than 0.1. All data point
priorities were set to 1.
In Fig. 2.6C we show the errors associated with the prediction of each data
point, which are almost null for Keq and kcat, but just below 4% for SFBP0.5 and
slightly above 2% for the Hill coefficient. This means that the sigmoidal curve is
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not reproduced perfectly, but the deviation from the true curve is most likely still
within the uncertainty of the experimental measurements. In Fig. 2.6D we show the
clustering results of all elementary equilibrium constant sets with ssld below 0.1. We
do not show the rate constant sets because we have again 14 rate constants which
become hard to interpret, as in the FBA1 case study. Overall the FBP binding
steps, K1 and K2, seem to be favorable, especially the second, with an elementary
equilibrium constant considerably higher than one. The conversion step, K3, seems to
be favorable in general, while the product release steps, K4−7 seem to be unfavorable
with a few exceptions. Using a cutoff distance of 40 we distinguish five clusters in
Fig. 2.6E. In cluster two, the release of the first F6P molecule, K4, is more favorable
than in the other clusters. The same is true for the release of the first PI molecule,
K6, in cluster three. Also the conversion step, K3, seems to be more favorable in
clusters three and four, and the release of the second PI molecule, K7, more favorable
in cluster one.
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Figure 2.6: (A) Enzyme mechanism for FBP2. (B) Data used to fit the enzyme
FBP2. (C) Error associated to the prediction of the kinetic parameters used to fit
the elementary rate constants. (D) Clustering of all elementary equilibrium constant
sets with ssld< 0.1. (E) Clusters obtained with a cutoff distance of 40.
The Haldane relation used to fit the Keq is the following:
Keq =
−→
k 1
−→
k 2
−→
k 3
−→
k 4
−→
k 5
−→
k 6
−→
k 7←−
k 1
←−
k 2
←−
k 3
←−
k 4
←−
k 5
←−
k 6
←−
k 7
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The equations used to fit the effective forward kcat and the SFDP0.5 can be found in
section 2.4.2.2.
The Hill coefficient is fitted by simulating data for the SFDP0.5 using the Hill equa-
tion. For FBP2 the simulated curve to be fitted is shown in Fig. 2.7.
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Figure 2.7: Simulated data to fit the S0.5 for FDP and respective nH .
The predicted Hill coefficient is then found by fitting the resulting predicted curve
for SFDP0.5 .
Regarding the results reproducibility, we repeat the enzyme 100 fits three times,
and bin the resulting rate constant sets with an ssld < 0.1. However, there are no
patterns common to all the three sets of 100 fits, as in FBA1. This again seems
to indicate that with 14 rate constants it requires considerably more fits to find all
possible combinations that fit the kinetic data. Again, we assembled enzyme-level
ODE models from the rate constant sets with ssld< 0.1, for each of the 3 sets of fits,
leading to three model ensembles. The omics data used to assemble the ODE models
can be found in section 2.4.9. We simulated the resulting model ensembles as a closed
system and, as can be seen in Fig. 2.8, the metabolite time-courses are fairly similar
for different model ensembles, where each ensemble is plotted in a different column.
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Figure 2.8: Metabolite time-courses for the three model ensembles built through
MASSef for FBP2. Each column represents a different model ensemble, and each row
a different metabolite, from top to bottom: FDP, F6P, and PI. Each line corresponds
to one model. There are a total of 90 models per ensemble.
Finally, we compare the metabolite time-courses obtained through our approach,
with those that would be obtained by simulating the enzymatic reaction with a simple
Hill rate law. Yet, this comparison is not straightforward. Given the kinetic data
available in the literature, we would only be able to use the irreversible Hill rate law.
But this wouldn’t be a fair comparison, since our model generated through MASSef
is modeling a reversible reaction. Thus, we used the reversible Hill rate law for one
substrate/two products reactions developed in [17] to compare the model simulations:
v =
[FBP2] kcat [FDP ]sFDP0.5
(
[FDP ]
sFDP0.5
+ [F6P ][PI]
sF6P0.5 s
PI
0.5
)nH−1 (
1− [F6P ][PI]
KFBP2eq [FDP ]
)
1− 2
(
[FDP ]
sFDP0.5
)nH
+
(
[FDP ]
sFDP0.5
+ [F6P ]
sF6P0.5
)nH
+
(
[FDP ]
sFDP0.5
+ [PI]
sPI0.5
)nH
+
(
[FDP ]
sFDP0.5
+ [F6P ][PI]
sF6P0.5 s
PI
0.5
)nH
To define the values of the effective Km for F6P and PI, we used the respective
equations defined in MASSef and integrated the respective rate constant values. We
did the same for the parameters found in the literature, so that the uncertainty with
which they are predicted is also included in the Hill models. The results are shown
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in Fig. 2.9, and the metabolite time-courses are similar to the ones in Fig. 2.8, even
if the Hill models seem to lead to more diverse metabolite time-courses. Note that it
would not be possible to simulate the enzyme-level ODE models with a reversible Hill
rate law without the Km values inferred through MASSef. In section 2.4.7, we show
the metabolite time-courses obtained from simulating the irreversible Hill models.
These were built with the parameters obtained from the corresponding models built
through MASSef. Moreover, note that we could also model FBP2 as an irreversible
reaction with MASSef if we had chosen to do so.
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Figure 2.9: Metabolite time-courses obtained from simulating the reversible Hill mod-
els for FBP2. Each column represents a model ensemble, build from the parameters
inferred through MASSef. Each row represents a different metabolite. Each model
ensemble contains 90 models.
Case study 4: Handling inhibition in Fructose-bisphosphate Aldolase
class 2 (FBA2)
Finally, we use MASSef to handle both competitive and mixed inhibition in FBA2.
FBA2 shows product inhibition by both DHAP and G3P with regards to FDP. In
particular, DHAP is a competitive inhibitor with regards to FDP, while G3P is both
a competitive and uncompetitive inhibitor with regards to FDP. For the enzyme
mechanism and the inhibition reactions see Fig. 2.10A. In Fig. 2.10B we show the
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kinetic data to be fitted, where: Kic stands for the competitive inhibition constant
of DHAP with regards to FDP; Kincc stands for the competitive inhibition constant
of G3P with regards to FDP, as part of the mixed inhibition; Kincu stands for the
uncompetitive inhibition constant of G3P with regards to FDP, as part of the mixed
inhibition.
For FBA2 we fitted the enzyme 200 times to get 51 rate constant sets with a ssld
lower than 0.0035. In this case it means the largest error between the fitted data
points and respective predictions is below 27%. Although most rate constant sets
lead to predictions an error below 10%, as shown in Fig. 2.10C.
To fit the Keq we used the following Haldane relation:
Keq =
−→
k 1
−→
k 2
−→
k 3
−→
k 4←−
k 1
←−
k 2
←−
k 3
←−
k 4
The equations used to fit the kcat, Km, and the inhibition constants can be found
in section 2.4.2.3.
Since this enzyme model includes 14 rate constants, in Fig. 2.10D we show only the
clustering results for the elementary equilibrium constants. Overall product release,
K3 and K4, seems to be unfavorable, while substrate binding, K1, and the conversion
step, K2, seem to be favorable. Using a maximum distance of 48 for the hierarchical
clustering, we distinguish four clusters. In clusters three and four the competitive
binding of G3P, KG3Pincc , seems more favorable than in cluster one and two. In cluster
one both the competitive binding of G3P, KG3Pincc , and the binding of FDP to the
enzyme-G3P complex, KG3Pnc , seem less favorable than in other clusters, while in
cluster two the uncompetitive binding of G3P, KG3Pinccu, seems less favorable than in
the other clusters.
53
CHAPTER 2. BOTTOM-UP PARAMETERIZATION OF ENZYME RATE
CONSTANTS USING CORRECTED ENZYME KINETIC DATA
Parameter Metabolite
Co-
substrates
Value
ܭ௘௤ 	 - ͲǤͲͲͲͳ͸
݇௖௔௧ 	 - ͳͲǤͷ ݏ
ିଵ
௠ 	 - ͲǤͲͲͲͳ͹ 
ܭ୧ୡ  - ͲǤͲͲͲͳ͵ 
ܭ୧୬ୡୡ 
͵ - ͲǤͲͲͲͲ͵ 
ܭ୧୬ୡ௨ 
͵ - ͲǤͲͲͲʹ͵ 
 FBA2FBA2 G3P
A
B C
DHAP
G3P
FDPFDP +
1
1
DHAP
2
2
3
3
4
4
+ +FBA2  FBA2 FBA1
D
Individual elem
entary K
eq  sets
10-5 100 105 1010 101510-1010-15
Elementary Keq value
E
C
luster 2
C
luster 3
C
luster 4
C
luster 1
DHAP FBA2+
ic,DHAP
ic,DHAP
FBA2 DHAP G3P FBA2+
incc,G3P
incc,G3P
FBA2 G3P
 FBA2G3P
nc,G3P
nc,G3P
 FBA2G3P
DHAP+DHAP FBA2G3P
incu,G3P
incu,G3P
FDP
G3P  FBA2
FDP
+
Figure 2.10: (A) Enzyme mechanism for FBA2 in the first row, and the inhibition
reactions in the last two rows. (B) Data used to fit the enzyme FBA2. (C) Error
associated to the prediction of the kinetic parameters used to fit the elementary rate
constants. (D) Clustering of all rate elementary equilibrium sets with ssld< 0.0035.
(E) Clusters obtained with a cutoff distance of 40. Kic stands for the competitive
inhibition constant of DHAP with regards to FDP; Kincc stands for the competitive
inhibition constant of G3P with regards to FDP; Kincu stands for the uncompetitive
inhibition constant of G3P with regards to FDP.
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To assess the results reproducibility, we do three sets of 200 fits and bin the
resulting rate constant sets. As for FBA1 and FBP2, there are no overlaps between
the three sets of fits. Again indicating that for enzymes with a high number of
elementary rate constants a larger number of rate constant sets needs to be fitted in
order to sample the space of equivalent optima.
2.3 Discussion and conclusions
In this work, we presented eMASS, a workflow for the parameterization of detailed
kinetic models of enzyme reactions using enzyme kinetic data, and the respective soft-
ware tool, MASSef. This software tool has a number of powerful features. First, the
workflow allows flexible user-defined reaction mechanisms and can handle the majority
of common reaction schemes, including different binding orders, reaction mechanisms
such as ping-pong mechanisms, inhibition schemes, protonation reactions, and, in
principle, allostery. Second, the workflow enables the fitting of standard kinetic data
types, including thermodynamic and initial rate data, and can in principle correct
these data to in vivo-like conditions. Third, the optimization procedure can handle
the inherently highly nonlinear least-squares optimization and sample rate constant
sets to deal with under-determined systems. Finally, the workflow is able to model the
effect of enzyme inhibitors and activators even when inhibition/activation constants
are not available. For instance, if a kcat is measured in the presence and absence of
an activator, we can fit both values by defining two catalytic pathways: one where
activator is bound to the enzyme for all elementary steps, and one where it is absent.
Also, one advantage of this framework is that one does not need to find the appro-
priate rate law to model each process, instead one needs to specify the appropriate
mechanisms. Besides, it can highlight conflicts between different kinetic data.
The modeling procedure here depends on user-specified reaction mechanisms. The
reaction schemes that we have tested thus far are those based on standards set by
Cleland and others enzymologists. These reaction mechanisms have certain assump-
tions but have seen practical success in representing enzyme behavior in initial rate
and progress curve experiments. There are additional levels of detail that potentially
could be represented that we have not yet tested. These include additional breakdown
of catalysis into individual interactions between the substrate and catalytic residues
as well as breakdown of common deterministic and well-mixed assumptions due to
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restricted geometries, low copy numbers, channeling, stochastic behavior, proton tun-
neling, and other more complex kinetic phenomena. These more complex situations
have been handled by others in various ways but not yet integrated into our workflows.
The current workflows have been developed to handle reaction Keq values as well
as enzyme initial rate data such as kcat, Km, and Ki, due to the dominance of these
data types in the enzyme kinetic literature. However, in principle this workflow could
be extended to additional data types such as progress curve data and stopflow data.
The requisite for utilizing these data types is the construction of model equations to
be used in the least-squares optimization. For example, to compare to progress rate
data, the mass balance equations for the enzyme would be integrated over time and
compared to the experimental time course. This is feasible in principle but would have
an unknown computational complexity. Additionally, in the current procedure we use
simulated experimental curves that are effectively back-calculated for the parameters
in the case of Km and Ki. This procedure was implemented because the original data
curves were often not available or were inconvenient to extract from the literature.
However, in principle the original data plots could be fit directly and should have
mostly equivalent results to the current workflow.
The current workflow attempts to correct for difference between the experimental
conditions and in vivo environment by correcting for temperature and pH. These cor-
rection methods are taken largely from approaches used by enzymologists to model
these same effects. We could also correct concentrations to the more accurate chem-
ical activities using a Debye-Huckel model for the activity coefficient given the ionic
strength under experimental conditions [34]. However, these methods often require
a large amount of data on particular enzymes across various conditions and thus are
difficult to apply to the majority of enzymes. Additionally, there are also often a num-
ber of unknown effects, such as buffer interactions with enzyme or macromolecular
crowding effects in vivo, that we currently cannot account for. Thus, there appears
to be much work required to continue to improve our ability to utilize in vitro enzyme
kinetic assay data to model in vivo systems. Both sensitivity analysis and adequate
benchmarking will be critical to determine which of these corrections are important
and can be performed with sufficient accuracy.
Mass action enzyme systems have many more rate constants than kinetic data
typically, and thus are highly underdetermined. One of the most powerful aspects
of this workflow is the ability to fit rate constants to measured kinetic data without
requiring that these rate constants are fully specified, due to the inherent randomized
parameter sampling built into the optimization procedure. This is enabled by the
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pseudo-random start points for the LMA optimization that are provided by the initial
non-derivative based PSO optimization. One potential issue is to determine how
completely the parameter space is being sampled. We attempt to address this by
both clustering the rate constants through successive optimizations and binning each
rate constant set, and considering the parameter space to be fully specified when
new clusters or new rate constant set patterns are no longer found. However, this
procedure cannot discount inherent bias in the optimization procedure that would
lead parameters with particular biases to be oversampled.
Kinetic modeling of metabolic networks has seen a resurgence in recent years,
driven largely by parameterization strategies involving sampling and system-level pa-
rameter fitting. The work here is intended to increase the accessibility of a ‘bottom-
up’ parameterization approach that makes use of the plethora of historical enzyme
kinetic data available in the literature. As these models are parameterized enzyme-
by-enzyme, this approach is expected to scale well to the network scale. Additionally,
there have been efforts recently to fill gaps in critical parameters such as turnover
rates at the genome-scale that should further enable these efforts. As parameter-
ization becomes increasingly computationally feasible and biochemically accurate,
practical kinetic models will likely soon become commonly accessible and powerful
tools available to the systems biology community.
2.4 Supplementary information
2.4.1 Experimental data used in the case studies
2.4.1.1 TPI
Parameter Weight Metabolite Co-substrate Value T (°C) pH Buffer Salts Reference (PMID)
Keq 1 G3P - 9.35 7.5 - - eQuilibrator
kcat 1 G3P - 27025.3 s−1 37 7.6 teoahcl, 0.1 M - 9442062
Km 1 G3P - 0.00103 M 25 7.6 teoahcl, 0.1 M - 9442062
2.4.1.2 FBA1
Parameter Weight Metabolite Co-substrate Value T (°C) pH Buffer Salts Reference (PMID)
Keq 1 FDP - 0.00016 - 7.5 - - eQuilibrator
kcat 2 FDP - 0.41 s−1 37 8 trishcl, 0.05 M - 9531482
kcat 1 FDP citrate, 0.011 M 6 s−1 37 8 trishcl, 0.05 M - 9531482
Km 10 FDP - 0.00002 M 30 8 trishcl, 0.05 M - 9531482
Km 10 FDP citrate, 0.011 M 0.00007 M 30 8 trishcl, 0.05 M - 9531482
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2.4.1.3 FBP2
Parameter Weight Metabolite Co-substrate Value T (°C) pH Buffer Salts Reference (PMID)
Keq 1 FDP - 41.5 - 7.5 - - eQuilibrator
kcat 1 FDP - 5.7 s−1 37 9 chesk, 0.5 M Mn2+, 0.02M,
Cl−, 0.04 M
19073594
S0.5 1 FDP - 0.00007 M 37 9 chesk, 0.5 M Mn2+, 0.02M,
Cl−, 0.04 M
19073594
nH 1 FDP 20.5 37 9 chesk, 0.5 M Mn2+, 0.02M,
Cl−, 0.04 M
19073594
2.4.1.4 FBA2
Parameter Weight Metabolite Co-substrate Value T (°C) pH Buffer Salts Reference (PMID)
Keq 1 FDP - 0.00016 7.5 - eQuilibrator
kcat 1 FDP - 37 8 trishcl, 0.05 M - 10712619
Km 1 FDP 0.00017 M 30 8 trishcl, 0.05 M - 10712619
Kic 1 DHAP 0.00013 M 30 8 trishcl, 0.05 M - 10712619
Kincc 1 G3P - 0.00003 M 30 8 trishcl, 0.05 M - 10712619
Kincu 1 G3P 0.00023 M 30 8 trishcl, 0.05 M - 10712619
2.4.2 Equations used to fit data in the case studies
2.4.2.1 FBA1
Given the elementary reactions:
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the equation used to fit the forward kcat is:
and the equation used to fit the Km for FDP is:
2.4.2.2 FBP2
Considering the elementary reactions for FBP2:
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we use the following equation to fit the forward kcat
and the following equation to fit the S0.5 for FDP:
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2.4.2.3 FBA2
FBA2 has the following elementary reactions:
Which lead to the following equation to fit the forward kcat:
the equation to fit the Km for FDP:
the equation to fit the competitive inhibition by DHAP, which is generated by
dividing vss for FBA2 by the respective Vmax,eff (vss when the substrate concentration
is 1 M) and setting only [G3P] to null:
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the equation to fit the mixed inhibition by G3P, which is generated by dividing
vss for FBA2 by the respective Vmax,eff (vss when the substrate concentration is 1 M)
and setting only [DHAP] to null::
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2.4.3 Rate constants clustermaps for TPI
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Figure 2.11: Rate constant clustering results for two out of three sets of 100 fits for
TPI.
2.4.4 Elementary equilibrium constants clustermaps for FBA1
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Figure 2.12: Elementary equilibrium constant clustering results for two out of three
sets of 1000 fits for FBA1. Only elementary equilibrium constant sets with ssld lower
than 0.005 are shown.
2.4.5 Elementary equilibrium constants clustermaps for FBP2
65
CHAPTER 2. BOTTOM-UP PARAMETERIZATION OF ENZYME RATE
CONSTANTS USING CORRECTED ENZYME KINETIC DATA
10-5 100 105 1010 101510-1010-15
Elementary Keq value
(a)
10-5 100 105 1010 101510-1010-15
Elementary Keq value
(b)
Figure 2.13: Elementary equilibrium constant clustering results for two out of three
sets of 100 fits for FBP2. Only elementary equilibrium constant sets with ssld lower
than 0.1 are shown.
2.4.6 Elementary equilibrium constants clustermaps for FBA2
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Figure 2.14: Elementary equilibrium constant clustering results for two out of three
sets of 200 fits for FBA2. Only elementary equilibrium constant sets with ssld lower
than 0.0035 are shown.
2.4.7 Irreversible Hill models for FBP2
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Figure 2.15: Metabolite time-courses obtained from simulated the irreversible Hill
models. Each column represents a model ensemble, build from the parameters inferred
through MASSef. Each row represents a different metabolite. For given metabolite,
all models lead to the same predicted time-course.
2.4.8 Omics data used in FBA1 enzyme models
Species Concentration (M)
FBA1 1.12× 10−6 [36]
F6P 2.52× 10−3 [29]
FDP 1.52× 10−2 [29]
PI 2.39× 10−2 [29]
Table 2.2: Omics data used to build the enzyme-level models for FBA1.
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2.4.9 Omics data used in FBP2 enzyme models
Species Concentration (M)
FBP2 9.72× 10−8 [36]
DHAP 3.06× 10−3 [29]
FDP 1.52× 10−2 [29]
G3P 2.71× 10−4 [29]
Table 2.3: Omics data used to build the enzyme-level models for FBP2.
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Chapter 3
Elementary Mass Action
Stoichiometric Simulation models
predict non-negligible fractions of
enzyme-bound metabolite
concentrations
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Abstract
To improve cell factory performance to the point where production of cho-
sen molecules becomes economically profitable, extensive metabolic mod-
ification is required. Computational metabolic models have been used
to both provide new insights into the inner workings of metabolism and
new directions for strain engineering. Kinetic models in particular are key
to model the dynamics of metabolism and substrate-level enzyme regula-
tion. Two main approaches to build kinetic models are: bottom-up, which
relies mostly on enzyme kinetic data, and top-down which relies mostly
on omics data. Here, we use the elementary Mass Action Stoichiometric
Simulation (eMASS) framework, an approach that integrates both enzyme
kinetic data and omics data, to build a prototype kinetic model ensemble
for eight enzymes in E. coli’s glycolysis. Following eMASS we decompose
each reaction into elementary steps, so that we explicitly model free and
enzyme-bound metabolite concentrations. This way we can drop the as-
sumption that enzyme-bound metabolite concentrations are negligible, i.e.
xtot ≈ xfree. Preliminary results show that the fraction of enzyme-bound
metabolite vs. total metabolite can be as high as 0.4, i.e. the amount of
enzyme-bound metabolite may not be negligible.
The underlying code is available at https://github.com/martamatos/eMASS.
3.1 Introduction
Cell factories have the potential to provide a more sustainable alternative to produce
many of the molecules our society relies on. However, achieving yields that are com-
mercially viable typically requires extensive cell engineering. Well studied organisms
such as Escherichia coli and Saccharomyces cerevisiae are commonly used in cell fac-
tories due to the amount of existing tools to genetically engineer them. Since these
are well studied organisms, several computational models for E. coli’s and S. cere-
visiae’s metabolism have been built throughout the years, from simple stoichiometric
models at genome-scale [12, 24, 21, 10] to generally smaller kinetic models [16, 17,
19, 20, 31, 7, 26, 14, 9], and some combinations thereof [8, 29], as well as models
integrating metabolic networks with signaling networks [6], gene networks [23], or
including enzyme structural details [4].
While stoichiometric models have provided new insights over the years on the
inner workings of metabolism [18], these do not account for substrate-level enzyme
regulation, which can be key to, e.g. make sense of omics data. For instance, van
Eunen et al [9] showed that, if pyruvate kinase activation by fructose-1,6-biphosphate
(F16bP) is not included in a S. cerevisiae glycolysis model, there is accumulation of 3-
phospho-D-glycerate (3PG), 2-phospho-D-glycerate (2PG), and phosphoenolpyruvate
(PEP) due to a lack of homeostatic regulation. To explicitly model substrate-level
enzyme regulation we need to resort to kinetic models which are able to provide de-
tailed information on time-dependent metabolite concentrations and reaction fluxes.
However, this extra information comes at the cost of more data to parameterize the
models. To build a metabolic kinetic model, two main approaches can be distin-
guished: a bottom-up approach and a top-down approach. Briefly, in a bottom-up
approach the rate laws that model each enzymatic reaction are parameterized indi-
vidually by, e.g. measuring the enzyme’s macroscopic kinetic parameters kcat, Km;
while in a top-down approach the rate laws are formulated and the kinetic parameters
are determined by fitting the rate law equations to omics data. However, it is not
uncommon to start with a bottom-up approach and fit unknown parameters at the
system level [19].
Here, we start by following a bottom-up approach, where we first model each en-
zyme individually by generating fully functional enzyme-level kinetic Ordinary Differ-
ential Equations (ODE) models. Each differential equation models the concentration
changes for a given metabolite or enzyme form, where enzyme forms refer to both free
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enzyme and enzyme bound to substrate(s)/product(s). We then combine the enzyme-
level models to assemble a prototype ensemble of system-level ODE models for eight
enzymes in E. coli’s glycolysis. We call this approach to assemble a system-level ODE
model out of individual enzyme-level ODE models eMASS, elementary Mass Action
Stoichiometric Simulation. eMASS builds on the MASS formalism [15] but decom-
poses all enzymatic reactions into their respective elementary reactions. While in the
original MASS approach only regulatory enzymatic reactions are decomposed into
elementary steps and the remaining reactions are modeled by generalized mass action
rates law which are parameterized by integrating omics data and equilibrium con-
stants. eMASS was implemented as a software package, MASSef, and introduced in
chapter 2. As in other current approaches for building kinetic models that distinguish
different enzyme forms (i.e. complexes of enzyme bound to substrates/products and
free enzyme) [32, 17, 28, 27, 20, 19], in eMASS we initially assumed the concentration
of metabolites bound to enzymes to be negligible, i.e. xfree ≈ xtot, where xtot is the
total metabolite concentration in the cell and xfree is the concentration of metabolite
not bound to any macromolecule. Total metabolite concentrations xtot are commonly
reported in metabolic profiling data obtained through mass spectrometry, as these
experimental approaches cannot distinguish between metabolite free in the cell and
bound to macromolecules [3, 2, 16, 5]. However, preliminary results from building a
kinetic model for each enzyme individually showed that the assumption xfree ≈ xtot
may not always hold. Therefore, we drop the assumption xfree ≈ xtot and explicitly
model both concentrations.
When distinguishing explicitly free and total metabolite concentrations, xfree is
the quantity being simulated in the model while xtot only defines the value taken by the
sum of free metabolite and metabolite bound to enzyme(s). However, we only get xtot
from metabolomics experiments and thus need to determine the initial concentrations
for xfreeto be able to simulate the ODEmodel. Consequently, when we fully build each
enzyme-level ODE model individually and then combine these models into an ODE
system-level model, we can no longer guarantee that the initial concentrations of free
metabolite are non-negative. For instance, if a given metabolite A participates in two
distinct reactions, and in the enzyme model for reaction r1 70% of A is predicted to be
bound to enzyme at t = 0 s and in the enzyme model for reaction r2 50% of the same
metabolite A is predicted to be bound to the enzyme at t = 0 s, when we put these
models together to build a system-level ODE model, 120% of the total metabolite
concentration will be bound to enzyme at t = 0 s, and the initial free metabolite
concentration will be -20% of the total initial metabolite concentration. Hence, to
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avoid negative initial free metabolite concentrations,we develop a two-step approach,
eMASS2, to determine the initial free metabolite concentrations and thus set up an
ODE system-level model. In eMASS2, we first use MASSef to generate a set of rate
constants for each enzymatic reaction, and then build a system of equations at the
system-level composed of all steady-state flux equations for the enzymes in the system,
and a total metabolite conservation equation for each metabolite in the system, where
xtot =
∑
i xbound,i + xfree. Both the flux and the metabolite conservation equations
depend on steady-state concentrations of total enzyme and free metabolite, which
are then sampled to fit steady-state fluxomics and metabolomics data at the system
level. The sampled free metabolite concentrations and total enzyme concentrations
are then defined as the initial concentrations in the system-level ODE model.
We use both eMASS and eMASS2 to build a model prototype that includes eight
enzymes in Escherichia coli’s glycolysis: FBA1, FBA2, TPI, GAPDH, PGK, PGMd,
PGMi, and ENO. In eMASS, a model is built for each enzyme individually, using
MASSef, and the system-level model is defined as the union of all enzyme-level models,
while in eMASS2, MASSef is used to generate rate constant sets for each enzyme,
and enzyme concentrations as well as free metabolite concentrations are globally fit to
fluxomics and metabolomics data. Preliminary results show that, although in many
cases the amount of metabolite bound to enzymes can indeed be neglected, in some
cases it may go up to 40% of the total metabolite concentration.
3.2 Methods
3.2.1 Enzyme-level models
Using MASSef (see chapter 2 for more details), we build an enzyme-level ODE model
ensemble for each enzyme in our system-level ODE model prototype. To build each
enzyme-level model we follow the workflow in Figure 3.1. First, we decompose the
reaction into its elementary steps, according to the enzyme mechanism, and add regu-
latory steps if needed. Second, we generate a mass-action rate law for each elementary
reaction, which results in two elementary rate constants per elementary reaction, −→k
and←−k describing the reaction velocities of the forward and reverse directions, respec-
tively. Third, we find the overall steady-state flux equation, vss, by solving the system
of mass balance equations at steady-state subject to the conservation of total enzyme
concentration constraint, i.e. the total enzyme concentration is the sum of its enzyme
forms (enzyme bound to substrates or products and free enzyme). Assuming the net
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flux through the reaction’s conversion step is equal to the reaction’s measured flux,
this leads to the overall flux equation, vss, for each enzymatic reaction as a function of
rate constants k, metabolite concentrations x, and total enzyme concentration Etot.
This flux equation vss is then used as a basis to generate the equations used to fit
the kinetic data (e.g. Km, kcat, Ki). Here, we use steady-state equations to fit the
kinetic data because the steady-state was also assumed when measuring such data.
This assumption is valid as long as the substrate concentration is much larger than
the enzyme concentration, which is typically the case in in vitro experiments. Once
we obtain the rate constant values, these are valid for other conditions as well.
To illustrate the workflow we take the reaction catalyzed by Enolase as an example,
a one substrate and one product reaction in glycolysis. We start by decomposing the
reaction into its elementary steps:
ENO + 2PG
 ENO&2PG
 ENO&PEP 
 ENO + PEP
where ENO&2pg is the complex formed by the enzyme and the substrate 2PG.
We generate a mass action rate law for each step:
v1 =
−→
k 1[ENO][2PG]−←−k 1[ENO&2PG]
v2 =
−→
k 2[ENO&2PG]−←−k 2[ENO&PEP ]
v3 =
−→
k 3[ENO&PEP ]−←−k 3[ENO][PEP ]
we assume that the reaction’s steady-state flux is the same as the flux through the
conversion step v2:
vss = v2 =
−→
k 2[ENO&2PG]−←−k 2[ENO&PEP ] (3.1)
to find [ENO&2PG] and [ENO&PEP ] in terms of rate constants k and metabo-
lite concentrations [2PG] and [PEP ], we solve the system of steady-state equations
for all enzyme-form concentrations together with the total enzyme conservation equa-
tion :
81
CHAPTER 3. ELEMENTARY MASS ACTION STOICHIOMETRIC
SIMULATION MODELS
d
dt
[ENO] = v3 − v1 = 0
d
dt
[ENO&2PG] = v1 − v2 = 0
d
dt
[ENO&PEP ] = v2 − v3 = 0
ENOtot = [ENO] + [ENO&2PG] + [ENO&PEP ]
once this system is solved and we know [ENO&2PG] = h[ENO&2PG](ENOtot, 2PG,PEP,k)
and [ENO&PEP ] = h[ENO&PEP ](ENOtot, 2PG,PEP,k), we substitute these into
equation 3.1 and get vss = fvss(ENO, 2PG,PEP,k):
vss = fvss(ENO, 2PG,PEP,k)
= −→k 2 · h[ENO&2pg](ENOtot, 2PG,PEP,k)−←−k 2 · h[ENO&pep](ENOtot, 2PG,PEP,k)
= [ENOtot]([2PG]
−→
k 1
−→
k 2
−→
k 3 − [PEP ]←−k 1←−k 2←−k 3)
[2PG]−→k 1(−→k 2 +←−k 3 +−→k 3) +←−k 1(−→k 2 +←−k 3) +−→k 2−→k 3 + [PEP ]←−k 2(←−k 1 +←−k 3 +−→k 3)
We then use vss to generate the appropriate equations to fit the elementary rate
constants k to kinetic data (kcat, Km, Ki, etc.) while assuming Etot,i to be 1. In
particular, kcat values are defined as an effective kcat and are simply vss/Etot when
product concentrations are null. Km is also defined as an effective Km and is simply
vss/Vmax,eff = 0.5 solved for the substrate in question. Vmax,eff is the effective Vmax,
i.e. vss when product concentrations are null and the concentration for the substrate
in question is saturating. We assume a saturating concentration of 1 M. Since in
general the kinetic data can be explained equally well by different sets of elementary
rate constants, this leads not to a single model, but to a model ensemble, where
each model corresponds to a different set of rate constants k. For further details see
chapter 2.
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𝑣𝑟𝑒𝑙 = ℎ 𝑬, 𝒙, 𝒌
𝒂𝑨 + 𝒃𝑩 ↔ 𝒒𝑸+ 𝒑𝑷
𝐸 + 𝐴 ↔ 𝐸𝐴
𝐸𝐴 + 𝐵 ↔ 𝐸𝐴𝐵
𝐸𝐴𝐵 ↔ 𝐸𝑃𝑄
𝐸𝑃𝑄 ↔ 𝐸𝑃 + 𝑄
𝐸𝑃 ↔ 𝐸 + 𝑃
𝑣𝑠𝑠 = 𝑓 𝑬, 𝒙, 𝒌
𝑣𝑎𝑏𝑠 = 𝑔 𝑬, 𝒙, 𝒌
⋮
A
B
D
𝑣
𝑆
E
Get reaction mechanism
Decompose reaction mechanism
Generate equations to fit the data
Fit rate constants to kinetic data
𝑣1 = 𝑘1
+ 𝐸 𝐴 − 𝑘1
− 𝐸𝐴
𝑣2 = 𝑘2
+ 𝐸𝐴 𝐵 − 𝑘2
− 𝐸𝐴𝐵
⋮
C
Generate mass action rate laws
Figure 3.1: MASSef workflow to generate rate constant sets that fit kinetic data. For
a given reaction (A) get the reaction mechanism from literature, (B) decompose the
reaction mechanism into its elementary steps, (C), generate a mass action rate law
for each elementary step, (D) generate flux equation and equations to fit the kinetic
data (kcat, Km, etc), (E) fit the rate constants to kinetic data using PSO (particle
swarm optimization) and LMA (Levenberg-Marquardt algorithm).
3.2.2 System-level model
eMASS
To set up a system-level ODE model that can be simulated we take the rate con-
stants determined by MASSef for each enzyme, but we still need to define the initial
concentrations for free metabolite and enzyme forms. Thus, we follow the workflow in
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Figure 3.2, where, for each enzyme-level model, we start by finding all enzyme form
concentrations. Hence, we:
1. take vss,i = fvss,i(Etot,i,x,k) (defined above), where i represents reaction i in a
system of n reactions;
2. calculate the steady-state total enzyme concentration in terms of vss,i: Etot,i =
gEtot,i(vssi ,xtot,k), by solving fvss,i(Etot,i,x,k) for Etot,i and integrate the rate
constant values, experimental steady-state total metabolite concentrations, xtot,
and steady state flux for each reaction, vss,i, obtained either from fluxomics data
or Flux Balance Analysis (FBA) (or similar methods);
3. calculate each enzyme form concentration eij by solving heij(Etot,i,xtot,k), where
j represents enzyme form j of enzyme i.
The calculated enzyme form concentrations are then integrated in the enzyme-level
model as initial concentrations for the enzyme forms. This results in an enzyme-
level model that can be simulated, and by taking the union of all enzyme-level ODE
models we get a working system-level ODE model. Finally, in the system-level model
we update the free metabolite concentrations xfree by subtracting the enzyme-bound
metabolite concentrations xbound from xtot. However, because we do not have only
one model for each enzyme but a model ensemble for each enzyme, we take all the
combinations of the best three models per enzyme (lowest sum of squared errors) to
build a system-level model ensemble comprised of 6561 models.
Alternatively, the model can be built by integrating steady-state total enzyme con-
centrations Etot,i instead of steady-state reaction fluxes vss. For a detailed example,
see chapter 2.
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eMASS workflow
Calculate 𝐸𝑡𝑜𝑡 and 𝑒𝑖𝑗
concentrations 
Define system-level model as 
the union of all enzyme-level 
models
Assign values to 𝑣𝑠𝑠
from fluxomics or FBA 
Express 𝑣𝑠𝑠 in terms 
of 𝐸𝑡𝑜𝑡
Determine equivalent rate 
constant sets with MASSef
Figure 3.2: eMASS workflow to build system-level models by combining fully func-
tional enzyme-level kinetic models.
eMASS2
A more precise way to determine the initial free metabolite and enzyme form con-
centrations is to use eMASS2. To set up a system-level ODE model using eMASS2,
we follow the workflow in Figure 3.3. First, we take all the combinations of the best
three enzyme-level ODE models for each enzyme which, for eight enzymes, leads to
6561 system-level ODE models. For each model with n reactions (n = 8 in this
case) and m1 metabolites (m1 = 13 in this case) we define the following system of
equations:
vssi = fvss,i(Etoti , xjl,k),
xtotj =
m2∑
l=1
xjl
where i ∈ [1, n], j ∈ [1,m1] and j represents metabolite j, and l ∈ [1,m2] repre-
sents the metabolite form l of metabolite j which can be found in m2 forms (enzyme-
bound and free forms). The sum of both free and enzyme-bound metabolites xjl must
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be equal to the respective steady-state total concentration, xtotj , measured experimen-
tally. The steady-state flux equation fvss,i(Etoti , xjl,k), defined for each reaction (the
same equation as in chapter 2) must fit the steady-state fluxes, vssi , measured either
experimentally or obtained from FBA or similar methods. We use the Levenberg-
Marquardt algorithm (implemented in the LMfit package for Python [22]) to solve
this system of equations, by finding free metabolite concentrations xjl and steady-
state total enzyme concentrations Etoti that minimize the differences between 1) the
measured vssi and the calculated fvss,i(Etot,i, xjl,k), and 2) the measured xtotj and the
sum xjl over all l metabolite forms. We consider only models where the difference
between the true and predicted vssi and xtotj values is less than 10%, and discard the
others. The enzyme form concentrations are calculated from h[enz−form](Etot,xfree,k)
defined in section 3.2.1. The resulting steady-state free metabolite and enzyme form
concentrations are then defined as initial concentrations in the respective system-level
ODE model. Note that these steady-state flux equations are used only to find the
initial steady-state free metabolite and enzyme form concentrations for the respec-
tive system-level ODE model. The reason we use steady-state flux equations to do
so is because: 1) to the best of our knowledge, most omics datasets are measured at
steady-state; and 2) it is an efficient way to find the values for free metabolite and
total enzyme initial concentrations.
For isoenzymes we set the flux through the respective enzyme as the ratio of
the isoenzyme concentration and the sum of all isoenzyme concentrations, e.g. if
[FBA1]=1× 10−6 M and [FBA2]=3× 10−6 mol/L, then the flux through FBA1 will
be 1/4 of the total, while the flux through FBA2 will be 3/4 of the total.
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eMASS2 workflow
Assign values to 𝑣𝑠𝑠
from fluxomics or FBA 
Assign values to 𝑣𝑠𝑠 from 
metabolomics data 
Define equation system 
• 𝑣𝑠𝑠 = 𝑓(𝑬𝑡𝑜𝑡, 𝒙𝑓𝑟𝑒𝑒 , 𝒌)
• 𝑥𝑡𝑜𝑡 = σ𝑖 𝑥𝑏𝑜𝑢𝑛𝑑,𝑖 + 𝑥𝑓𝑟𝑒𝑒
Determine equivalent rate 
constant sets with MASSef
Globally fit 𝐸𝑡𝑜𝑡 and 𝑥𝑓𝑟𝑒𝑒 to 
𝑣𝑠𝑠 and 𝑥𝑡𝑜𝑡
Integrate 𝐸𝑡𝑜𝑡 and 𝑥𝑓𝑟𝑒𝑒
values in the system-level 
model
Figure 3.3: eMASS2 workflow to build system-level kinetic models by integrating flux-
omics and metabolomics data and globally sampling total enzyme and free metabolite
concentrations.
Total enzyme concentrations were sampled in the interval [10−12, 5×10−3] M and
free metabolite concentrations were sampled in the interval [10−12, 10−1] M.
Alternatively, total enzyme concentrations Etot,i can be expressed in terms of vss,i,
and proteomics data can be integrated instead of fluxomics.
3.2.3 Data used for model fitting
The kinetic data used to fit each enzyme model individually can be found here. The
metabolomics data was obtained from [25], where E. coli K-12 strain NCM3722 was
grown in Gutnick minimal medium [11]. The proteomics data was obtained from [30]
for E. coli BW25113 grown in glucose. And the fluxomics data was obtained from
parsimonious Flux Balance Analysis of the iJO1366 model [24], with the glucose and
the oxygen flux set to −2.93 mmol/gDW/h and −5.79 mmol/gDW/h, respectively.
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The objective function for pFBA is cell growth. The results were then converted to
mol/L/s, using a dry cell weight of 2.8 × 10−13 gDW from [13], and cell volume of
3.2× 10−15 L from [33] for cells grown on glucose.
3.2.4 Model simulations
To check for differences in the dynamic behavior between the ODE models assembled
through eMASS and the ODE models assembled through eMASS2, we simulate the
models for a 100 s as an open system.
Both metabolite/enzyme concentrations and reaction fluxes at t = 0 s are steady-
state concentrations/fluxes. Thus, we define exchange fluxes for each modeled metabo-
lite such that, in the absence of perturbations, the models are effectively at steady-
state at t = 0 s. Except for FBP and PEP, the exchange flux for each metabolite
is constant and defined as the difference between the fluxes for reactions that pro-
duce and consume a given metabolite. For instance, 2PG is produced by PGM and
consumed by ENO, thus the exchange flux for 2PG is vENO − vPGM , where the ex-
change reaction is 2PG → ∅. For FBP the exchange flux is defined as vEX,FBP =−→
k EX,FBP [FBPEX ], where vEX,FBP is the flux for the exchange reaction FBPEX →
FBP which is set to be equal to the flux through FBA at t = 0 s, the only re-
action that consumes FBP. FBPEX is the external concentration of FBP and is a
constant defined to be the same as the intracellular concentration of free FBP at
t = 0 s. Finally −→k EX,FBP = vEX,FBP/[FBPEX ]. For PEP, the exchange flux is defined
as vEX,PEP =
−→
k EX,PEP [PEP ], where vEX,PEP is the flux for the exchange reaction
PEP → ∅, and is defined to be the same as the flux through ENO at t = 0 s, the only
reaction that produces PEP. [PEP ] is the time-dependent intracellular concentration
of free PEP. −→k EX,FBP is defined based on the values for vEX,PEP and [PEP ] at t = 0
s as −→k EX,FBP = vEX,PEP/[PEP ] .
Finally, as we do not model co-factor regeneration, the concentrations for ATP,
ADP, NAD, NADH, and PI are defined as constants, their values being set to their
respective free metabolite concentrations predicted by eMASS/eMASS2.
3.3 Results
Using eMASS and eMASS2 we build two prototype model ensembles for eight enzymes
in E. coli’s glycolysis: FBA1, FBA2, TPI, GAPDH, PGK, PGMd, PGMi, and ENO.
We take all combinations of the best three enzyme-level models for each enzyme,
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resulting in a system-level model ensemble with 6561 models. Note that we take
only the best three enzyme-level models whose metabolite initial concentrations at
the enzyme-level are non-negative. From here on, we refer to the model ensemble
generated through eMASS as the eMASS model ensemble, and to the model ensemble
generated through eMASS2 as the eMASS2 model ensemble. In the eMASS2 model
ensemble only 3407 models are considered, as for the remaining models the difference
between true and predicted fluxes and total metabolite concentrations is larger than
10%. For the eMASS and eMASS2 results to be comparable in a fair way, the eMASS
model ensemble is reduced to the same 3407 models present in the eMASS2 model
ensemble.
3.3.1 Predicted free metabolite concentrations
We start by comparing the fractions of bound metabolite concentrations predicted
by each approach, see Figure 3.4. By fraction of bound metabolite we mean the con-
centrations ratio of metabolite bound to enzyme over total metabolite, xbound/xtot =
1− xfree/xtot. The results are relatively similar, with both approaches predicting non
negligible fractions of bound metabolite. Both eMASS and eMASS2 predict non-
negligible fractions of bound metabolite for 13DPG, 3PG, and PEP, while eMASS
also predicts a ∼ 0.15 fraction of bound metabolite for ATP. Yet, eMASS tends to
predict higher fractions of bound metabolite than eMASS2. This is most likely due
to the difference in the metabolite concentrations used to define the enzyme-form
concentrations, which seems to lead to higher predictions for enzyme-bound metabo-
lite concentrations. The enzyme form concentrations (free and metabolite bound
enzyme) depend on the free metabolite concentrations. In eMASS the free metabo-
lite concentrations used to calculate the enzyme-form concentrations are the total
metabolite concentrations, which are equal or higher than the free metabolite con-
centrations used to calculate enzyme-form concentrations in eMASS2. Even though
the relationship between enzyme-form concentration and free metabolite concentra-
tions is non-linear, it is possible that higher free metabolite concentrations lead to
higher metabolite-bound enzyme concentrations.
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Figure 3.4: Predicted fraction of bound metabolite, xbound, for each model in the
eMASS (blue) and eMASS2 (green) model ensembles. Grey dots represent the par-
ticular values predicted by each approach.
The above results are not totally unexpected if we look at the total enzyme and to-
tal metabolite concentration distributions used to generate the models, which overlap
slightly, see Figure 3.5. In this figure we considered only the sum of all isoenzymes for
each reaction. The overlap is most likely due to the low concentrations for 13DPG,
NADH, 2PG, and 23DPG, all with concentrations on the order of 10−5M. For ex-
act values see section 3.5. The metabolites with higher predicted fractions of bound
metabolite have total concentrations ranging from 10−5 M for 13DPG to 10−3 M for
3PG, with PEP and ATP having a total concentration on the order of 10−4 M. What
these metabolites have in common is that all are involved in reactions catalyzed by
the enzymes with higher concentrations in the model, on the order of 10−5 M. This
seems to indicate that higher total enzyme concentrations lead to higher fractions of
bound metabolite, which intuitively makes sense. Yet, it also hints at another issue
with this model ensemble prototypes: if for a given metabolite, only some of the reac-
tions in which it is involved are included in the model (as opposed to all the reactions
where it is either a product or substrate in the cell metabolism), the predicted free
metabolite concentrations might be overestimated.
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Figure 3.5: Distribution of total metabolite and total enzyme concentrations used to
build the model ensembles. The space in between dashed lines corresponds to the
intersection of both distributions.
Finally, note that all system-level models included both in the eMASS and the
eMASS2 ensembles only include non negative free metabolite concentrations. How-
ever, for each enzyme we built between 50 and 100 enzyme-level models using the
eMASS approach. Of these, the ones that do not fit the respective kinetic data with
a tolerance of 10% are discarded. Still, some of the remaining enzyme-level models
have negative initial free metabolite concentrations. In particular, for FBA1 one of
the best three enzyme-level models contains a negative free metabolite concentration,
and for PGK all three best models include a negative free metabolite concentrations.
These are substituted by the next best models with non negative free metabolite
concentrations. Yet, as a test, we also used eMASS2 to build the system-level model
ensemble without substituting those enzyme-level models with negative initial free
metabolite concentrations. It led to only ∼ 700 models with a difference between true
and predicted fluxes and total metabolite concentrations lower than 10%, compared
to more than 3000 models when enzyme-level models with negative free metabolite
concentrations were removed.
3.3.2 Predicted total enzyme concentrations
By integrating flux data, either experimentally measured or calculated through FBA
methods, the total enzyme concentrations Etot,i are left as dependent variables that
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can be calculated as a function of the elementary rate constants k, the metabolite
concentrations x, and the flux values vss,i. Here we used flux data determined through
pFBA. Thus, we look at the resulting total enzyme concentration values predicted
by each model in the eMASS and eMASS2 ensembles, and compare both with ex-
perimental data from [30] and vi/n∗kcat,i in Figure 3.6. v is the flux obtained from
pFBA, kcat is the kcat used to fit the enzyme rate constants, and n is the number
of active sites in the enzyme. For the enzymes used in this model the number of
enzyme subunits and active sites are the same. Etot,i = vi/n∗kcat,i should provide a
lower bound on the predicted total enzyme concentration, as it gives us the minimum
enzyme concentration needed to catalyze a certain reaction with flux vi . However, in
practice it is likely that higher enzyme concentrations are needed to attain the same
flux, as not all enzymes are necessarily in an active state [1] and substrate concentra-
tions may not be saturating either. Also, for FBA1 the respective vi/n∗kcat,i is actually
lower than the experimental Etot,i, indicating that perhaps the kcat used to fit the rate
constants for this enzyme is too low. In fact, FBA1 has two sets of kcat and Km, one
set measured with citrate as cosubstrate and another without citrate. When citrate
is a co-substrate the kcat value is higher. Yet, we used the kcat determined in the
absence of citrate, as citrate wasn’t produced by any enzyme in the model.
Overall, eMASS models predict higher enzyme concentrations than eMASS2 mod-
els, predicting such high concentrations that are not even realistic. This might be
again because in eMASS Etot,i is calculated based on total metabolite concentrations
which are either equal or higher than the free metabolite concentrations. This can
lead to higher enzyme-form concentrations and thus total enzyme concentrations. Re-
garding Etot,i predicted by eMASS2 models, these are always above the lower bound
provided by vi/kcati, making them consistent with the data used to fit the models.
However, with a few exceptions, Etot,i values tend to be overestimated by eMASS2
models when comparing to the experimental Etot,i concentrations. This could be a
result of not taking into account all the reactions in which the metabolites included
in the models are either substrates or products, which most likely leads to higher free
metabolite predictions than in a larger model.
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Figure 3.6: Predicted vs experimental total enzyme concentrations, Etot. The box-
plots represent the predicted enzyme concentrations by each model in each model en-
semble: eMASS in blue, and eMASS2 in green. The red lines represent the measured
enzyme concentrations in [30]. Grey dots represent the particular values predicted
by each approach.
3.3.3 Comparing the dynamics of eMASS and eMASS2 model
ensembles
Finally, we simulate all the 3407 models built both through eMASS and eMASS2 for
100 s. By visual inspection, we find that simulating the models for 100 s is enough
to assess their behavior in the absence of perturbations, in particular if the models
are at steady-state at t = 0 s and whether metabolite concentrations diverge or not.
We do not compare their predictions to experimental time-course data, because we
consider the models to be very incomplete at this point, missing key enzymes, such
as PFK and PYK, which modulate the dynamic behavior of glycolysis. These models
are simply a prototype and at this stage we want to compare only the eMASS and
eMASS2 approaches.
The free metabolite time-courses resulting from simulating the eMASS and eMASS2
ensembles are shown in Fig. 3.7. While all free metabolite concentrations in the
eMASS2 models (Fig. 3.7B) are constant for most of the simulation, these are def-
initely not constant in the eMASS models (Fig. 3.7A). Even though both model
ensembles are fitted with steady-state data, the fluxes in eMASS2 are fitted at the
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system-level and the free metabolite and total enzyme concentrations are such that
the whole system will indeed be at steady-state, when the appropriate exchange re-
actions are included in the model. On the other hand, the fluxes in eMASS are fitted
at the enzyme-level, which means total enzyme concentrations are determined at the
enzyme level, such that the enzyme model is at steady-state at t = 0 s. But this
does not mean that the system-level model will be at steady-state at t = 0 s once all
enzymes are combined into a single system-level. Therefore, the system-level models
built through eMASS will not be at steady-state at t = 0 s. However, these do seem
to reach a steady-state within 100 s. Also, we should note that the metabolite concen-
trations generated through eMASS2 start diverging slightly after 50 s of simulation.
This can have two reasons: 1) numerical precision in the calculation of the metabolite
concentrations over time, and 2) some of the Jacobian eigenvalues have positive real
parts, with the highest one being on the order to 10−3.
A B
Figure 3.7: Free metabolite time courses for (A) eMASS and (B) eMASS models in
the absence of perturbations.
3.4 Conclusions
Here, we presented and compared two new approaches to build system-level kinetic
models: eMASS where we use MASSef to generate equivalent rate constant sets for
each enzyme compatible with the experimental kinetic data, and integrate fluxomics
and metabolomics data with each enzyme-level model individually, leading to a fully
functional enzyme-level kinetic model. The system-level kinetic model is then defined
as the union of all the enzyme-level models. In eMASS2 we use MASSef to generate
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equivalent rate constant sets for each enzyme compatible with the experimental ki-
netic data, and then globally fit total enzyme and free metabolite concentrations to
fluxomics and metabolomics data. One key difference between these methods is that
enzyme concentrations in eMASS2 are a function of free metabolite concentrations,
as the latter are predicted at the system level. On the other hand, in eMASS, be-
cause fluxes are integrated individually with each enzyme model, the free metabolite
concentrations at the system-level are unknown. Thus, we use the total metabolite
concentrations to calculate enzyme concentrations. This leads to predictions of en-
zyme concentrations higher than in eMASS2 models and to higher enzyme-bound
metabolite concentrations. In eMASS free metabolite concentrations are calculated
after assembling the system-level model by simply subtracting enzyme-bound metabo-
lite concentrations from the total metabolite concentrations. This would also explain:
1)why eMASS tends to predict higher total enzyme concentrations and higher frac-
tions of enzyme-bound metabolite, and 2) why the eMASS models are not at steady-
state at t = 0 s in the absence of perturbations.
eMASS2 is no doubt a more correct approach to build the system-level kinetic
model, as fluxes are functions of free metabolite concentrations, as it should be, and
not total metabolite concentrations. Also it leads to considerably less overestimation
of total enzyme concentrations, and the models generated through eMASS2 fitted
with steady-state omics data are indeed at steady-state at t = 0 s in the absence
of perturbations. The only reason that could eventually justify the use of eMASS
instead of eMASS2, is that eMASS is easier to scale up to hundreds of enzymes as
it does not involve global fitting. However, it would probably need to be re-thought
and its predictions thoroughly validated.
Summing up, besides being a more correct approach to build a system-level kinetic
model for metabolism, eMASS2 also leads to more reasonable results. It predicts
non-negligible fractions of enzyme-bound metabolite concentrations, which can be as
high as 0.4. These predictions will probably change as more enzymes are included
in the model though. Also, by expanding the model, more accurate total enzyme
predictions may be achieved, since, if free metabolite concentrations are lower because
each metabolite participates in more than one reaction, then predicted total enzyme
concentrations will likely be lower as well and closer to experimental values. However,
eMASS2 still needs to be validated against metabolite time-course data. One reason
we did not do such validation at this point, is because we consider the model to be
too incomplete to be validated, with key glycolytic enzymes missing, e.g. PFK and
PYK. Instead, we focused on comparing eMASS and eMASS2
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Future work includes adding the remaining enzymes in E. coli glycolysis to the
model and properly validating it against experimental data. Also the method used
to combine the enzyme-level models into system-level models in eMASS2 should be
improved, such that more enzyme-level models can be considered instead of just the
best three. One option would be to just randomly sample combinations of enzyme-
level models instead, another option would be to do the same in a more intelligent way
with an evolutionary algorithm or similar. eMASS2 could, in principle, also be used
to fit the rate constant values when no kinetic data is available for a given enzyme.
Finally, an alternative to predicting free metabolite concentrations through eMASS2,
which would considerably simplify the workflow, would be to somehow estimate the
free metabolite concentrations at the genome-scale level for each metabolite in the
model. These concentrations would then just be integrated into the models, avoiding
the need to predict free metabolite concentrations.
.
3.5 Supplementary information
3.5.1 Metabolomics data
Metabolite Concentration (M)
13DPG 1.65× 10−5
2PG 9.18× 10−5
23DPG 8.29× 10−5
3PG 1.54× 10−3
ADP 5.55× 10−4
ATP 9.63× 10−3
DHAP 3.06× 10−3
FDP 1.52× 10−2
G3P 2.71× 10−4
NAD 2.55× 10−3
NADH 8.36× 10−5
PEP 1.84× 10−4
PI 2.39× 10−2
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3.5.2 Proteomics data
Isoenzyme Reaction Concentration (M)
fbaA FBA2 5.22× 10−6
fbaB FBA1 1.25× 10−7
gpmI PGMi 1.27× 10−6
gpmA PGMd 3.64× 10−6
eno ENO 9.51× 10−6
gapA GAPDH 6.02× 10−6
pgk PGK 1.95× 10−5
tpi TPI 1.89× 10−6
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Chapter 4
Using molecular dynamics
simulations to parameterize models
of enzyme reaction kinetics
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Abstract
Kinetic models of metabolism are central to systems biology and under-
standing the inner workings of cellular metabolism. Yet, models account-
ing for enzyme regulation are hard to parameterize due to a general lack
of kinetic data. Even where available, multiple measured data may be
inconsistent with general enzyme kinetic parameters or existing data on a
given enzyme. To overcome this challenge, we introduce a novel method
which pairs molecular dynamics simulations, which estimate free energy of
binding differences using molecular mechanics, and enzyme-level kinetic
models for E. coli. Here, we use MM-PBSA to estimate the relative bind-
ing energy, ∆∆G, between substrate(s) and product(s) for three enzymes
in E. coli’s central carbon metabolism, and integrate this calculated ∆∆G
with the respective enzyme-level metabolic kinetic models. We perform
this analysis using the elementary Mass Action Stoichiometric Simulation
(eMASS) modeling framework, which allows for integration of different
kinds of kinetic data as constraints on the model. Using this platform, we
assess the consistency of the computed ∆∆G with other enzyme-specific
kinetic data and the degree to which this ∆∆G constrains the sampled
elementary rate constants of the enzyme kinetic models. We compare the
impact of this constraint to that of integrating other kinetic parameters,
such as a kcat or a Km. We find that the calculated ∆∆G values are com-
patible with the remaining enzyme-specific kinetic data used here. Also, it
is generally as constraining as other kinetic/thermodynamic parameters,
e.g. Km, kcat, or Keq. Thus MM-PBSA calculated parameters provide a
promising alternative to parameterize reactions with missing data. Code
and results are available at https://github.com/martamatos/eMASS-MD.
4.1 Introduction
Calculating binding energies of small molecules to proteins for drug design is a typ-
ical application of molecular dynamics methods [72, 69, 43, 9]. However, a change
in binding affinity can have consequences at the cellular level as well, which these
methods cannot capture. To capture such effects, one needs to integrate the results
of atomistic methods with methods that can model the whole network around the
protein of interest [62], e.g. signaling or metabolic networks. The potential for inte-
gration of atom-level simulations and cellular systems biology has been demonstrated
by Gabdoulline et al [14], who used Brownian dynamics simulations to estimate an
undetermined rate constant for the association of superoxide with peroxidase in the
peroxidase-oxidase reaction. Also, more recently, Mih and Brunk [40] integrated
molecular dynamics methods with a metabolic model of the human red blood cell.
They first quantified the impact of enzyme mutations on drug binding affinities, and
then integrated the difference in drug binding affinities with a metabolic model of the
human red blood cell to understand the impact in the cellular metabolism. Such a
multi-scale approach can be very useful in the age of personalized medicine, e.g. to
take into account an individual’s mutations when prescribing a given drug.
Another field where assessing the impact of enzyme mutations on cell metabolism
is important is metabolic engineering, where the goal is typically to increase the
production of a given molecule in a given host organism. To do so, one may follow
a rational strain design approach where metabolic models are used to decide on the
strategy to follow [70, 23, 37], e.g. which genes to knockout or to insert, or which
enzymes to engineer.
Two main types of metabolic models are: 1) stoichiometric models [52], usually
built at genome-scale, these consist of the set of biochemical reactions encoded in the
organism’s genome and are assumed to be at steady-state, i.e. metabolite concentra-
tions are constant and not state variables of the system, thus only steady-state fluxes
can be predicted; 2) kinetic models [2, 8], typically on a smaller scale, these model
the kinetics of the involved enzymes in detail, and therefore enable time-resolved
predictions of metabolite concentrations and reaction fluxes.
One key advantage of kinetic models over stoichiometric models is their ability
to model substrate-level enzyme regulation, e.g. allosteric regulation, competitive
inhibition, or substrate activation, which ultimately depend on the concentration of
the metabolites involved and is therefore outside the scope of stoichiometric models.
4.1. INTRODUCTION
Kinetic models, on the other hand, are hard to build due to the amount of param-
eters involved. This is where integration with computational approaches that can
estimate kinetic parameters from three-dimensional protein structures is important
[63]. Here, relative binding energies estimated through molecular dynamics simula-
tions can be used not only to assess the impact of enzyme mutations on metabolism,
but to parameterize the model in the first place.
Different types of methods are available to calculate relative binding energies:
docking and scoring methods, which are fast but not very accurate. Alchemical
methods [60], e.g. FEP or TI, on the other hand are known to be precise but time-
consuming, also presenting some limitations regarding ligand similarity and charge
[17]. More recently, end-point methods have been introduced, such as LIE [22, 3],
LRA, PDLD/S, PDLD/S-LRA [36, 38, 27, 58], or MM-PBSA/GBSA [61, 31]. Sev-
eral studies have been performed to compare the accuracy and precision of different
alchemical and end-point methods, giving mixed results, with different methods per-
forming better in different systems [16, 4, 32, 24, 55, 43, 41, 34, 21, 66, 20, 47, 26,
18, 57, 15].
Here, we use MM-PBSA to calculate relative binding energies, as it offers a good
trade-off between speed and accuracy/precision [17, 50]. We choose three enzymatic
reactions in the Escherichia coli metabolism and calculate the binding energy of sub-
strates and products to the respective enzymes. We then subtract the binding energy
for the substrate(s) to the binding energy for the product(s), to obtain a relative
binding energy, ∆∆G. Each relative binding energy is then converted into a rela-
tive binding constant, ∆Kb, which is readily integrated with an enzyme-level kinetic
model for the respective reaction. In this kinetic model reactions are decomposed into
elementary steps, where each step is modeled by a mass action rate law. This leads
to several elementary rate constants, which are fitted to macroscopic kinetic data.
By integrating ∆Kb with the enzyme-level kinetic model, we expect to constrain the
sampling space for the reaction’s rate constants. Once ∆Kb is integrated in the re-
spective enzyme model, we 1) assess if its compatibility with the kinetic data already
used to fit the model, 2) assess how much it constrains the model’s rate constants
sampling space, and finally 3) how it impacts the dynamic behavior of the system.
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4.2 Modeling E. coli’s enzyme kinetics with mass
action reaction mechanisms
A common approach to model the dynamics of metabolism is to model each reaction
in the system using Michaelis-Menten rate laws, whose parameters consist mostly of
turnover rates, kcat, and Michaelis-Menten constants, Km, which are usually measured
in in vitro experiments.
One drawback of this approach is that it relies on the quasi-steady-state assump-
tion, according to which the concentration of the intermediate compounds in the
reaction barely changes while the reaction takes place. To avoid this and other is-
sues, we use the elementary Mass Action Stoichiometric Simulation (eMASS) frame-
work introduced in chapter 2, to build a kinetic model for E. coli’s central carbon
metabolism. The eMASS framework is a more general bottom-up approach, where
each metabolic reaction is modeled independently, and then all enzyme-level models
can be integrated to form a final model for the metabolic system of interest. This
system-level model can then be further constrained by integrating omics data. Each
individual enzyme-level model in particular is built by decomposing the reaction into
elementary steps, according to its mechanism, i.e. the order in which substrates and
products bind to and are released from the enzyme, respectively, which we either
obtain from literature or assume to be random. Each elementary reaction step is
modeled with mass action kinetics and no assumptions are made. Yet, this results
in several rate constants whose values we do not know, thus, to estimate them we fit
each enzyme model to macroscopic kinetic parameters, such as Keq, kcat, Km, or Ki.
Two key advantages of the eMASS framework is that it does not assume any
particular reaction mechanism and it can integrate kinetic parameters from different
sources, e.g. two kcat measurements with different cosubstrate concentrations. Fur-
thermore, any parameter defined in terms of rate constants can be readily integrated
in the model.
However, a common issue with building kinetic models following a bottom-up
approach is the lack of macroscopic kinetic parameters. Thus, here we test if using
MM-PBSA to estimate relative binding constants is a viable approach to overcome
this lack of data.
To do so, we follow the workflow detailed in Figure 4.1: 1) once the relative
binding energy between substrate(s) and product(s) has been calculated, we convert
it into a relative binding constant, ∆Kb, by using the following relation between the
Gibbs energy and binding constant:
106
4.3. MOLECULAR DYNAMICS SIMULATIONS TO PARAMETERIZE E. COLI
ENZYME-LEVEL KINETIC MODELS
∆G = −RT ln (Kb)
where ∆G is in kcal mol-1, R is the relative gas constant in kcal K-1 mol-1, T
is the absolute temperature in Kelvin, and Kb is a binding constant. This relative
binding constant can be expressed in terms of rate constants and integrated in the
enzyme-level kinetic model. See section 4.7.2 for details on the ∆∆G conversion to
∆Kb for each enzyme. 2) We perform a parameter scan over ∆Kb, to check which
values integrate better with the enzyme’s kinetic data. In particular, if the value
estimated through MM-PBSA is in that range. 3) Add ∆Kb to the data used to
fit the enzyme, generate 100 model ensembles with 100 models each. 4) Filter out
models that do not fit properly, the criterion being defined by a cutoff on the sum
of squared errors between the logarithm of the data used to fit the model and the
logarithm of the predicted values. 5) Analyze the impact of ∆Kb both on each rate
constant interquartile range and on the possible combinations of rate constants in
each model ensemble. 6) Analyze the impact of ∆Kb on the reaction’s dynamics.
Finally, because simulations of enzyme models not constrained by a kcat can take an
irrealistically long time to converge (∼ 3000 years), we add an estimated kcat value
for ENO, which was not part of the original dataset.
4.3 Molecular Dynamics simulations to parame-
terize E. coli enzyme-level kinetic models
We choose three enzymes in E. coli’s central carbon metabolism to test the inte-
gration of MD simulations with metabolic kinetic models. The enzymes are enolase
(ENO), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and transaldolase B
(TALB). ENO and GAPD are part of glycolysis, while TALB is part of the pentose-
phosphate pathway. ENO has only one substrate, 2-phospho-D-glycerate (2PG), and
one product, phosphoenolpyruvate (PEP), thus the binding energy is stimated for
both metabolites and ∆∆G = ∆GPEP − ∆G2PG. There is little kinetic data avail-
able for this enzyme: an equilibrium constant, Keq, obtained from the eQuilibrator
web-server [12, 44], and a Michaelis-Menten constant, Km. GAPD has 3 substrates:
nicotinamide adenine dinucleotide (NAD), glyceraldehyde 3-phosphate (G3P), and
phosphate (PI), and 2 products: nicotinamide adenine dinucleotide reduced (NADH)
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Kinetic modeling workflow
Convert 𝛥𝛥𝐺 to 𝛥𝐾𝑏
Add 𝛥𝐾𝑏 as a constraint
for enzyme model fit
Analyze impact of 𝛥𝐾𝑏 on rate 
constants
Evaluate model fitness, remove
models with low fitness
Fit enzyme model
Analyze impact of 𝛥𝐾𝑏 on 
enzyme model dynamics
Do parameter scan on  
𝛥𝐾𝑏 to assess quality
Figure 4.1: Workflow used to assess the impact of ∆∆G on a metabolic kinetic model
at the enzyme level.
and 3-phospho-D-glyceroyl phosphate (13DPG). We calculate the binding energy for
the complex NAD-G3P and then the binding energy for NADH-13DPG, thus the
difference in binding energy is ∆∆G = ∆GNAD−G3P − ∆GNADH−13DPG. Regarding
the available kinetic data for GAPD, there is a Km for NAD, G3P, and PI, a kcat for
the forward direction, a Keq, and a dissociation constant for NAD. Finally, TALB has
2 substrates: D-sedoheptulose 7-phosphate (S7P) and D-glyceraldehyde 3-phosphate
(G3P) and 2 products: D-fructose-6-phosphate (F6P), and D-erythrose 4-phosphate
(E4P),. Because this enzyme follows a ping pong mechanism, we estimate the binding
energy only for the first metabolite to bind and the last metabolite to be released, as
we did not model the enzyme structural change upon binding of the first metabolite.
Thus, ∆∆G = ∆GS7P−∆GF6P . For TALB, there is a Keq, a Km for each metabolite,
two kcat for the forward direction, and an inhibition constant for phosphate, which is
competitive with regard to all metabolites. For the detailed enzyme mechanisms, see
figure 4.3. With these three enzymes, we can assess what is the impact of including
the ∆∆G in three different scenarios: 1) in enzyme models for which there is little
kinetic data available but the ∆∆G includes all substrates and products, thus tightly
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constraining the reaction’s conversion step when combined with the reaction’s Keq
(ENO); 2) when there is enough kinetic data available and we constrain the binding
of almost all substrates vs all products (GAPD), which means ∆Kb includes most
rate constants in the enzyme model; 3) when there is enough kinetic data available
but we only constrain the binding of only the first substrate vs. the last product
(TALB), which means ∆Kb includes less than half the rate constants in the enzyme
model.
To calculate ∆∆G for all enzymes, we follow the general workflow in Figure 4.2,
where we 1) first select a wild type enzyme crystal structure from the protein data
bank [6] (see table 4.2 in the methods section for more details); 2) perform a MD
simulation of the chosen crystal structure for ∼ 100 ns to obtain an ensemble of
representative enzyme conformations. For ENO we simulate only the holo form with
two Mg2+ ions bound, for GAPD we perform two simulations for the holo form,
one with NAD bound and the other with NAD and G3P bound, and for TALB we
simulate both the apo form and the holo form with S7P. This leads to 3) an ensemble
of representative enzyme conformations with ∼ 700 enzyme conformations (where
G3P and S7P were removed from the respective conformations), to which we 4) dock
the substrate and product separately using DOCK6 [35]. For ENO we dock 2PG and
PEP; for GAPD, we dock G3P and 13DPG; for TALB, we dock F6P and S7P. 5)
We cluster the ∼ 700 docking poses according to the distances between three chosen
atoms in the ligand and three chosen atoms in the binding residues, take between
four and ten of the largest clusters, and pick representative frames from each one
such that we have between 40 and 50 docking poses for each enzyme-ligand complex,
which we 6) use as a starting point for an MD simulation of ∼ 1 ns. The first 0.1
ns is discarded from this MD simulation, as the complex is considered to be still
equilibrating during this time, and the remaining 0.9 ns are used to 7) do MM-PBSA
and obtain the binding energy for the enzyme-ligand complex. Finally, we 8) subtract
the binding energy for the substrate from the product and obtain a ∆∆G. The reason
we are interested in the ∆∆G instead of the binding energy for a given substrate or
product, is because this way we can avoid calculating the entropy term in step 7 [39,
17]. Calculating the entropy term in step 7 would lead to longer running times for
the MM-PBSA algorithm [42, 25] and probably to higher uncertainties as well [25,
17].
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Molecular Dynamics workflow
Dock a ligand to each 
conformation
Cluster docking poses and 
select representative
MD simulation (~20ns), 
with ligand bound
400+ different enzyme 
conformations
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structure
Do MMPBSA over the 
trajectory
Figure 4.2: Workflow used to estimate ∆∆G values for substrate(s) vs product(s) of
3 enzymes using molecular dynamics methods.
4.4 Results
4.4.1 ∆∆G calculation using MM-PBSA
In table 4.1, we show the ∆∆G and respective standard error and ∆Kb values
obtained for ENO (∆GPEP −∆G2PG), GAPD (∆GNAD−G3P −∆GNADH−DPG), and
TALB (∆GF6P−∆GS7P ), by following the workflow in Figure 4.2. The standard error
for each ∆∆G value is propagated from the respective ∆G values, which in turn is
taken as the standard error of the mean ∆G across the respective MD simulations.
The ∆G values obtained from each MD simulation for each enzyme-ligand complex
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NAD G3P
GAPD GAPD-NAD GAPD-NAD-G3P GAPD-NADH-13DPG GAPD-NADH GAPD
13DPG NADHPI
GAPD-NAD-G3P-PI
S7P
TALB TALB´-S7P TALB´-E4P TALB´G3P TALB-F6P TALB
E4P F6PG3P
TALB´
2PG
ENO ENO-2PG ENO-PEP ENO
PEP
A
B
C
Figure 4.3: Enzymatic reaction and respective mechanisms for substrate binding and
product release for (A) ENO, (B) GAPD, and (C) TALB. Enzyme-ligand complexes
are denoted enzyme− ligand.
Enzyme ∆∆Gmean(kcal/mol) ∆∆Gsem(kcal/mol) ∆Kb
ENO −11.58 1.84 3.6× 10−9
GAPD −0.41 1.77 0.5
TALB 8.39 1.92 1.3× 106
Table 4.1: ∆∆G values and respective standard error of the mean and ∆Kb for each
enzyme.
are shown in section 4.7.1. For GAPD and TALB we estimate ∆G for each enzyme-
ligand complex from 40 to 50 independent MD simulations (apo and holo enzyme
forms, four to five clusters per enzyme form, five to ten representative frames per
cluster). For ENO, we first used the crystal structure 1E9I [33], subunit D with two
Mg2+ ions bound and followed the same workflow, at first with one enzyme form,
three clusters per enzyme form, and four representative frames per cluster. However,
the variance among ∆G values is very high, see Fig. 4.4. This might be due to the
presence of the metal ions and their influence on the docking of 2PG and PEP [72].
Besides, the second Mg2+ ion is known to bind only after the ligand [33]. Hence, a
better approach would have been to bind the second Mg2+ ion manually after docking
2PG and PEP with DOCK6 [35]. Therefore, we use the crystal structure 3H8A [45]
instead, and bind the second Mg2+ ion manually as well as 2PG and PEP, run a ≈ 75
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ns MD simulation, take one frame every ≈ 1 ns from the last 25 ns of simulation,
cluster all 250 frames, take the five largest clusters, and pick 10 to 20 representative
from each cluster to start new MD simulations, which are used to calculate the Gibbs
binding energies.
For all enzymes we discarded all positive ∆G values, as we do not think these
represent productive binding events, in the sense that a binding conformation with
∆G < 0 would probably not lead to the conversion of the complex enzyme-substrate
to the complex enzyme-product. Also, for the binding of PEP to ENO, the ∆GPEP
distribution seems to be bi-modal, see Fig. 4.5, with a group of mean values of ∼ 30
kcal mol-1, and a second group of ∼ 100 kcal mol-1. Given the results for the binding
of 2PG, we consider the second group of binding energies for PEP to not be realistic
and remove it from the final ∆GPEP calculation. Therefore, for ENO, the final ∆∆G
is calculated based on 50 simulations for the complex ENO-2PG and 43 simulations
for ENO-PEP. For GAPD we calculate the final ∆∆G based on 50 MD simulations
for each enzyme-ligand complex, and for TALB the final ∆∆G is calculated based on
45 MD simulations for the complex TALB-S7P and 40 simulations for the complex
TALB-F6P. The starting frames for each enzyme-ligand complex can be obtained at:
https://github.com/martamatos/eMASS-MD.
4.4.2 Integrating ∆∆G with enzyme-level kinetic models
∆Kb impact on model fitness
To check if the ∆Kb value calculated with MM-PBSA is compatible with the other
macroscopic kinetic parameters, we follow the workflow in figure 4.1 and start by
doing a parameter scan over ∆Kb from 10−12 to 1012. The quality of the fit of each
model is measured using the sum of squared log-deviations defined as:
ssld =
n∑
i=0
(log(xdatai)− log(xpredictedi))2
The reason to take the logarithm of the data to be fitted and the predicted data
is that, for very small data values, e.g. 10−10, even if the deviation from the data is
one or two orders of magnitude, the typical sum of squared deviations is still small.
Thus, wrongly giving the impression that the models fit the data well.
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Figure 4.4: ∆G values for each ENO-ligand complex MD simulation when using the
1E9I structure. The starting frames for these simulations where selected from three
different clusters, three frames per cluster, where e.g. 1.2 means cluster 1, frame 2.
The error bars represent the standard deviation associated with the mean value.
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Figure 4.5: ∆G values for each ENO-ligand complex MD simulation when using the
3H8A structure. The starting frames for these simulations where selected from five
different clusters for 2PG and six for PEP, five to ten frames per cluster, where e.g. 1.2
means cluster 1, frame 2. The error bars represent the standard deviation associated
with the mean value.
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Figure 4.6: Parameter scan results over ∆Kb for ENO, GAPD, and TALB, which are
represented in the rows, while the columns correspond to the different values of ∆Kb
used. The first column corresponds to the ssldmedian when ∆Kb is not part of the
fitting dataset. White corresponds to low ssldmedian values, i.e. higher fitness, while
dark red corresponds to high ssdmedian values, i.e. lower fitness. The value closest to
the true ∆Kb for each enzyme is surrounded by a blue square.
To measure the impact of each ∆Kb value on the fit quality, for each ∆Kb value,
we generate 10 model ensembles, each with a 100 models. We then take the best
ssld value for each model, and the median over these for each ensemble. Finally, we
take the median of the resulting 10 median values (one per model ensemble), which
corresponds to the ssldmedian values plotted in Figure 4.6. In the first column of
Figure 4.6, we show the ssldmedian when ∆Kb is not included in the dataset used to
fit the enzyme. This reference value is the same for GAPD and TALB than when
∆Kb is included in the fitting dataset, but seems to be lower for ENO. Regarding
the effect of changing ∆Kb’s value, generally there is a wide range of values that are
compatible with the rest of the fitting dataset. The ∆Kb for ENO, 3.6 × 10−9, is
actually at the point where lower values are increasingly incompatible with the rest
of the fitting dataset. However, when it is included in the dataset the ssld is still on
the order of 5× 10−9, so it is still compatible with the remaining data points used for
the fitting. This can also be seen in section 4.7.4, where we show all ssld values for
all models when a given parameter is removed from the fitting dataset. In particular
in Fig. 4.19a, we can see that the ssld when ∆Kb is removed from the fitting dataset
does not change considerably. Hence, we consider the estimated ∆Kb values through
MM-PBSA to be valid in the context of enzyme-level metabolic kinetic models.
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∆Kb impact on rate constant values
After evaluating the validity of the ∆Kb values in the context of metabolic kinetic
models, we now check whether the rate constants sampling space was constrained or
not when including ∆Kb in the enzyme fitting dataset. To do so, we generate 100
model ensembles, each with a 100 models, and discard all models with an ssld lower
than 0.11. Models with ssld lower than 0.1 will be referred to as valid models from
here on. Also, only models with ssld lower than 0.1 are used in further analyses. For
the valid models, we calculate the interquartile range (IQR) for each rate constant in
each model ensemble and take the median IQR value over all model ensembles plus
respective median absolute deviation, and check how these vary when different data
points are removed from the fitting dataset. The results are presented in Figure 4.7.
Generally, the parameters with greater impact on all rate constants IQR are the the
kcat and the Keq. Yet, for ENO ∆Kb has a greater impact than Keq, for GAPDo has
less impact, and for TALB it does not considerably constrain the IQR of the rate
constants, except for the first reverse and the last forward rate constants, which are
part of the rate constant ratio constrained by the ∆Kb.
Besides analyzing how much ∆Kb restricts the rate constants IQR, we also ask if
the number of possible combinations of rate constants in a given model ensemble is
affected by ∆Kb. To answer this question, we start by doing a hierarchical clustering
of all the valid models in a given model ensemble by rate constant values, and the
difference is remarkable in the case of ENO. In Figure 4.8 we show an example of such
clusterings for ENO where (a) ∆Kb was not part of the enzyme fitting dataset, and
(b) ∆Kb was part of the enzyme fitting dataset. Basically, once the ∆Kb is included in
the enzyme fitting dataset, there are only a few rate constant combinations that can
fit the kinetic/thermodynamic data, as opposed to several rate constant combinations
when ∆Kb is not part of the enzyme fitting dataset. The differences for GAPD and
TALB are not as clear (see section 4.7.3), most likely because: 1) the proportion of rate
constants constrained by ∆Kb is smaller than for ENO, and 2) these are constrained
by more data points than ENO. Moreover, one reason for the combination of valid rate
constant sets to decrease so dramatically in ENO is that the ∆Kb value is very close
to the threshold where lower values become incompatible with the remaining fitting
1By setting the ssld threshold at 0.1, all models reproduce the kinetic/thermodynamic
data for the fitting with an error up to 10% and some outliers below 40%, see
https://github.com/martamatos/eMASS-MD for details.
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Figure 4.7: Order of magnitude of the rate constants’ median interquartile range
(IQR) over each enzyme model ensemble when different kinetic parameters are re-
moved from the fitting dataset one at a time. Red dots/lines represent values obtained
when all parameters were included in the fitting dataset, blue dots/lines represent
values obtained when ∆Kb was removed from the fitting dataset, and so on. The er-
rorbars represent the median absolute deviation associated to the respective median
IQR value. 117
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Figure 4.8: Clustermap over all rate constant sets for one model ensemble for ENO:
(a) when ∆Kb is not included in the fitting dataset and (b) when ∆Kb is included
. Each row represents one rate constant set in the model ensemble, and each col-
umn represents one rate constant. The color represents the rate constant’s order of
magnitude: white represents a lower order of magnitude (≈ 10−6) while darker red
represents higher order of magnitude (up to 109).
dataset, since ∆Kb values on the order of 10−5 for ENO are constraining but not as
much. See https://github.com/martamatos/eMASS-MD for all clustering results.
To quantify how much ∆Kb restricts the number of possible combinations of rate
constants, k, in a given model ensemble, we discretize the rate constant values by
binning them into the following bins: [10−6, 10−3[, [10−3, 100[, [100, 103[,[103, 106[,
[106, 109[, since k ∈ [10−6, 109]. The combination of the bins that form one model is
a pattern. We use Shannon’s entropy [59] to quantify how many different patterns,
i.e. how many different combinations of discretized rate constant values exist in one
model ensemble. Shannon’s entropy is defined as:
H(X) =
n∑
i=1
P (xi) log10 P (xi)
where xi is one pattern and P (xi) the probability of observing that pattern in
a model ensemble with n models. To have a more meaningful metric, we use the
relative Shannon entropy, which is calculated by dividing H(x) by the maximum
118
4.4. RESULTS
possible entropy, which corresponds to observing all the possible patterns: log10 5n,
where n is the number of rate constants in a model and 5 is the number of bins.
We compare how much the relative Shannon entropy is decreased by including
∆Kb in the dataset used to fit the enzyme to how much it decreases by including any
of the other parameters. We do this comparison by answering the following question:
having a complete dataset to fit the enzyme parameters, how much does the Shannon
entropy increase when one data point is removed from the complete dataset? To
answer this question, we take the complete dataset, remove one data point at a time,
generate a 100 model ensembles for each of those incomplete datasets (where one data
point was removed), and calculate the Shannon entropy for each of the 100 model
ensembles generated from each incomplete dataset. This results in a 100 Shannon
entropy values for each incomplete dataset. Also here, for each model ensemble, we
only consider models with ssld < 0.1.
The Shannon entropy results for the three enzymes are shown in Figure 4.9. From
these we can see that ∆Kb can considerably reduce the Shannon entropy in the rate
constant combinations. Overall, ∆Kb can be as constraining as a kcat or a Km. ENO
seems to be an extreme case, where including ∆Kb in the enzyme fitting dataset leads
to only a few possible rate constant patterns. For TALB removing either the kcat,
Ki, or Km from the fitting dataset reduces the Shannon entropy rather than increase
it. By looking at the number of valid models per ensemble in section 4.7.5, we see
that removing the kcat or the Ki from TALB’s fitting dataset, reduces the number of
valid models. The same thing happens for ENO when the Keq is removed from the
fitting dataset and for GAPD when kcat is removed from the fitting dataset. Thus, we
calculate the relative Shannon entropy again considering only 50 models per ensemble
for ENO, and 30 models per ensemble for GAPD and TALB. This way any change
of entropy for each model ensemble shouldn’t be related to the actual ensemble size.
The results are shown in Figure 4.10. Overall the effect of including the ∆Kb in
the enzymes fitting datasets is still comparable to that of any other parameter. For
TALB removing the Km for F6P still reduces the entropy, perhaps because removing
it changes the fitness landscape in such a way that the amount of equivalent optima
is reduced. We do recognize, however, that more models should be generated for
each model ensemble, such that each ensemble contains at least 100 models with ssld
< 0.1.
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Figure 4.9: Relative Shannon entropy results over 100 model ensembles for each enzyme.
Each box represents the relative Shannon entropy when a given data point is removed from
the fitting dataset. In red all data points were used to fit the enzyme, in blue ∆Kb was
removed from the fitting dataset, and so on. Each model ensemble contains up to 100
models with ssld < 0.1. The red line represents the median Shannon entropy value when
the complete dataset is used to fit the enzyme. The blue line represents the median Shannon
entropy value when ∆Kb is removed from the fitting dataset.
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Figure 4.10: Relative Shannon entropy results over 100 model ensembles for each enzyme,
however, here each model ensemble contains only up to 30 models with ssld < 0.1 for GAPD
and TALB, and up to 50 models for ENO. Each box represents the relative Shannon entropy
when a given data point is removed from the fitting dataset. In red all data points were
used to fit the enzyme, in blue ∆Kb was removed from the fitting dataset, and so on. The
red line represents the median Shannon entropy value when the complete dataset is used
to fit the enzyme. The blue line represents the median Shannon entropy value when ∆Kb
is removed from the fitting dataset.
122
4.4. RESULTS
The results from chapter 2 suggest however that, for enzymes with a high number
of rate constants such as GAPD and TALB, the rate constant sets obtained in each
model ensemble might not be reproducible. Hence, for each enzyme and each fitting
dataset, we took all the model ensembles and checked how many different rate con-
stant patterns were found as a percentage of the total number valid of rate constant
patterns. We also checked what was the overlap between the patterns found when the
complete dataset was used to fit the enzyme model and when each of the incomplete
datasets were used. We show these results in Figure 4.11. In most cases, generating
a 100 model ensembles with a 100 models each seems to be enough to sample the
space of equivalent optima, even if not all models have an ssld < 0.1 and are thus
discarded. The exception is when the kcat is removed from the fitting dataset, and
over 80% of the fitted rate constant sets are different, i.e. only 20% are repeated.
Yet, here each model ensemble contains less than 40 rate constant sets. Overall, for
GAPD the overlap of the rate constant sets obtained when using the complete fit-
ting dataset and when using each of the incomplete fitting datasets is quite high, at
least 80%, except when the Keq and the kcat are removed. For the latter it might
be a matter of generating more models with ssld < 0.1 for each ensemble, while for
the former it might be that Keq is very constraining, as suggested by the Shannon
entropy results. Thus, when it is removed from the fitting dataset the fitness land-
scape changes significantly, which would also be consistent with the higher number
of different patterns found when the Keq is not part of the fitting dataset. We see
the same trends for TALB, although the overlap between the different patterns found
when using the complete dataset for fitting and using each of the incomplete datasets
is generally lower. This can be either because: a) as a data point is removed from
the fitting dataset the fitness landscape changes causing some optima to appear and
others disappear, or b) because not enough models were generated. Yet, given that,
for instance, when the Km for F6P is removed the % of different patterns is below
10%, but the overlap with the complete dataset is lower than 40%, there might indeed
be that the fitness landscape changes such that the optima change, which hints at a
conflict between different data points. This hypothesis is also consistent with the re-
sults of the parameter scan in Figure 4.6, where we see that the lowest ssld for TALB
is higher than for GAPD and ENO, suggesting also a conflict between different data
points. Finally, it is interesting to note that, even though GAPD and TALB have the
same number of rate constants, for GAPD the amount of allowed combinations of rate
constant patterns is much lower than for TALB. Without including ∆Kb in the fitting
dataset, for GAPD only less than 5% of the total number of rate constant patterns
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are different, while for TALB there are still ∼ 40%. This might be because the fitting
dataset for GAPD includes a dissociation constant for NAD, which together with the
enzyme’s Keq becomes quite constraining.
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Figure 4.11: Relative Shannon entropy results over 100 model ensembles for each
enzyme, however, here each model ensemble contains only 30 models for GAPD and
TALB, and 50 models for ENO. Each box represents the relative Shannon entropy
when a given data point is removed from the fitting dataset. In red all data points
were used to fit the enzyme, in blue ∆Kb was removed from the fitting dataset, and
so on.
∆Kb impact on enzyme kinetic model dynamics
Finally, we check if the integration of ∆Kb affects the enzyme-level kinetic model
dynamics. Since including the ∆Kb in the fitting dataset has a greater impact on
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ENO, in Figure 4.12 we show the respective metabolite time courses obtained from
simulations in a closed system with no perturbations. Metabolite concentrations
are simply expected to evolve until equilibrium is reached. We simulate only one
model ensemble, however, the results are similar for all 100 ensembles. Each line
in the plots represent one model. When ∆Kb is included in the fitting dataset the
system dynamics are visibly more constrained, which is expected given that the rate
constant set patterns allowed are also drastically reduced. Since ENO is an extreme
case, in Figure 4.13 we show the metabolite time-courses for TALB. The impact of
∆Kb on TALB’s system dynamics seems to be almost negligible. The same happens
for GAPD. Thus, we conclude that only when the number of rate constant sets is
dramatically constrained is there a visible impact on the metabolite time-courses at
the enzyme-level.
A B
Figure 4.12: Metabolite time course results for one ENO model ensemble when (A)
∆Kb was not included in the fitting dataset, and (B) when it was included in the
fitting dataset. Each line represents one model.
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A B
Figure 4.13: Metabolite time course results for one TALB model ensemble when (A)
∆Kb was not included in the fitting dataset, and (B) when it was included in the
fitting dataset. Each line represents one model.
4.5 Conclusions
In this work we used MM-PBSA to calculate relative binding energies between sub-
strate(s) and product(s) for three wild-type enzymes in the central carbon metabolism
of E. coli. For ENO we constrained the ratio of four out of six rate constants, for
GAPDH we constrained the ratio of eight out of 12 rate constants, and for TALB
we constrained the ratios of four out of 12 rate constants, thus being able to test the
impact of different degrees of constraining through ∆Kb. Regarding the reduction
of valid rate constant combinations, we find that ∆Kb is among the most powerful
parameters. Furthermore, when the ∆Kb value is on the limit of compatibility with
the remaining data points, the amount of valid rate constant combinations becomes
extremely reduced, with a significant impact on the respective enzyme-level dynamic
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Enzyme Crystal structure PDB
ENO 1E9I, subunit D [33]
ENO 3H8A, subunit A [45]
GAPD 1GAD [11]
TALB 1UCW [29]
Table 4.2: Crystal structures used for each enzyme.
behavior, which is otherwise barely visible. The similar impact of ∆Kb in the amount
of valid rate constant combinations in GAPD and TALB, despite the different pro-
portion of rate constants constrained by the ∆Kb, might be because GAPD is already
more tightly constrained before including the ∆Kb in the fitting dataset than TALB.
One obstacle to scale-up this approach to more enzymes in the metabolism seem
to be metalloenzymes such as Enolase. Even though we didn’t show it here, we also
applied this workflow to ADK1 which, like ENO, has two Mg2+ ions bound, and
the variance in ∆G was very high. Therefore we cannot simply apply an automatic
approach on metalloezymes, some steps may need to be done manually, e.g. docking
of ligands and/or metal ions. Other challenging enzymes could be allosteric enzymes
such as PFK or PYK, as it is hard to model the effect that effector molecule binding
has on enzyme conformation with molecular mechanics methods.
Therefore, we conclude that 1) non-allosteric and non metalloenzymes are the
best targets to apply the workflow presented here; and 2) ∆Kb can be as constraining
as any other kinetic/thermodynamic parameter and is definitely worth integrating it
with metabolic kinetic models.
Summing up, this is a promising workflow not only to parameterize metabolic
kinetic models, but also to evaluate enzyme substrate promiscuity and to take into
account enzyme mutations in kinetic models. Besides, it can be integrated with any
type of kinetic model that relies on elementary rate constants [64, 54, 53].
4.6 Methods
4.6.1 Enzyme crystal structures
See table 4.2 for the crystal structures used for the molecular dynamics simula-
tions. For the MD simulation of GAPD with both NAD and G3P bound, G3P was
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bound manually and the coordinates were taken from the structure 1DC4 [71]. For
the MD simulations of TALB with S7P bound, S7P was bound manually.
4.6.2 Ligand parameterization
The following ligands bound or to be docked to the enzyme were parameterized using
Gaussian 09 [13] in the gas phase at the HF/6-31G* level: 2PG, PEP, 13DPG, G3P,
F6P, S7P.The ligand charges were fitted using the RESP technique [5]. Antechamber
[65] was then used to assign charges and atom types for compatibility with the MD
simulations using the AMBER ff99SB force field. The ligand structures were obtained
from PDBeChem [10, 19], where the ideal structures were used. The parameters for
the cofactors NAD+, NADH, and Mg2+ were obtained from the AMBER parameter
database by the Bryce group [1].
4.6.3 Molecular dynamics simulations
The PMEMD module from the AMBER14 toolkit [7] is used to run all MD simu-
lations. Each simulation is preceded by a minimization step at constant volume for
up to 106 cycles, and an equilibration step at constant volume where the system is
heated from 50 K to 300 K from step=0 to step=40000, and from step=40000 to
step=500.000 temperature is kept constant at 300 K, while the enzyme and bound
ligands are kept restrained. MD production simulations start off from the equilibra-
tion step, and are done at constant pressure. The Langevin thermostat is used for
the equilibration and production runs, and the Particle Mesh Ewald (PME) cutoff is
set to 12 Å. This procedure is used for all MD simulations, where the only variable
is the length of the production simulation.
To generate topologies, the force field ff99SB was used, after which the system was
solvated in a TIP3P 12 Å periodic water box, where 12 Å is the minimum distance
between any atom in the enzyme/ligand and the periodic box boundary. Counterions
were added, either Na+ or Cl-. MD simulations are performed in two different phases.
In phase one the enzyme is simulated for at least 80 ns, to sample different enzyme
conformations for docking. From each simulation we take every 100th frame. See
table 4.3 for details on the simulations.
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Enzyme Cofactors/ligands bound Simulation time Number of frames
extracted for docking
ENO_1E9I Mg2+ 110 ns 750
ENO_3H8A 2 Mg2+, 2PG 75 ns 252
ENO_3H8A 2 Mg2+, PEP 75 ns 252
GAPDH NAD+ 110 ns 750
GAPDH NAD+, G3P 110 ns 745
TALB - 83.6 ns 803
TALB S7P 59.5 ns 493
Table 4.3: For each MD simulation, which enzyme was simulated, which cofac-
tors/ligands were bound, how long was the simulation (in ns), and how many frames
were extracted from each simulation for docking.
In phase two, MD simulations are run for 1 ns for all enzyme-ligand complexes:
ENO_3H8A-2PG, ENO_3H8A-PEP, GAPDH-NAD-G3P, GAPDH-NAD-13DPG, TALB-
S7P, and TALB-F6P. The results from these simulations are then used to estimate
the ligand-enzyme binding energies with MM-PBSA.
Because force fields in general cannot model the interactions of metal ions with
the enzyme/ligand properly, in all ENO’s simulations, we restricted the position of
the Mg2+ atoms by defining distances restraints to nearby atoms.
4.6.4 Docking
From the first MD simulation, we first remove any ligands that were bound (but not
cofactors), then we load it on Chimera [49] using the MD Movie function and use
Dock Prep on it to extract each frame and prepare it for docking. We use DOCK6
[35] to flexibly dock the ligands to the respective enzyme, which is considered as a
single rigid structure. DOCK6 was used with the default parameters and the binding
residues were defined either based on literature or the ligand’s surrounding residues in
the respective crystal structure, see table 4.4. From this step, we get > 250 enzyme-
ligand complex frames which are then clustered according to the euclidean distances
for three atom pairs, where one atom is part of the ligand, and the other is part of
the enzyme. To do so we use the mean shift method implemented in scikit-learn [48].
The atom pairs to use are chosen based on the crystal structure, where the atoms in
the enzyme are chosen as the closest ones to the respective pair on the ligand. From
each of the five to ten largest clusters, we generate a set of representative frames, for
which each atom pair distance is within the respective cluster’smean±std. From this
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group of representative frames we choose n frames randomly (unless a frame looks
like an outlier) to run the second phase of MD simulations. See table 4.5 for details
on how many frames per enzyme-ligand complex were chosen as starting points for
the second phase MD simulation (MD2), and how many of these MD simulations
were considered to calculate the final ∆∆G value.
Enzyme Binding residues
ENO Lys341, Lys392 Arg370, Glu208, Ser371, Glu167,
His369, Ser368, Leu339
GAPDH Cys149, Ser148, Thr150, Thr208, Gly209,
Arg231, His17
TALB Asp17, Asn35, Lys132, Asn154, Ser176, Arg181,
Ser226, Arg228, Thr242, Thr32, Ser93
Table 4.4: Binding residues used to dock ligands to the respective enzyme.
Enzyme-ligand
complexes
Enzyme Cofactors/ligands
bound in MD1
Number of
starting frames
for MD2
Number of MD2
simulations used to
calculate the final
∆∆G
ENO-Mg2+-2PG ENO_1E9I 2 Mg2+ 12 -
ENO-Mg2+-PEP ENO_1E9I 2 Mg2+ 12 -
ENO-2Mg2+-2PG ENO_3H8A 2 Mg2+, 2PG 50 50
ENO-2Mg2+-PEP ENO_3H8A 2 Mg2+, PEP 67 43
GAPD-NAD-G3P GAPDH NAD+ 25 25
GAPD-NAD-
13DPG
GAPDH NAD+ 25 25
GAPD-NAD-G3P GAPDH NAD+, G3P 25 25
GAPD-NAD-
13DPG
GAPDH NAD+, G3P 25 25
TALB-F6P TALB - 25 20
TALB-S7P TALB - 25 20
TALB-F6P TALB S7P 25 25
TALB-S7P TALB S7P 25 20
Table 4.5: For each enzyme-ligand complex, which enzyme is part of it, which cofac-
tors/ligands were bound to the enzyme in the first MD simulation (used to generate the
docking conformations), how many starting frames for the second MD simulation were ex-
tracted, and how many MD2 simulations were considered to calculate the final ∆∆G value.
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4.6.5 MM-PBSA
MMPBSA.py [42] from the AMBER14 toolkit was used to run the MM-PBSA calcu-
lations using the single simulation approach. We did not estimate the entropy term.
To calculate the binding energies for a given enzyme and ligand, the MD simulations
from phase two are used, in which the ligand of interest is bound to the enzyme.
The first 0.1 ns of the simulation was always discarded, as we assume the enzyme-
ligand complex may still be stabilizing. A total of 62 frames were used as input to
the MMPBSA.py script for the 1 ns simulations. The bondi radii set was used by
AMBER to generate the parameter/topology sets. The parameters for MM-PBSA
were defined with a SASA-based model (inp=1) for non-polar solvation free energies
calculations.
4.6.6 Enzyme-level metabolic kinetic models
To build each enzyme kinetic model, we use MASSef, presented in chapter 2 a
Mathematicar software package that implements the eMASS framework. There-
fore, we first collect kinetic data, such as kcat or Km, from literature and relevant
databases, e.g. Brenda [51], Sabio-RK [68], or Biocyc [30]. Given an enzyme mech-
anism, which is assumed to be random if no information is found in the literature,
the biochemical reaction is divided into each elementary step. Each reaction elemen-
tary step is modeled by a mass action kinetic rate law, which results in several rate
constants whose values are fitted to the macroscopic kinetic data obtained from liter-
ature. The data points included in the dataset used for enzyme fitting are, in general,
different for each enzyme, the only data point available for every enzyme being the
equilibrium constant, obtained from eQuilibrator [12], which estimates equilibrium
constants using the component contribution framework [44]. The complete fitting
dataset for ENO includes the Keq, a Km for the reaction substrate 2PG, the ∆Kb
estimated from MD simulations, and a kcat whose value was set as the maximum
between PYK’s and PGM’s kcat - a kcat is needed for the metabolite concentration
changes to reach equilibrium in a reasonable time frame, i.e. 100 s rather than 107
s. GAPD’s complete fitting dataset includes, besides the respective Keq and ∆Kb, a
Km for each of the reaction substrates: G3P, PI, and NAD, a dissociation constant,
Kd, for NAD, and a kcat for the forward direction. TALB’s complete fitting dataset
includes the Keq, ∆Kb, a Km for each reaction substrate and product, two forward
kcat, and a Ki for phosphate inhibition with regards to all products and substrates.
To fit each enzyme’s rate constants to the respective kinetic data, a particle swarm
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optimization algorithm is used to generate a set of 100 initial solutions, which are
further optimized by the Levenberg-Marquardt algorithm, resulting in one model en-
semble with a 100 enzyme-level models. We then repeat the procedure a 100 times
to generate 100 model ensembles, with a 100 models each. These models’ fitness is
evaluated according to
ssldmodel =
n∑
i=0
(log(xdatai)− log(xpredictedi))2
If the model ssld is greater than 0.1 the model is discarded, hence some model
ensembles might have less than a 100 models. In this case an ssld < 0.1 means
that the maximum error associated with the prediction of the parameters used to fit
the elementary rate constants is less than 10% with some outliers below 40%. The
kinetic data used to fit each enzyme is available in the github repository, as well
as the Mathematicar notebooks used to generate the fitting data and treat the fit
results. For more details about building the enzyme-level kinetic models, please see
chapter 2.
4.6.7 Rate constant analysis
To plot the cluster tree and heatmap in Figure 4.8 we used the Python package
seaborn 0.7.0 [67]. This cluster tree represents the hierarchical clustering of each
model ensemble by rate constants. Only valid models, i.e. which satisfy ssldmodel <
0.1 are considered in this step.
4.6.8 Model dynamics analysis
To analyze each enzyme-level model dynamics, we need to first convert the kinetic
models made solely of rate constants into a model that includes also initial enzyme
form and metabolite concentrations, so that the system dynamics can actually be
simulated. We get the initial total metabolite concentrations from [46], while the
initial enzyme form (i.e. free enzyme and enzyme-ligand complexes) concentrations
are calculated by requiring the total enzyme concentration to be equal to the sum
of all enzyme form concentrations and the variation in enzyme form concentration
to be zero when the system is at steady-state. The total enzyme concentrations
are taken from the proteomics dataset in [28], and the molecular weights in Bio-
cyc [30] are used to convert the enzyme concentrations to units of M. Once the
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enzyme form concentrations have been calculated, the metabolite concentrations in
the system are updated by subtracting the amount of metabolite bound to enzyme.
The Mathematicar notebooks used to build such models can be downloaded from
https://github.com/martamatos/eMASS-MD. Once all models are in a format that
can be simulated, the MASS toolbox [56], a Mathematicar package, is used to sim-
ulate each model for a 100 s, which was determined by visual inspection to be long
enough for the system to reach equilibrium, i.e Keq =
∑
i[producti]/
∑
i[substratei]
and the flux through each elementary reaction is null. Only valid models are consid-
ered, i.e. which satisfy ssldmodel < 0.1 and whose initial metabolite concentrations
are non-negative.
4.7 Supplementary information
4.7.1 ∆G values
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Figure 4.14: Binding energy,∆G, values calculated from different molecular dynamics sim-
ulations for complexes formed by ENO and respective substrate (2PG, top) and product
(PEP, bottom). clx.y represents the MD simulations for which starting frame y was taken
from cluster x. The black line denotes the mean ∆G value for the respective complex. Error
bars correspond to the standard deviation associated to the ∆G values obtained from each
simulation.
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Figure 4.15: Binding energy,∆G, values calculated from different molecular dynamics sim-
ulations for complexes formed by GAPD and respective substrates (NAD and G3P, top)
and products (NADH and 13DPG, bottom). clx.y represents the MD simulations for which
starting frame y was taken from cluster x. The prefix rG3P means the starting frame was
obtained from the simulation of GAPD’s holo form with both NAD and G3P bound, where
G3P was removed before docking. The black line denotes the mean ∆G value for the re-
spective complex. Error bars correspond to the standard deviation associated to the ∆G
values obtained from each simulation.
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Figure 4.16: Binding energy,∆G, values calculated from different molecular dynamics sim-
ulations for complexes formed by TALB and respective substrate (S7P, top) and product
(F6P, bottom). clx.y represents the MD simulations for which starting frame y was taken
from cluster x. The prefix rS7P means the starting frame was obtained from the simulation
of TALB holo form with S7P bound, where S7P was removed before docking. The black
line denotes the mean ∆G value for the respective complex. Error bars correspond to the
standard deviation associated to the ∆G values obtained from each simulation.
4.7.2 Conversion of ∆∆G into ∆Kb
ENO
At equilibrium, we have:
−→
k1 [ENO][2PG] =
←−
k1 [ENO&2PG]
−→
k1←−
k1
= [ENO&2PG][ENO][2PG]
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−→
k2 [ENO&PEP ] =
←−
k2 [ENO][PEP ]
←−
k2−→
k2
= [ENO&PEP ][ENO][PEP ]
Calculating the difference in binding Gibbs energies:
∆GPEP −∆G2PG = −RT ln
←−k2−→
k2
+RT ln
−→k1←−
k1

= RT ln

−→
k1←−
k1←−
k2−→
k2

= RT ln
−→k1−→k2←−
k1
←−
k2

−→
k1
−→
k2←−
k1
←−
k2
= exp
(
∆GPEP −∆G2PG
RT
)
GAPD
At equilibrium, we have:
−→
k1 [GAPD][NAD] =
←−
k1 [GAPD&NAD]
−→
k1←−
k1
= [GAPD&NAD][GAPD][NAD]
−→
k3 [GAPD&NAD][G3P ] =
←−
k3 [GAPD&NAD&G3P ]
−→
k3←−
k3
= [GAPD&NAD&G3P ][GAPD&NAD][G3P ]
137
CHAPTER 4. USING MOLECULAR DYNAMICS SIMULATIONS TO
PARAMETERIZE MODELS OF ENZYME REACTION KINETICS
−→
k2 [GAPD&NADH] =
←−
k2 [GAPD][NADH]
←−
k2−→
k2
= [GAPD&NADH][GAPD][NADH]
−→
k4 [GAPD&NADH&DPG] =
←−
k4 [GAPD&NADH][DPG]
←−
k4−→
k4
= [GAPD&NADH&DPG][GAPD&NADH][DPG]
Calculating the difference in binding Gibbs energies:
∆GNADH&DPG −∆GNAD&G3P = −RL ln
←−k2−→
k2
←−
k4−→
k4
+RT ln
−→k1←−
k1
−→
k3←−
k3

= RT ln

−→
k1←−
k1
−→
k3←−
k3←−
k2−→
k2
←−
k4−→
k4

= RT ln
−→k1−→k3−→k2−→k4←−
k1
←−
k3
←−
k2
←−
k4

−→
k1
−→
k3
−→
k2
−→
k4←−
k1
←−
k3
←−
k2
←−
k4
= exp
(
∆GNADH&DPG −∆GNAD&G3P
RT
)
TALB
At equilibrium, we have:
−→
k1 [TALB][S7P ] =
←−
k1 [TALB&S7P ]
−→
k1←−
k1
= [TALB&S7P ][TALB][S7P ]
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−→
k2 [TALB&F6P ] =
←−
k2 [TALB][F6P ]
←−
k2−→
k2
= [TALB&F6P ][TALB][F6P ]
Calculating the difference in binding Gibbs energies:
∆GF6P −∆GS7P = −RT ln
←−k2−→
k2
+RT ln
−→k1←−
k1

= RT ln

−→
k1←−
k1←−
k2−→
k2

= RT ln
−→k1−→k2←−
k1
←−
k2

−→
k1
−→
k2←−
k1
←−
k2
= exp
(
∆GF6P −∆GS7P
RT
)
4.7.3 Clustermaps for GAPD and TALB
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Figure 4.17: Example of the results for the clustering of rate constant sets for GAPD
when (a) ∆Kb is not included in the fitting dataset, and (b) when ∆Kbis included in
the fitting dataset.
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100 103 106 10910-310-6
Rate constant value
Individual rate constant sets
(a) Without ∆Kb
100 103 106 10910-310-6
Rate constant value
Individual rate constant sets
(b) With ∆Kb
Figure 4.18: Example of the results for the clustering of rate constant sets for TALB
when (a) ∆Kb is not included in the fitting dataset, and (b) when ∆Kbis included in
the fitting dataset.
4.7.4 Parameter impact on model fitness
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(c) TALB
Figure 4.19: Logarithm of the sum of squared errors for each model when a given data
point was removed from the fitting dataset. Fits with ssld < 0.1 (horizontal black line) are
considered to be good fits.
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4.7.5 Parameter impact on the amount of valid models per
ensemble
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Figure 4.20: Number of models with ssld< 0.1 in each model ensemble l when a given data
point was removed from the fitting dataset.
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Chapter 5
Reaction control is altered on the
seconds timescale in pre-steady
state glycolysis: a rapid injection
NMR study and its computational
simulation
153
Abstract
Dynamic tracking of intracellular reaction cascades is a means of obtain-
ing mechanistic insight into metabolism. We combine time-resolved rapid
injection NMR spectroscopy with a computational simulation of the ex-
periment to detect changes of the rate limiting steps occurring during
the upstart of glycolysis. Bottlenecks in the glycolytic reaction cascade
shift from downstream to upstream reactions within few seconds owing to
rapid changes in cofactor pools. Computational systems models of central
metabolism appear to have achieved a level of quality that permits correct
mechanistic predictions of unanticipated biochemical events.
The model and code used for simulations are available at:
https://github.com/martamatos/Yeast-simulations.
5.1 Introduction
Living systems, and increasingly also designed systems, sense changes in their en-
vironment and respond to them. In living systems, these responses occur over a
broad timescale. Metabolic responses can occur on the seconds time scale to warrant
homeostasis, and fast metabolic reaction cascades such as Embden-Meyerhof-Parnas
glycolysis operate on this time scale (Figure 5.1). Failure to respond to dynamically
changing environments can lead to loss of fitness, disease or death. Such failed control
of Embden-Meyerhof-Parnas glycolysis occurs for instance in cancer and diabetes [9,
24].
Glucose
Fructose 1,6-bisphosphate
Dihydroxyacetone
phosphate
Glyceraldehyde 3-phosphate
3-Phosphoglycerate
Acetaldehyde + CO2
Ethanol
NAD+
NADH/H+
NAD+
NADH/H+
Pyruvate
ADP
ATP
reaction progress
changes cofactor pools
within seconds
Glucose 6-phosphate
Fructose 6-phosphate
2-Phosphoglycerate
Phosphoenolpyruvate
1,3-Diphosphoglycerate
ADP
ATP
Pi
ATP
ADP
ATP
ADP
Figure 5.1: Overview of Embden-Meyerhoff-Parnas glycolysis. Reaction progress can
affect redox (NADH/NAD+) and energy (ATP/ADP) currencies on the seconds time
scale
Unsurprisingly, the mechanistic understanding of robustness and adaptation of in-
tracellular reactions in changeable environments has remained poorly understood due
to technical challenges. Resolved signals from the different chemicals and sub-second
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harvest starvation hyperpolarized 
glucose
in-silico simulation 
of experiment using 
metabolic model
Figure 5.2: Experimental design to track pre-steady state glycolysis using a bolus
of hyperpolarized glucose probe in starved cells. Experimental data are rationalized
through a computational simulation of the experiment.
time resolution are needed to directly track the reaction cascade with sufficient data
points in the living state [3]. Computational models of reaction cascades in glycolysis
have been built from experimental Michaelis-Menten characterizations of the isolated
catalytic pathway enzymes [21, 7, 20]. In the absence of equivalent experimental data,
these models are hard to probe for their predictive value in the living system. NMR
spectroscopy can experimentally provide resolved signals from the different chemicals
in multistep reaction cascades. A variant of NMR spectroscopy combines chemical
labeling with the NMR-visible 13C isotope and a physical labeling approach that re-
distributes (“hyperpolarizes”) [1] nuclear spin states to achieve a short-lived boost
of NMR sensitivity. The 13C-labeled hyperpolarized probe molecule improves signals
of interest relative to the background 105-106 fold and makes detection of reactions
on the 0.1-100 seconds time scales feasible. Thus, hyperpolarized NMR spectroscopy
can provide valuable data to further validate kinetic models for different metabolic
pathways.
Hyperpolarized NMR spectroscopy can noninvasively track the dynamic conver-
sion of carbohydrate spins to glycolytic intermediates and end products. The system
remains largely underdetermined, however, relative to the number of unknowns, in-
cluding metabolite concentrations, association constants and the rates of forward and
backward reactions in each cascade step. We therefore combine experimental ob-
servations of pre-steady state glycolysis in starved cells and the simulation of the
experiments using metabolic in silico models to identify changes of the rate limiting
steps in the upstart of glycolysis (Figure 5.2).
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5.2 Results
In cancer cells, bacteria and yeast, dihydroxyacetone phosphate was previously iden-
tified as a main intermediate of the glycolytic reaction cascade [13, 14, 8, 5, 17,
12]. Dihydroxyacetone phosphate equilibrates with a minor species of its aldehyde
epimer glyceraldehyde 3-phosphate, which is subsequently oxidized and phosphory-
lated in a reaction catalyzed by the enzyme glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH).
The accumulation of dihydroxyacetone phosphate is unanticipated from early com-
putational models of yeast glycolysis, but is consistent with experimental determina-
tions of metabolite concentrations at steady state [21]. The kinetic experiments re-
sulted in metabolites where a C-2H rather than a C- 1H bond is broken by GAPDH.
Hence, it remained unclear, whether the disagreement between experimental data
and early computational models results form experimental isotope effects or from
shortcomings of the model [13, 11]. In order to probe if dihydroxyacetone phosphate
oxidation is a bottleneck in natural glycolytic reaction cascades, we employed various
hyperpolarized substrates that result in protonated positions for dehydrogenase re-
actions (shown in the Supporting information, Figure 5.6). These experiments with
substrates that yield protonated C-1 positions of glyceraldehyde intermediate show
that dihydroxyacetone phosphate accumulates as an intermediate in the living sys-
tem both for subsequent C1H and C2H cleavage. Hence, other factors than CH bond
cleavage are limiting for the GAPDH catalyzed conversion of the dihydroxyacetone
phosphate intermediate in the living state. Notably, the GAPDH reaction has also
been identified as a rate determining step in computational models of cancer glycol-
ysis [19], and in more recent models of yeast glycolysis [7, 20]. Encouraged by the
agreement of experimentally observed and computationally predicted bottlenecks, we
undertook to study mechanistic responses in pre-steady state glycolysis. This under-
taking is further motivated by: (i) the rapid fading of hyperpolarized NMR signal
inside living cells [10], implying that changing pathway bottlenecks can be probed in
a time-resolved manner (rather than an influx of the probe into cellular steady state
pools); and (ii) the fast real time detection of in vivo spectra (on the sub-second
timescale) allowing pre-steady state in vivo measurements [15].
To probe pre-steady state reactions in the upstart of glycolysis, cells were starved
for 20 minutes. Upon a glucose pulse applied to starved cell suspensions, 3-phosphoglycerate
[23] was initially labeled, alongside minor formation of phosphoenolpyruvate (Figure
5.7). These metabolites are formed downstream of the GAPDH reaction, showing
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that the GAPDH reaction is not limiting in starved cells, but only becomes limiting
during the upstart of glycolysis. Thus, the rate-determining step in the glycolytic
reaction cascade dynamically changes upon an external glucose stimulus within few
seconds (Figure 5.3a). The increasingly upstream bottlenecks have conceivable func-
tions in avoiding the exhaustion of cofactors used in upper glycolysis [22].
Experimental data of the detected changes of the rate limiting steps in pre-steady
state glycolysis were compared to predictions from a computational simulation of
the experiment using a recent kinetic model of Saccharomyces cerevisiae glycolysis
[20]. The model comprises network topology and the enzyme kinetic parameters
obtained under standardized conditions. Simulations of time-dependent metabolite
concentrations were conducted using the MASS toolbox in Mathematicar [18]. The
yeast metabolic model was used to evolve intracellular metabolite pools in the ab-
sence of glucose for 20 minutes to mimic starvation, prior to simulating a glucose
bolus (Figure 5.3b). This simulation correctly predicts the initial accumulation of
3-phosphoglycerate, followed by accumulation of dihydroxyacetone phosphate and
fructose 1,6-bisphosphate. Thus, experiment and simulation show the same shifts of
bottlenecks towards upstream cascade steps on the seconds timescale in pre-steady
state glycolysis (Figure 5.3c). However, the in vivo kinetics seem to be considerably
faster than the in silico kinetics, with the measured glycolytic intermediates accu-
mulating faster in vivo than in silico. This seems to indicate that the enzymes’ kcat
and/or the active enzyme concentrations are higher in vivo than in silico. One reason
for slower kinetics in silico could be that there was a higher than expected inactive
amount of enzyme in the assay used to measure the kinetic parameters. This could be
due to enzyme instability or simply due to enzymes being in a conformation to which
substrates cannot bind [16, 2, 20], possibly due to the purification or assay meth-
ods used. Moreover, even though the kinetic parameters were measured in standard
conditions defined to resemble physiological conditions, the presence of e.g. certain
ions in the media can lead to enzyme activation or inactivation that may or may not
happen in vivo [6].
The observed slowdown in labeling of 3-phosphoglycerate in pre-steady glycolysis
could result from an increasing exhaustion of NAD+ (Figure 5.1). In order to test the
role of the cellular redox state in regulation of glycolysis, an established experimental
perturbation was applied, where acetaldehyde is coinjected with glucose [4]. Acetalde-
hyde is an easily membrane permeable electron acceptor that regenerates NAD+ for
the GAPDH reaction. Accordingly, fluorescence measurements had shown an increase
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Figure 5.3: (a) Formation of cellular fructose 1,6-bisphosphate (Fbp), dihydroxyace-
tone phosphate (DHAP) and 3-phosphoglycerate from exogenous glucose. 13C NMR
spectroscopic data when using hyperpolarized [U-13C, 2H]glucose are shown (top) in
addition to corresponding signal integrals (bottom), showing that labeling of lower
glycolytic intermediates precedes labeling of upper intermediates. Signals fade as
non-equilibrium hyperpolarization fades. (b) Simulated response of the startup of
glycolysis in starved yeast cells. The simulation qualitatively reproduces the trend
shown in (a). Changes of the rate limiting steps occur during the startup of glycolysis
on the seconds time scale, shifting bottlenecks upstream (c).
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of the free cytosolic NAD+/NADH ratio when coinjecting acetaldehyde with a glu-
cose bolus to yeast cells (2.3 mM of acetaldehyde and glucose), while a drop in the
NAD+/NADH ratio had been measured when injecting glucose without acetaldehyde
[4]. Measurements of pre-steady state glycolysis under redox perturbation show that
dynamic labeling of 3-phosphoglycerate persists in the presence of electron acceptor.
The GAPDH reaction does not become rate limiting within few seconds if NAD+ is
regenerated (Figure 5.4). In the conversion of glucose to ethanol, presence of added
acetaldehyde makes acetaldehyde reduction to ethanol limiting due to the exhaustion
of NADH (Figure 5.4). In the presence of the reducing carbon source ethanol, effects
are opposite to those of added acetaldehyde, resulting in a more severe bottleneck at
the GAPDH reaction but less severe bottleneck at the 3-phosphoglycerate isomeriza-
tion step, consistent with a more reducing cellular milieu in the presence of electron
donor. Hence, the bottlenecks of upper and lower glycolysis indirectly probe the cel-
lular redox state (Figure 5.5). Notably, the experimentally observed effects of redox
perturbation on accumulation of 3-phosphoglycerate, pyruvate, and dihydroxyacetone
phosphate could all be simulated in silico (Figures 5.8-5.10).
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Figure 5.4: Real-time spectroscopy of glucose conversion to intracellular metabolites
in response to disturbed redox state. Coninjection of acetaldehyde as an electron
acceptor increases dihydroxyacetone phosphate conversion and maintains the down-
stream reaction of 3-phosphoglycerate as a bottleneck.
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Figure 5.5: Opposing effects of external electron acceptor (addition of acetaldehyde)
and electron donor (growth in ethanol) on rate-limiting steps in the glycolytic cas-
cade. (A) Sum spectra of time-resolved rapid-injection experiments show the shifts in
cascade bottlenecks, resulting in signal areas that are dependent on redox state (B).
5.3 Final remarks
In conclusion, shifts in rate limiting steps as the cell responds to the availability of
glucose can be probed by rapid injection NMR spectroscopy. Metabolites are labeled
by nuclear spins deriving from glucose in an order that demonstrates a change of rate-
limiting steps in glycolysis within seconds. Self-regulation of the glycolytic cascade
sustains flux at low substrate concentrations but avoids an exhaustion of cofactors in
upper glycolysis when ample substrate is available. A role of the cellular redox state
in the regulation of cascade bottlenecks was deduced by perturbation experiments.
Acetaldehyde had been known to elicit dynamic responses in cells, most notably by
inducing glycolytic oscillations. Herein, acetaldehyde was shown to shift glycolytic
dynamics by maintaining a state that is reminiscent of glycolytic upstart, causing a de-
layed burst in acetaldehyde formation from glucose substrate. Experimental findings
on time- and redox-dependent changes of the rate limiting steps in pre-steady state
glycolysis could be qualitatively validated by in silico simulations using metabolic
models. Thus, systems models of central metabolism appear to have achieved a level
of quality that permits correct mechanistic predictions of unanticipated biochemical
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events. Inaccuracies in the predictions can be identified experimentally, such as an
underestimation of pathway control by GAPDH in earlier models [21] and an over-
estimation of phosphoenolpyruvate formation in recent models [20]. The combined
use of rapid injection NMR spectroscopy in starved cells and in silico modeling thus
provides a promising method for characterizing cellular metabolism with increasing
mechanistic detail.
5.4 Supplementary information
Experimental details
Chemicals
Isotope-enriched metabolic substrates [U-13C, U-2H] glucose, [2-13C]-fructose and
[6-13C,6,6’-2H2]-glucose) were purchased from Cortec (Voisins-Le-Bretonneux, France),
Cambridge Isotope Laboratories (Tewksbury, MA, USA) and Medical Isotopes Inc.
(Pelham, NH, USA). All other chemicals were purchased from Sigma Aldrich (An-
dover, MA, USA).
Cell growth
Shake flask cultures of S. cerevisiae BY4743 (MATa/MATα; his3∆1/his3∆1 leu2∆0/leu2∆0
lys2∆0/LYS2 met15∆0/MET15 ura3∆0/ura3∆0) were inoculated in 250 ml Erlen-
myer flasks containing 250 mL YPD medium (yeast extract (1% w/v), peptone (2%
w/v), glucose (2 % w/v)) from YPD agar plates and incubated over night under
shaking at 200 rpm at 30 °C in. These over night precultures were used to inoculate
the main yeast cultures of 100 mL YPD (in one-liter Erlenmyer flasks) at a dilution
of 1:100, resulting in a OD600 = 0.15–0.20. The shake flask cultures were grown
at 30 °C and 200 rpm shaking to OD600 = 0.8. The cultures were harvested by
centrifugation in 50 mL Falcon tubes (5000 g, 5 min) and the cell pellet was washed
with 20 mL MES buffer (30 mM, pH 5.65). After a second centrifugation the pellet
was resuspended in 2.2 mL fresh MES buffer (30 mM, pH 5.65) prior to transfer to
a 10 mm NMR tube. Yeast cell suspensions were starved in the absence of added
glucose or other carbon source for a total of 20 minutes prior to the in cell NMR
experiment. For the in cell NMR experiment, cell suspensions were placed in a 600
MHz Bruker spectrometer 20 min after the last resuspension. In order to evaluate
the effect of reducing environment on cellular glycolysis, yeast cells were maintained
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for 30 minutes in YPE medium (yeast extract (1% w/v), peptone (2% w/v), ethanol
(2 % v/v)) prior to harvest and in cell NMR experiment.
DNP hyperpolarization of hexoses
Solid state DNP polarization of all hexose substrates were performed as previ-
ously described using trityl radical OX063 (27 mm; Oxford Instruments, Abingdon,
UK) and trimeric gadolinium chelate of 1,3,5-tris-(N-(DO3A-acetamido)-N-methyl-
4-amino-2-methylphenyl)-[1,3,5]triazinane-2,4,6-trione (0.9 mm; GE Healthcare) [10,
13]. Samples contained 90 µmol hexose in 19 mg of aqueous polarization medium
containing 27 mM trityl radical OX063 and 0.9 mM trimeric Gd chelate. Samples
were flash-frozen in liquid helium and polarization transfer was conducted for one
hour at 1.2 K by microwave irradiation at 93.89 GHz with 100 mW in a magnetic
field of 3.35 T. The solid state polarization buildup was monitored every 5 minutes
and solid state polarizations in the self-glassing carbohydrate syrup achieved on the
order of 30%. After 1 hour of polarization, the samples were dissolved with heated
Milli-Q water (4.5 mL containing EDTA (100 mg/L)) to yield liquid samples with a
final substrate concentration of 20 mM hexose. Hyperpolarized substrates (600 µL)
were forcefully, manually injected into 2.4 mL of the cell suspension placed inside a
600 MHz Bruker spectrometer. This preparation resulted in a final concentration of
4 mM hyperpolarized carbohydrate substrate for the in-cell NMR experiment.
In cell NMR
All spectra were recorded on a DRX600 spectrometer (Bruker, Karlsruhe, Ger-
many) equipped with a 10 mm BBO probe head that was thermally equilibrated to
30 °C. Glycolytic reaction was followed by a series of 13C NMR spectra that were
recorded as pseudo-2D spectra using low flip angle (5º) pulses for excitation. A
13C NMR spectrum of 16384 complex data points was record every 0.5 s. As data
acquisition was started prior to substrate injection, experimental dead-time upon
substrate feeding was minimized. All spectra were processed in Topspin 3.5 (Bruker)
with extensive zero filling and an exponential line broadening of 10 Hz; spectra were
integrated in the same software.
NAD+/NADH alteration
Experiments with experimental modulation of the cellular NAD+/NADH ratio were
performed as described above with the exception that acetaldehyde at the desired
concentration was dissolved in 0.5 mL Milli-Q water and placed in the bottom of the
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receiving container for the hyperpolarized hexose in order to achieve a coninjection
of acetaldehyde [4] with the received hyperpolarized glucose substrate. Subsequently,
in cell NMR experiments were conducted as described above.
In silico modeling
Model simulations
The glycolysis model by Smallbone et al [20] was used for the in silico modeling of
Saccharomyces cerevisiae glycolysis, and all simulations were carried out in the MASS
toolbox [18] in Mathematicar. Experiments were simulated in silico as follows: the
cell starvation was simulated by setting the extracellular glucose concentration to 0.1
mM for 20 minutes. The extracellular glucose concentration is defined as a constant
in the model utilized here. In order to simulate the glucose pulse, the extracellular
concentration of glucose was raised to 4 mM after the 20 minutes starvation period
and the evolution of key metabolites and fluxes in yeast glycolysis were simulated for
60 seconds, i.e. the approximate time of the in cell DNP-NMR experiment. In order
to simulate the coinjection of glucose and acetaldehyde, the extracellular concentra-
tion of glucose was raised to 4 mM and the internal concentration of acetaldehyde was
raised to either 2.3 mM or 12 mM after the 20 min starvation period. Simulations cor-
rectly predict a rapid drop in cellular NAD+/NADH ratio upon a glucose pulse, but
a rapid increase in NAD+/NADH upon coinjection of acetaldehyde (see Figures 5.7,
5.8). Likewise, a rapid accumulation of 3-phosphoglycerate, dihydroxyacetone phos-
phate, and fructose 1,6-bp on the seconds time scale were correctly predicted upon
a glucose pulse (Section 5.2, Figure 5.3), as were significantly lower accumulation of
fructose-1p and glyceraldehyde 3-phosphate. A comparison between the model and
transient NMR data shows that the model appears to overestimate the accumulation
of phosphoenolpyruvate. This finding is consistent with reported difficulties in deter-
mining and modeling kinetic parameters in the conversion of 3-phosphoglycerate to
phosphoenolpyruvate [20] and with previous determinations of much lower phospho-
enolpyruvate levels than predicted from the current model [20]. Glycolytic responses
upon a modulation of the cellular redox state are consistent between DNP-NMR data
of pre-steady glycolysis and simulation, yielding increased accumulation of pyruvate
and 3-phosphoglycerate, but lower accumulation of dihydroxyacetone phosphate upon
coinjection of acetaldehyde in the upstart of glycolysis (Figure 5.9).
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The model
The final mathematical model developed in [20] was used, model 18 in the article. The
model is also available at http://identifiers.org/biomodels.db/MODEL1303260018.
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The model includes the following (iso)enzymes:
Reaction Reaction abbreviation Isoenzymes
acetate branch acetate branch
Alcohol dehydrogenase ADH Adh1p, Adh5p
Adenylate kinase AK -
ATPase ATPase -
Enolase ENO Eno1p, Eno2p
Fructose-bisphosphate
aldolase
FBA Fba1p
Glyceraldehyde phosphate
dehydrogenase
GAPDH Tdh1p, Tdh2p, Tdh3p
Glycerol 3-phosphate
dehydrogenase
GPD -
Phosphoglyceromutase GPM Gpm1p
Glycerol 3-phosphatase GPP -
Hexokinase HXK Glk1p, Hxk1p, Hxk2p
Glucose transport HXT -
Pyruvate decarboxylase PDC Pdc1p, Pdc5p, Pdc6p
Phosphofructokinase PFK Pfk1p and Pfk2p
Phosphoglucose isomerase PGI Pgi1p
3-phosphoglycerate kinase PGK Pgk1p
Phosphoglucomutase PGM -
Pyruvate kinase PYK Cdc19p, Pyk2p
Succinate branch succinate branch -
T6P synthase TPS -
Triosephosphate isomerase TPI Tpi1p
T6P phosphatase TPP -
UDP glucose phosphorylase UGP -
UDP to UTP
pseudoreaction
UDP-to-UTP -
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The corresponding rate laws are:
vacetate_branch = kacetate branch[AcAld][NAD]
vADH1 =
[ADH1]kcat,ADH1
(
[AcAld][NADH]
KAcAldm,ADH1K
NADH
i,ADH1
− [ETOH][NAD]
KAcAldm,ADH1K
NADH
i,ADH1Keq,ADH
)
1 + [NADH]
KNADHi,ADH1
+
[AcAld]KNADHm,ADH1
KNADHi,ADH1K
AcAld
m,ADH1
+
[ETOH]KNADm,ADH1
KNADi,ADH1K
ETOH
m,ADH1
+ [NAD]
KNADi,ADH1
+ [AcAld][NADH]
KNADHi,ADH1K
AcAld
m,ADH1
+
[NAD][ETOH]KNADm,ADH1
KNADHi,ADH1K
NAD
i,ADH1K
ETOH
m,ADH1
+
[AcAld][NAD]KNADHm,ADH1
KNADHi,ADH1K
NAD
i,ADH1K
AcAld
m,ADH1
+ [ETOH][NAD]
KNADi,ADH1K
ETOH
m,ADH1
+ [AcAld][NADH][ETOH]
KNADHi,ADH1K
ETOH
i,ADH1K
AcAld
m,ADH1
+ [AcAld][ETOH][NAD]
KAcAldi,ADH1K
NAD
i,ADH1K
ETOH
m,ADH1
vADH5 =
[ADH5]kcat,ADH5
(
[AcAld][NADH]
KAcAldm,ADH5K
NADH
i,ADH5
− [ETOH][NAD]
KAcAldm,ADH5K
NADH
i,ADH5Keq,ADH
)
1 + [NADH]
KNADHi,ADH5
+
[AcAld]KNADHm,ADH5
KNADHi,ADH5K
AcAld
m,ADH5
+
[ETOH]KNADm,ADH5
KNADi,ADH5K
ETOH
m,ADH5
+ [NAD]
KNADi,ADH5
+ [AcAld][NADH]
KNADHi,ADH5K
AcAld
m,ADH5
+
[NAD][ETOH]KNADm,ADH5
KNADHi,ADH5K
NAD
i,ADH5K
ETOH
m,ADH5
+
[AcAld][NAD]KNADHm,ADH5
KNADHi,ADH5K
NAD
i,ADH5K
AcAld
m,ADH5
+ [ETOH][NAD]
KNADi,ADH5K
ETOH
m,ADH5
+ [AcAld][NADH][ETOH]
KNADHi,ADH5K
ETOH
i,ADH5K
AcAld
m,ADH5
+ [AcAld][ETOH][NAD]
KAcAldi,ADH5K
NAD
i,ADH5K
ETOH
m,ADH5
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vAK = kAK
(
[ADP ][ADP ]− [AMP ][ATP ]
Keq,AK
)
vATPase =
Vmax,ATPase
(
[ATP ]
KATPm,ATPase
)
1 + [ATP ]
KATPm,ATPase
vENO1 =
[ENO1]kcat,ENO1
(
[2PG]
K2PGm,ENO1
− [PEP ]
K2PGm,ENO1Keq,ENO
)
1 + [2PG]
K2PGm,ENO1
+ [PEP ]
KPEPm,ENO1
vENO2 =
[ENO2]kcat,ENO2
(
[2PG]
K2PGm,ENO2
− [PEP ]
K2PGm,ENO2Keq,ENO
)
1 + [2PG]
K2PGm,ENO2
+ [PEP ]
KPEPm,ENO2
vFBA =
[FBA1]kcat,FBA1
(
[FBP ]
KFBPm,FBA1
− [DHAP ][G3P ]
KFBPm,FBA1Keq,FBA
)
1 + [FBP ]
KFBPm,FBA1
+ [DHAP ]
KDHAPm,FBA1
+ [G3P ]
KG3Pm,FBA1
+ [FBP ][G3P ]
KFBPm,FBA1K
G3P
i,FBA1
+ [DHAP ][G3P ]
KDHAPm,FBA1K
G3P
m,FBA1
vGAPDH1 =
[TDH1]kcat,GAPDH1
(
[G3P ][NAD]
KG3Pm,GAPDH1K
NAD
m,GAPDH1
− [13DPG][NADH]
KG3Pm,GAPDH1K
NAD
m,GAPDH1Keq,GAPDH
)
(
1 + [G3P ]
KG3Pm,GAPDH1
+ [13DPG]
K13DPGm,GAPDH1
)(
1 + [NAD]
KNADm,GAPDH1
+ [NADH]
KNADHm,GAPDH1
)
vGAPDH2 =
[TDH2]kcat,GAPDH2
(
[G3P ][NAD]
KG3Pm,GAPDH2K
NAD
m,GAPDH2
− [13DPG][NADH]
KG3Pm,GAPDH2K
NAD
m,GAPDH2Keq,GAPDH
)
(
1 + [G3P ]
KG3Pm,GAPDH2
+ [13DPG]
K13DPGm,GAPDH2
)(
1 + [NAD]
KNADm,GAPDH2
+ [NADH]
KNADHm,GAPDH2
)
vGAPDH3 =
[TDH3]kcat,GAPDH3
(
[G3P ][NAD]
KG3Pm,GAPDH3K
NAD
m,GAPDH3
− [13DPG][NADH]
KG3Pm,GAPDH3K
NAD
m,GAPDH3Keq,GAPDH
)
(
1 + [G3P ]
KG3Pm,GAPDH3
+ [13DPG]
K13DPGm,GAPDH3
)(
1 + [NAD]
KNADm,GAPDH3
+ [NADH]
KNADHm,GAPDH3
)
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vGPD =
Vmax,GPD
(
[DHAP ][NADH]
KDHAPm,GPDK
NADH
m,GPD
− [Glyc3P ][NAD]
KDHAPm,GPDK
NADH
m,GPDKeq,GPD
)
(
1 + [FBP ]
KFBPm,GPD
+ [ATP ]
KATPm,GPD
+ [ADP ]
KADPm,GPD
)(
1 + [DHAP ]
KDHAPm,GPD
+ [Glyc3P ]
KGlyc3Pm,GPD
)(
1 + [NADH]
KNADHm,GPD
+ [NAD]
KNADm,GPD
)
vGPM1 =
[GPM1]kcat,GPM1
(
[3PG]
K3PGm,GPM1
− [2PG]
K2PGm,GPM1Keq,GPM1
)
1 + [3PG]
K3PGm,GPM1
+ [2PG]
K2PGm,GPM1
vGPP =
Vmax,GPP
(
[Glyc3P ]
KGlyc3Pm,GPP
)
1 + [Glyc3P ]
KGlyc3Pm,GPP
vGLK1 =
[GLKL1]kcat,GLK1
(
[Glccell][ATP ]
KGlcm,GLK1K
ATP
m,GLK1
− [G6P ][ADP ]
KGlcm,GLK1K
ATP
m,GLK1Keq,HXK
)
(
1 + [Glccell]
KGlcm,GLK1
+ [G6P ]
KG6Pm,GLK1
)(
1 + [ATPl]
KATPm,GLK1
+ [ADP ]
KADPm,GLK1
)
vHXK1 =
[HXK1]kcat,HXK1
(
[Glccell][ATP ]
K
Glccell
m,HXK1K
ATP
m,HXK1
− [G6Pl][ADP ]
K
Glccell
m,HXK1K
ATP
m,HXK1Keq,HXK
)
(
1 + [Glccell]
K
Glccell
m,HXK1
+ [G6P ]
KG6Pm,HXK1
+ [T6P ]
KT6Pi,HXK1
)(
1 + [ATP ]
KATPm,HXK1
+ [ADP ]
KADPm,HXK1
)
vHXK2 =
[HXK2]kcat,HXK2
(
[Glccell][ATP ]
K
Glccell
m,HXK2K
ATP
m,HXK2
− [G6Pl][ADP ]
K
Glccell
m,HXK2K
ATP
m,HXK2Keq,HXK
)
(
1 + [Glccell]
K
Glccell
m,HXK2
+ [G6P ]
KG6Pm,HXK2
+ [T6P ]
KT6Pi,HXK2
)(
1 + [ATP ]
KATPm,HXK2
+ + [ADP ]
KADPm,HXK2
)
vHXT =
Vmax,HXT
(
[Glcex]−[Glccell]
KGlcm,HXT
)
1 + [Glcex]
KGlcm,HXT
+ [Glccell]
KGlcm,HXT
+
Ki,HXT [Glcex]
KGlc
m,HXT
[Glccell]
KGlcm,HXT
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vPDC1 =
[PDC1]kcat,PDC1
(
[Pyr]
KPyrm,PDC1
)
1 + [Pyr]
KPyrm,PDC1
vPDC5 =
[PDC5]kcat,PDC5
(
[Pyr]
KPyrm,PDC5
)
1 + [Pyr]
KPyrm,PDC5
vPDC6 =
[PDC6]kcat,PDC6
(
[Pyr]
KPyrm,PDC6
)
1 + [Pyr]
KPyrm,PDC6
vPFK =
min([PFK1], [PFK2]) kcat,PFK
gRPFK
[F6P ][ATP ]
KF6Pm,PFKK
ATP
m,PFK
1− [FBP ][ADP ][F6P ][ATP ]
Keq,PFK
(1 + [F6P ]
KF6Pm,PFK
+ [ATP ]
KATPm,PFK
+
gRPFK [F6P ]
KF6Pm,PFK
KATPm,PFK
+ [FBP ]
KFBPm,PFK
+ [ADP ]
KADPm,PFK
+
gRPFK [FBP ]
KFBPm,PFK
[ADP ]
KADPm,PFK1 + [F6P ]
KF6Pm,PFK
+ [ATP ]
KATPm,PFK
+
gRPFK [F6P ]
KF6Pm,PFK
[ATP ]
KATPm,PFK
+ [FBP ]
KFBPm,PFK
+ [ADP ]
KADPm,PFK
+
gRPFK [FBP ]
KFBPm,PFK
KADPm,PFK

2
+ L0,PFK
1 +
CATPi,PFK [ATP ]
KATPi,PFK
1 + [ATP ]
KATPi,PFK

21 +
CAMPPFK [AMP ]
KAMPm,PFK
1 + [AMP ]
KAMPm,PFK

21 +
CF26BPPFK [F26BP ]
KF26BPm,PFK
+ C
FBP
PFK [FBP ]
KFBPm,PFK
1 + [F26BP ]
KF26BPm,PFK
+ [FBP ]
KFBPm,PFK

2
(
1 + C
ATP
PFK [ATP ]
KATPm,PFK
)2
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vPG11 =
[PGI1]kcat,PGI1
(
[G6P ]
KG6Pm,PGI1
− [F6P ]
KG6Pm,PGI1Keq,PGI1
)
1 + [G6P ]
KG6Pm,PGI1
+ [F6P ]
KF6Pm,PGI1
vPGK1 =
[PGK1]kcat,PGK1
(
[ADP ]
KADPm,PGK1
)nADPH,PGK−1 ( [13DPG][ADP ]
K13DPGm,PGK1K
ADP
m,PGK1
− [3PG][ADP ]
K13DPGm,PGK1K
ADP
m,PGK1Keq,PGK1
)
(
1 + [13DPG]
K13DPGm,PGK1
+ [3PG]
K3PGm,PGK1
)(
1 +
(
[ADP ]
KADPm,PGK1
)nADPH,PGK
+ [ATP ]
KATPm,PGK1
)
vPGM =
Vmax,PGM
(
[G6P ]
KG6Pm,PGM
− [G1P ]
KG6Pm,PGMKeq,PGM
)
1 + [G6P ]
KG6Pm,PGM
+ [G1P ]
KG1Pm,PGM
vCDC19 =
[CDC19]kcat,CDC19
(
[PEP ][ADP ]
KPEPm,CDC19K
ADP
m,CDC19
− [Pyr][ATP ]
KPEPm,CDC19K
ADP
m,CDC19Keq,PY K
)
1 + [PEP ]
KPEPm,CDC19
+ [Pyr]
KPyrm,CDC19
+ L0,CDC19
[ATP ]
KATP
i,CDC19
+1
[FBP ]
KFBP
m,CDC19
+1
(1 + ADP
KADPm,CDC19
+ [ATP ]
KATPm,CDC19
)
vPY K2 =
[PY K2]kcat,PY K2
(
[PEP ][ADP ]
KPEPm,PYK2K
ADP
m,PYK2
− [Pyr][ATP ]
KPEPm,PYK2K
ADP
m,PYK2Keq,PY K
)
1 + [PEP ]
KPEPm,PYK2
+ [Pyr]
KPyrm,PYK2
+ L0,PY K2
[ATP ]
KATP
i,PY K2
+1
[FBP ]
KFBP
m,PYK2
+1
(1 + ADP
KADPm,PYK2
+ [ATP ]
KATPm,PYK2
)
vsuccinate_branch = ksuccinate_branch[Pyr][NAD]
vTPS =
Vmax,TPS
(
[G6P ][UDPglc]
KG6Pm,TPSK
UDPglc
m,TPS
)
(
1 + [G6P ]
KG6Pm,TPS
)(
1 + [UDPglc]
K
UDPglc
m,TPS
)
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vTPI1 =
[TPI1]kcat,TPI
(
[DHAP ]
KDHAPm,TPI1
− [G3P ]
KDHAPm,TPI1Keq,TPI
)
1 + [DHAP ]
KDHAPm,TPI1
+ [G3P ]
KG3Pm,TPI1
(
1 +
(
[G3P ]
KG3Pi,TPI
)4)
vTPP =
Vmax,TPP
(
[T6P ]
KT6Pm,TPP
)
1 + [T6P ]
KT6Pm,TPP
vUGP =
Vmax,UGP
(
[UTP ][G1P ]
KUTPm,UGPK
G1P
m,UGP
)
KUTPi,UGP
KUTPm,UGP
+ [UTP ]
KUTPm,UGP
+ [G1P ]
KG1Pm,UGP
+ [UTP ][G1P ]
KUTPm,UGP+K
G1P
m,UGP
+
KUTP
i,UGP
KUTP
m,UGP
[UDPglc]
K
UDPglc
i,UGP
+ [G1P ][UDPglc]
KG1Pm,UGPK
UDPglc
i,UGP
vUDP−to−UTP = kUDP−to−UTP [UDP ][ATP ]
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The system of Ordinary Differential Equations is the following:
d([ADP ])
dt
= vUDP−to−UTP − vPY K2 − vCDC19 − vPGK1 + vPFK
+ vHXK2 + vHXK1 + vGLK1 + vATPase − 2 · vAK
d([ATP ])
dt
= −vUDP−to−UTP −+vPY K2 + vCDC19 + vPGK1
− vPFK − vHXK2 − vHXK1 − vGLK1 − vATPase + 2 · vAK
d([AcAld])
dt
= vPDC6 + vPDC5 + vPDC1 − vacetate branch − vADH5 − vADH1
d([13DPG])
dt
= vTDH1 − vPGK1 + vGAPDH2 + vGAPDH3
d([DHAP ])
dt
= vFBA − vTPI − vGPD
d([FBP ])
dt
= vPFK − vFBA
d([F6P ])
dt
= vPGI − vPFK
d([G1P ])
dt
= vPGM − vUDG
d([Glyc3P ])
dt
= −vGPP + vGPD
d([G6P ])
dt
= −vPGM − vPGI + vHXK2 + vHXK1 + vGLK1 − vTPS
d([G3P ])
dt
= −vGAPDH1 − vGAPDH2 − vGAPDH3 + vFBA + vTPI
d([Glccell])
dt
= vHXT − vHXK1 − vHXK2 − vGLK1
d([NAD])
dt
= −vGAPDH1 − vGAPDH2 − vGAPDH3 − 3 · vsuccinate branch
+ vGPD − vacetate branch + vADH5 + vADH1
d([2PG])
dt
= vGPM1 − vENO1 − vENO2
d([3PG])
dt
= vPGK1 − vGPM1
d([PEP ])
dt
= −vPY K2 − vCDC19 + vENO1 + vENO2
d([Pyr])
dt
= vPY K2 + vCDC19 − vPDC1 − vPDC5 − vPDC6 − vsuccinate branch
d([T6P ])
dt
= vTPS − vTPP
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d([UDP ])
dt
= −vUDP−to−UTP + vTPSe
d([UTP ])
dt
= vUDP−to−UTP − vUDG
To this system of ODEs the following mass conservation equations are added:
[AMP ] = sumAXP − [ATP ]− [ADP ]
[NADH] = sumNAD − [NAD]
[UDPglc] = sumUXP − [UTP ]− [UDP ]
energy_charge =
[ATP ] + [ADP ]2
sumAXP
where:
sumAXP = [AMP ] + [ADP ] + [ATP ] = 6.02
sumNAD = [NAD] + [NADH] = 1.59
sumUXP = [UDPglc] + [UDP ] + [UTP ] = 1.4
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The enzyme concentrations used are:
Isoenzyme Concentration (mM/L)
ADH1 0.164
ADH5 0.0042
CDC19 2.05
ENO1 0.686
ENO2 1.97
FBA1 1.34
GLK1 0.045
GPD1 0.0068
GPD2 0.00079
GPM1 0.73
HOR 0.0055
HXK1 0.017
HXK2 0.061
PDC1 1.07
PDC5 0.012
PDC6 0.0065
PFK1 0.047
PFK2 0.039
PGI1 0.14
PGK1 0.26
PGM1 0.0033
PGM2 0.0013
PYK2 0.0061
RHR2 0.051
TDH1 0.35
TDH2 0
TDH3 4.2
TPI1 0.29
TPS1 0.0034
TPS2 0.0027
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The initial metabolite concentrations are:
Metabolite Concentration (mM) Is the concentration constant?
13DPG 0.00074 No
2PG 0.0677 No
3PG 0.47 No
AcAld 0.178 No
Acetate 223 Yes
ADP 1.29 No
ATP 4.29 No
DHAP 1.16 No
ETOH 221.9 Yes
FBP 4.58 No
F26bP 0.003 Yes
F6P 0.24 No
G1P 0.54 No
G6P 0.77 No
Glccell 6.28 No
G3P 0.32 No
Glycerol 0.15 Yes
Glyc3P 0.27 No
NAD 1.5 No
PEP 0.61 No
Pyr 2.1 No
Succinate 0 Yes
Trehalose 0.015 Yes
T6P 0.02 No
UDP 0.28 No
UGP1 0.0062 Yes
UTP 0.65 No
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The parameter values are:
Reaction Isoenzyme Parameter Value
Acetate branch - k 0.0055 s−1
ADH - Keq 14492.8
ADH Adh1p kcat 176 s−1
ADH Adh1p KETOHm 17 mM
ADH Adh1p KETOHi 90 mM
ADH Adh1p KAcAldm 0.4622 mM
ADH Adh1p KAcAldi 1.1 mM
ADH Adh1p KNADm 0.17 mM
ADH Adh1p KNADi 0.92 mM
ADH Adh1p KNADHm 0.11 mM
ADH Adh1p KNADHi 0.031 mM
ADH Adh5p kcat 0 s−1
ADH Adh5p KETOHm 17 mM
ADH Adh5p KETOHi 90 mM
ADH Adh5p KAcAldm 1.11 mM
ADH Adh5p KAcAldi 1.1 mM
ADH Adh5p KNADm 0.17 mM
ADH Adh5p KNADi 0.92 mM
ADH Adh5p KNADHm 0.11 mM
ADH Adh5p KNADHi 0.031 mM
AK - Keq 0.45
AK - k 0.75 s−1
ATPase - Vmax 6.16 mM/s
ATPase - KATPm 3 mM
ENO - Keq 6.7
ENO Eno1p kcat 7.6 s−1
ENO Eno1p K2PGm 0.043 mM
ENO Eno1p KPEPm 0.5 mM
ENO Eno2p kcat 19.9 s−1
ENO Eno2p K2PGm 0.104 mM
ENO Eno2p K2PGm 0.5 mM
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FBA - Keq 0.069
FBA Fba1p kcat 4.14 s−1
FBA Fba1p KFBPm 0.451 mM
FBA Fba1p KG3Pm 2.4 mM
FBA Fba1p KG3Pi 10 mM
FBA Fba1p KDHAPm 2 mM
GAPDH - Keq 0.0053
GAPDH Tdh1p kcat 19.1 s−1
GAPDH Tdh1p KG3Pm 0.495 mM
GAPDH Tdh1p K13DPGm 0.0098 mM
GAPDH Tdh1p KNADm 0.09 mM
GAPDH Tdh1p KNADHm 0.06 mM
GAPDH Tdh2p kcat 8.63 s−1
GAPDH Tdh2p KG3Pm 0.77 mM
GAPDH Tdh2p K13DPGm 0.0098 mM
GAPDH Tdh2p KNADm 0.09 mM
GAPDH Tdh2p KNADHm 0.06 mM
GAPDH Tdh3p kcat 18.2 s−1
GAPDH Tdh3p KG3Pm 0.423 mM
GAPDH Tdh3p K13DPGm 0.909 mM
GAPDH Tdh2p KNADm 0.09 mM
GAPDH Tdh2p KNADHm 0.06 mM
GPD - Keq 10000
GPD - Vmax 0.78 mM/s
GPD - KADPm 2 mM
GPD - KATPm 0.73 mM
GPD - KDHAPm 0.54 mM
GPD - KFBPm 4.8 mM
GPD - Kglyc3Pm 1.2 mM
GPD - KNADm 0.93 mM
GPD - KNADHm 0.023 mM
GPP – Vmax 0.883 mM/s
GPP - KG3Pm 3.5 mM
GPM - Keq 0.19
GPM Gpm1p kcat 400 s−1
GPM Gpm1p K2PGm 1.41 mM
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GPM Gpm1p K3PGm 1.2 mM
HXK - Keq 2000
HXK Glk1 kcat 0.0721 s−1
HXK Glk1 KGlcm 0.0106 mM
HXK Glk1 KATPm 0.865 mM
HXK Glk1 KADPm 0.23 mM
HXK Glk1 KG6Pm 30 mM
HXK Hxk1p kcat 10.2 s−1
HXK Hxk1p KGlcm 0.15 mM
HXK Hxk1p KATPm 0.293 mM
HXK Hxk1p KADPm 0.23 mM
HXK Hxk1p KG6Pm 30 mM
HXK Hxk1p KT6Pi 0.2 mM
HXK Hxk2p kcat 63.1 s−1
HXK Hxk2p KGlcm 0.2 mM
HXK Hxk2p KATPm 0.195 mM
HXK Hxk2p KADPm 0.23 mM
HXK Hxk2p KG6Pm 30 mM
HXK Hxk2p KT6Pi 0.04 mM
HXT - Kglcm 0.9 mM
HXT - Ki 0.91 mM
HXT - Vmax 3.35 mM/s
PDC Pdc1p kcat 12.1 s−1
PDC Pdc1p KPY Rm 8.5 mM
PDC Pdc5p kcat 10.3 s−1
PDC Pdc5p KPY Rm 7.08 mM
PDC Pdc6p kcat 9.21 s−1
PDC Pdc6p KPY Rm 2.92 mM
PFK - Keq 800
PFK Pfk1:Pfk2 kcat 210 s−1
PFK Pfk1:Pfk2 Camp 0.0845 mM
PFK Pfk1:Pfk2 Catp 3 mM
PFK Pfk1:Pfk2 CFBP 0.397 mM
PFK Pfk1:Pfk2 CF26BP 0.0174 mM
PFK Pfk1:Pfk2 CATPi 100 mM
PFK Pfk1:Pfk2 KADPm 1 mM
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PFK Pfk1:Pfk2 KAMPm 0.0995 mM
PFK Pfk1:Pfk2 KATPm 0.71 mM
PFK Pfk1:Pfk2 KFBPm 0.111 mM
PFK Pfk1:Pfk2 KF26BPm 0.000682 mM
PFK Pfk1:Pfk2 KF6Pm 0.1 mM
PFK Pfk1:Pfk2 KATPi 0.65 mM
PFK Pfk1:Pfk2 L0 0.66
PFK Pfk1:Pfk2 gR 5.12
PGI - Keq 0.29
PGI Pgi1p kcat 487 s−1
PGI Pgi1p KG6Pm 1.03 mM
PGI Pgi1p KF6Pm 0.307 mM
PGK Pgk1p kcat 58.6 s−1
PGK Pgk1p Keq 3200
PGK Pgk1p K3PGm 4.58 mM
PGK Pgk1p KATPm 1.99 mM
PGK Pgk1p K13DPGm 0.003 mM
PGK Pgk1p KADPm 0.2 mM
PGK Pgk1p nADPH 2
PGM - Keq 0.1667
PGM - Vmax 0.128 mM/s
PGM - KG1Pm 0.023 mM
PGM - KG6Pm 0.05 mM
PYK - Keq 6500
PYK Cdc19p kcat 20.1 s−1
PYK Cdc19p KPEPm 0.281 mM
PYK Cdc19p KADPm 0.243 mM
PYK Cdc19p KPY Rm 21 mM
PYK Cdc19p KATPm 1.5 mM
PYK Cdc19p KFBPm 0.2 mM
PYK Cdc19p KATPi 9.3 mM
PYK Cdc19p L0 100
PYK Pyk2p kcat 0 s−1
PYK Pyk2p KPEPm 0.19 mM
PYK Pyk2p KADPm 0.3 mM
PYK Pyk2p KPY Rm 21 mM
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PYK Pyk2p KATPm 1.5 mM
PYK Pyk2p KFBPm 0.2 mM
PYK Pyk2p KATPi 9.3 mM
PYK Pyk2p L0 100
succinate branch - k 0 s−1
T6P phosphatase - Vmax 2.34 mM/s
T6P phosphatase - KT6Pm 0.5 mM
T6P synthase - Vmax 0.49 mM/s
T6P synthase - KG6Pm 3.8 mM
T6P synthase - KUDGm 0.886 mM
TPI - kcat 0.045 mM
TPI Tpi1p kcat 564 s−1
TPI Tpi1p KDHAPm 6.45 mM
TPI Tpi1p KG3Pm 5.25 mM
TPI Tpi1p KG3Pi 35.1 mM
UGP - Vmax 13.26 mM/s
UGP - KG1Pm 0.32 mM
UGP - KUDGi 0.0035 mM
UGP - KUTPi 0.11 mM
UGP - KUTPm 0.11 mM
UDP-to-UTP - k 0.075 s−1
5.5 Supplemental figures
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Figure 5.6: In-cell experiments showing that dihydroxyacetone phosphate accumu-
lates as reaction intermediate using various molecular probes. Dihydroxyacetone
phosphate formed from [2-13C]-fructose and [6-13C,6,6’-2H2]-glucose is not protonated
at the position that is dehydrated in the glyceraldehyde-3-phosphate dehydrogenase
reaction (encircled position). GAPDH is thus a limiting step under physiological con-
ditions and other factors than C-H cleavage appear to limit reaction dihydroxyacetone
phosphate conversion.
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Figure 5.7: Intracellular metabolites formed in Saccharomyces cerevisiae upon a pulse
of hyperpolarized glucose. Signals formed within the first 5 seconds (A) show that 2-
phosphoglycerate predominates under the up-start of glycolysis, with smaller amounts
of 2-phosphoenolpyruvate forming concurrently (B), real-time series of 13C NMR spec-
tra). The concurrent emergence of 2-phosphoenolpyruvate and 3-phosphoglycerate is
consistent with an equilibrium between mono-phosphorylated C3-acids, while their
initial accumulation is consistent with an abundance of NAD+ and lack of ADP dur-
ing pre-steady state glycolysis. Minor formation of 2-phosphoenolpyruvate during
pre-steady state glycolysis is consistent with steady state metabolite levels, while its
formation is overestimated by some recent metabolic models [20].
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Figure 5.8: Schematic depiction of Saccharomyces cerevisiae cytosolic free
NAD+/NADH ratios in response to a 2.3 mM glucose pulse in the presence (grey) and
in the absence (red) of 2.3 mM acetaldehyde coinjection, as determined by Canelas
et al [4] and assuming a pH near 6.45 in the vacuole of non-growing yeast.
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Figure 5.9: Predicted evolution of intracellular NAD+/NADH ratio in response to
a 4 mM glucose pulse in the presence (grey) and in the absence (red) of 2.3 mM
acetaldehyde coinjection.
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Figure 5.10: Predicted trends for the effects of acetaldehyde coinjection during startup
of glycolysis, suggesting increases of 3-phosphoglycerate and pyruvate formation, but
a decrease of dihydroxyacetone phosphate, consistent with experimental data shown
in Figures 5.4 and 5.5.
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Chapter 6
Discussion and future work
In this thesis we focused on kinetic models for metabolism. We first aimed at devel-
oping an approach to build mechanistic kinetic models while making as little assump-
tions as possible. Towards this goal, in chapter 2, we start by developing a highly
flexible software package to parameterize enzymatic reactions individually (MASSef).
With MASSef we decompose the enzymatic reaction into its elementary steps and use
mass action rate laws to model each step. This results in different sets of elementary
rate constants k that can reproduce the kinetic data (e.g. Km, kcat, Ki) used to fit
the model equally well. Hence, we end up not with a single model for each enzyme,
but a model ensemble.
Building enzyme-level kinetic models using MASSef has a key limitation. It re-
quires kinetic data that is not always available and is usually hard to find for less
studied organisms. On the other hand, the software allows one to fit different ki-
netics, such as Michaelis-Menten or Hill kinetics, simply by specifying the correct
mechanism. Also, it can fit different kinetic parameter values measured under differ-
ent conditions, and, in principle, it can highlight incompatibilities between different
kinetic parameters, which lead to a higher sum of squared log-deviations.
Future work on MASSef
While working on MASSef, we found that the solution previously implemented to
model allosteric enzymes, and based on the mechanism described in [9], was not able
to reproduce the sigmoidal kinetics measured experimentally in [2]. This solution
is based on the Monod-Wyman-Changeux (MWC) model, which assumes that the
enzyme can be in two different conformations: one where substrate affinity is lower,
termed the tense (T) state, and another where the substrate affinity is higher, termed
the relaxed (R) state. A key assumption of the MWC formalism is that, at any given
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time point, all enzyme protomers are in the same form, i.e. either all protomers are in
the R state or in the T state. The mechanism proposed in [9] defines an extra catalytic
track per allosteric site in the enzyme, where a catalytic track is the minimal set of
elementary reactions that converts substrates into products in a given reaction. For
instance, if the enzyme has four allosteric sites, there will be one catalytic track with
one effector bound, another with two effectors bound, and so on. If the effector is
an inhibitor, upon binding the enzyme transitions into the T state and it is assumed
that the reaction cannot proceed. See Figure 6.1 for a detailed description. This
mechanism does not reproduce sigmoidal kinetics though.
𝒓𝑷𝑭𝑲: 𝑨𝑻𝑷 + 𝑭𝟔𝑷 ⇌ 𝑨𝑫𝑷 + 𝑭𝟏𝟔𝒃𝑷
𝑃𝐹𝐾0 + 𝐴𝐷𝑃 ⇌ 𝑃𝐹𝐾1 𝑃𝐹𝐾0 + 𝑃𝐸𝑃 ⇌ 𝑃𝐹𝐾1
𝑃𝐹𝐾1 + 𝐴𝐷𝑃 ⇌ 𝑃𝐹𝐾2 𝑃𝐹𝐾1 + 𝑃𝐸𝑃 ⇌ 𝑃𝐹𝐾2
𝑃𝐹𝐾2 + 𝐴𝐷𝑃 ⇌ 𝑃𝐹𝐾3 𝑃𝐹𝐾2 + 𝑃𝐸𝑃 ⇌ 𝑃𝐹𝐾3
𝑃𝐹𝐾3 + 𝐴𝐷𝑃 ⇌ 𝑃𝐹𝐾4 𝑃𝐹𝐾3 + 𝑃𝐸𝑃 ⇌ 𝑃𝐹𝐾4
𝑃𝐹𝐾0 ⇌ 𝑃𝐹𝐾0
𝑃𝐹𝐾𝑖 + 𝐴𝑇𝑃 ⇌ 𝑃𝐹𝐾𝑖&𝐴𝑇𝑃
𝑃𝐹𝐾𝑖&𝐴𝑇𝑃 + 𝐹6𝑃 ⇌ 𝑃𝐹𝐾𝑖&𝐴𝑇𝑃&𝐹6𝑃
𝑃𝐹𝐾𝑖&𝐴𝑇𝑃&𝐹6𝑃 ⇌ 𝑃𝐹𝐾𝑖&𝐴𝐷𝑃&𝐹16𝑏𝑃
𝑃𝐹𝐾𝑖&𝐴𝐷𝑃&𝐹16𝑏𝑃 ⇌ 𝑃𝐹𝐾𝑖&𝐴𝐷𝑃 + 𝐹16𝑏𝑃
𝑃𝐹𝐾𝑖&𝐴𝐷𝑃 ⇌ 𝑃𝐹𝐾𝑖 + 𝐴𝐷𝑃
A B
C
D
Figure 6.1: Original mechanism for allosteric enzymes, here exemplified for PFK.
ADP is an activator, PEP is an inhibitor. Green stands for the R state of the enzyme,
while red stands for the T state of the enzyme. The subscript i in PFKistands for
the number of effector molecules bound to the enzyme. (A) Specifies all reactions for
activator binding/release; (B) specifies all the reactions for inhibitor binding/release;
(C) specifies the spontaneous transition reaction between the R and T state; and (D)
specifies all catalytic reactions, where substrates bind to the enzyme R state and are
converted into products which are then released. When the enzyme is in the T state
no catalytic reactions occur.
A key assumption in this mechanism is that all enzyme protomers have a similar
behavior, which is not necessarily true. A more general, and possibly more accu-
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rate, mechanism is presented in [10], where all enzyme protomers are modeled and
all possible combinations of substrate/effector binding and product/effector release
are considered. However, this mechanism results in more elementary reactions and
respective rate laws than MASSef, and in particular Mathematicar, can handle to
generate the flux equations. Hence, we need to come up with a reasonable approxi-
mated mechanism to model sigmoidal kinetics. The reason we do not simply use the
generalized generalized MWC expression used in [7, 10] is that it does not distinguish
free and total metabolite concentrations.
In the future we will try an approach similar to the one in [13], where the flux
equation is divided into a catalytic and a regulatory part:
v = fcatalytic · fregulatory
where
fcatalytic = n · f(xM ,kR)
and f(xM ,kR) is generated from the enzyme mechanism following the usual work-
flow for a single protomer, n is the number of enzyme protomers, xM represents the
reaction’s substrates and products, and kR represents the kinetic parameters when
the enzyme is in the R form. The regulatory part will be based on the generalized
MWC model [11], which has the general form
fregulatory =
1 + (fT (xM ,kT )/fR(xM ,kR)) ·Q(L,xM ,xE,kR,kT ,kE)
1 +Q(L,xM ,xE,kR,kT ,kE)
where xE represents the enzyme effectors, kT represents the kinetic parameters
when the enzyme is in the T form, kE represents the kinetic parameters for the effec-
tors, L is the allosteric constant that represents the ratio of the enzyme concentration
in the T form and the R form, and Q is the function that describes the transition
between the R and T conformations and vice-versa. The idea would be to define fT ,
fR and Q using the workflow in MASSef, where fT and fR can already be generated
in a straightforward way, the challenge lying in the Q function.
Other features that will be soon implemented in MASSef are: 1) the simulation
of data to be fitted for enzyme activation based on [4](section 6.7), when activation
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constants are available; 2) the automatic addition of the relevant elementary reac-
tion for substrate inhibition and data simulation based on [4](section 6.9.2); 3) the
correction for chemical activities using a Debye-Huckel model.
In Chapter 3, we used the enzyme-level kinetic models built through MASSef
to build a prototype system-level model ensemble consisting of eight reactions in E.
coli’s glycolysis. We took two different approaches to build the system-level model,
which we named eMASS and eMASS2. In both approaches we drop the assumption
xfree ≈ xtot. Following eMASS we first build fully functional enzyme-level models by
integrating fluxomics and metabolomics data with each enzyme-level model individu-
ally, and only then define the system-level model as the union of all enzyme-level mod-
els. With eMASS2, we take the steady-state flux equations derived for each enzymatic
reaction, define a constraint on metabolite conservation xtot,i =
∑
j xbound,i,j + xfree,i
for each metabolite i, and globally sample total enzyme and free metabolite concen-
trations that fit the fluxomics and metabolomics data. With both approaches we
verified that xfree ≈ xtot does not always hold, as in some models the concentration
of e.g. free PEP was only 60% of the respective total concentration. Comparing both
approaches, eMASS2 is a more correct way to build a kinetic model as the total en-
zyme concentrations are calculated based on free metabolite concentrations which are
fitted globally. Besides, eMASS2 model simulations can be initialized with steady-
state conditions and indeed be at steady-state at t = 0 s, unlike eMASS. Furthermore
models built through eMASS2 lead to more reasonable predictions of total enzyme
concentrations.
The fact that eMASS2 tends to overestimate total enzyme concentrations might
be because the model encompasses only a tiny fraction of E. coli’s metabolism. This
most likely results in overestimated predictions of free metabolite concentrations,
which, in turn, can lead to overestimation of total enzyme concentrations, as these
depend on free metabolite concentrations. However, the expansion of the prototype
model ensemble generated through eMASS2 is dependent on MASSef’s ability to
model allosteric enzymes. Yet, there will be some technical challenges associated
with expanding eMASS/eMASS2. Using eMASS2 will mean longer running times to
globally fit the free metabolite and total enzyme concentrations. Currently, with 6561
models it takes ≈ 3 hours running in parallel on 122 CPU cores (Intel Xeon Processor
E5-2680 v2 – 10 cores, 2.80GHz, 25MB L3 Cache, 128GB RAM).
However, once eMASS/eMASS2 can be used to model, e.g. the central carbon
metabolism of E. coli, these approaches should lead to more accurate predictions.
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This would be particularly useful to design new strains for biotechnological applica-
tions.
Finally, it would be interesting to assess the impact of integrating xfree vs. xtot in
models based on Michaelis-Menten or convenience kinetics rate laws. What would be
the effect in model predictions? Given the results presented in [6] and our own pre-
liminary results, the impact might not be critical for most metabolites. However, for
metabolites with lower concentrations, such as NADH it might be enough to improve
predictions. In [6] the authors hypothesize the difference in NADH concentration
prediction vs. measured to be precisely because the model predicts free metabolite
while total metabolite is the measured quantity.
In Chapter 4, we tackled the consistent lack of data that has been plaguing ki-
netic models throughout the years. Using molecular dynamics methods, we estimated
the difference in binding energies, ∆∆G, between the reaction’s product(s) and sub-
strate(s), and integrated this ∆∆G with the respective enzyme-level kinetic model.
Here, we found metalloenzymes to be challenging, Still, we showed that, in terms
of the number of elementary rate constant combinations allowed in each model en-
semble, it can be as constraining as any other parameter. However, the impact of
including this ∆∆G at the system-level remains to be assessed. This will be part
of future work, as both GAPD and ENO are already part of the model prototypes
generated through eMASS/eMASS2. In particular, it would be interesting to assess
the impact of integrating ∆∆G in different enzyme models in a given pathway.
The general workflow developed in this project can be applied to any kinetic
model that decomposes each reaction into elementary steps. Hence, providing a
promising option to parameterize kinetic models and mitigate the lack of kinetic
data. Furthermore, the same approach can be applied to include the effect of enzyme
mutations in kinetic models.
In Chapter 5, we used a published kinetic model for the glycolysis pathway in Sac-
charomyces cerevisiae [14] to study the cellular response measured by hyperpolarized
NMR spectroscopy to: a) a glucose pulse, b) a glucose + acetaldehyde pulse, and c)
a glucose + ethanol pulse. The model predictions were in agreement with the exper-
imental results, and confirmed that the observed bottlenecks were due to a change
in the NAD+/NADH ratio, a result which is also consistent with the literature, thus
showing a practical application of a kinetic model. We also tried earlier to reproduce
these results using earlier models of S. cerevisiae glycolysis [15, 12], however, these
were not as successful. Thus emphasizing the importance of measuring the kinetic
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parameters each enzyme in standard conditions and modeling substrate-level enzyme
regulation.
Future work on analyzing hyperpolarized NMR spectroscopy data
In this project, an initial attempt was made to fit the kinetic model for glycolysis in
Saccharomyces cerevisiae to the measured time-course data. Yet, after several failed
attempts and a more careful analysis, we realized a new approach was needed. Since
the cells grow on unlabeled glucose until the starvation period of 20 min and are fed
labeled glucose only after this starvation period, to successfully model the cellular
response to a labeled glucose pulse the model would need to take into account both
labeled and unlabeled metabolites. This is because only labeled metabolites can
be measured, but unlabeled metabolites also contribute to the system’s observable
dynamics. Furthermore, after some time the labeled metabolites decay into unlabeled
metabolites, a behavior that also needs to be modeled.
Two approaches can, in principle, be taken towards modeling both labeled and
unlabeled metabolites in the cell. One approach would be to simply use eMASS2
to build a model considering two versions of each metabolite, a labeled version and
an unlabeled version. We would assume that, in a two substrates and two products
reaction, both substrates may be either labeled or unlabeled or one substrate may
be labeled and the other unlabeled, and likewise for products. We would assume
cofactors to be unlabeled. Another, approximate, approach would be to use the
original model’s rate laws. Here we would again consider both a labeled and an
unlabeled version of each metabolite, except for cofactors, and assume two types of
reactions: rl, involving only labeled metabolites, and ru, involving only unlabeled
metabolites. These reactions would need to be coupled such that
Vmax ≥ vl + vu
where vl represents the flux through the reaction that involves only labeled metabo-
lites, and vu represents the flux through the reaction that involves only unlabeled
metabolites. Since
Vmax ∝ [Etotal]
we assume
vl ∝ α[Etotal]
vu ∝ β[Etotal]
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where α = [El]/[Etotal] and [El] is the enzyme concentration bound to labeled metabo-
lites, β = [El]/[Etotal] and [Eu] is the enzyme concentration bound to unlabeled
metabolites. Finally,
[Etotal] = [El] + [Eu] + [Efree]
= α[Etotal] + β[El] + γ[Eu]
where γ = [Efree]/[Etotal]. An approximate form for α and β could, in principle,
be found by modeling the same system with MASSef but considering only two cat-
alytic tracks, one involving only labeled metabolites and the other only unlabeled
metabolites.
While the first approach is, in principle, easier to implement and should lead to
more accurate results, the second might turn out to be more practical, even though
find a form for α and β might prove challenging.
Overall the integration of computational models and experimental data is a pow-
erful way to study biological processes. In an iterative cycle, experiments provide data
to build computational models, which are then used to make predictions to be tested
experimentally. Mismatches between predictions and experimental results often lead
to new knowledge and improved models. Kinetic models are key to understand the
metabolism inherent dynamics. These models have been applied not only in strain
design for biotechnological applications [1, 8], but also to build personalized models
and identify individuals susceptible to drug side effects [3], as well as to find poten-
tial drug targets [5]. Briefly, two main approaches have been taken to build kinetic
models: bottom-up, relying on enzyme kinetic parameters, and top-down, relying
mostly on omics data. Both approaches have their strengths and weaknesses and,
to some extent, kinetics models end up being a combination of both. Yet, a general
lack of data has been a major bottleneck to build kinetic models. Here, we developed
a new workflow to build mechanistic kinetic models that bridges both bottom-up
and top-down approaches: we use historically measured enzyme-level data to build
a model ensemble which is then constrained by integrating recently measured omics
data, potentially leading to more accurate models. We further addressed data scarcity
by developing a workflow to use molecular dynamics to parameterize kinetic models.
The same workflow can be applied to model enzyme mutations and be used to study
disease.
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